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SUMMARY 
Endogenous electric ﬁelds (EFs) are present during a variety of physiologic and 
pathologic events, including penetrating injury to epithelial barriers. An applied 
electric ﬁeld with strength within the physiologic range can induce directional cell 
migration of epithelial cells, endothelial cells, ﬁbroblasts, and immune cells 
suggesting a potential role in controlling cell behaviours during wound healing. 
Dendritic cells (DCs) and dermal fibroblasts were used to explore the molecular 
mechanisms underlie EF-induced cell activities during two aspects of wound healing: 
immune response and remodelling. 
In this study, we investigated the effects of applied EFs on several types of DCs in 
response to IL18. DC progenitor cells KG-1 shows dose dependently response to EFs 
stimulation to increase IFN-γ expression. Moreover, the migration of KG-1-derived 
DCs and Langerhans cells (LCs) in mouse skin showed increased response to IL18 
with directional migration when exposed to EFs in vitro and ex vivo. Furthermore, the 
in vivo investigation suggested that pharmacologically increased trans-epithelial 
potential difference (TEPD) induced LCs to emigrate from skin to draining lymph 
node. The sensitization of DCs to IL18 can be strengthened by EFs through 
redistribution of IL18 receptors and phosphorylation of p38 MAPK.  
We also comparatively studied the responses of human chronic wound 
fibroblast (CWF) and chronic matched fibroblast (CMF) to applied EFs with addition 
of platelet derived growth factor (PDGF). The results indicate that 1) EFs induce 
human dermal fibroblast directional migration in a voltage dependent manner. 2) 
CWF shows impaired sensitivity in response to EFs compared to CMF and HF. 3) 
Activation of PDGFR and PI3K are both required for EF-induced directional 
migration. 4) PDGF attenuates EF-induced migration directedness through PDGFR-
ROCK other than PI3K pathway. 5) Optimised concentration of PDGF plus 
physiological EFs enhance chronic wound healing. 
We propose that the EF-induced re-distribution of the receptors on the cell surface 
results in a shift of membrane receptors between the cathode-facing and the anode-
facing membrane of the cell. There would be a higher probability to overcome the 
threshold of signal transduction at the higher density receptor side. The downstream 
IV 
 
signalling cascade therefore can be ignited. Understanding the signalling pathways 
underlying guidance cues (EFs, cytokines, chemokines) will help to optimise future 
therapies for immunomodulation, vaccination, wound healing and regeneration. 
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CHAPTER 1 INTRODUCTION 
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1.1 The concept of human skin 
1.1.1 The construction of skin 
Human skin is the largest organ of the body and is composed of two parts: a 
stratified, cellular epidermis and an underlying dermis of connective tissue (Figure 
1-1).  
The epidermis is mainly composed of keratinocytes and can roughly be divided 
into four layers; from the exterior inwards these are: stratum corneum, granular layer, 
spinous layer and basal layer. The specific proteins of keratinocytes, keratin and 
filaggrin, build the structure of the epidermis and contribute about 80-90% of the 
mass of the epidermis.  
The other cells of epidermis are melanocytes, Langerhans cells and Merkel cells. 
Melanocytes are differentiated from neural crest cells and are responsible primarily 
for skin colour by secreting the pigment protein melanin. The Langerhans cells are 
professional antigen-presenting cells and process antigens encountered by the skin to 
local lymph nodes. They are of mesenchymal origin and originate from bone marrow. 
Merkel cells are probably derived from keratinocytes and are somatosensory receptor 
cells which respond to touch. 
The epidermis is attached to the dermis via a complex network consisting of 
protein and glycoprotein. The epidermis-dermis connection is vitally important due to 
the roles it plays in cellular communication, nutrient exchange, absorption and other 
functions. In less than 200 μm of connecting area there are over 30 different 
macromolecules (collagens, laminins, integrins) which interact within the membrane 
zone. 
The dermis is made up mainly of elastic fibres and collagen floating in a 
polysaccharide and protein network. In contrast to the epidermis, it is vascularised, 
enabling it to not only provide energy and nutrition to the epidermis but also play a 
pivotal role in thermoregulation and wound healing. The major types of cells in the 
dermis are fibroblasts, macrophages and adipocytes.  
Fibroblasts mainly produce and organize the extracellular matrix and also express 
cytokines (e.g. FGF) to communicate with other cells residing in the skin. In addition, 
fibroblasts are the main force of contraction during wound healing.   
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Macrophages have their effective function during the wound healing by 
coordinating the healing process. Their functional phenotype is dependent on the 
wound microenvironment. During the early and short inflammatory phase 
macrophages exert pro-inflammatory functions like antigen-presenting, and the 
production of inflammatory cytokines and growth factors that facilitate the wound 
healing process; during the proliferative phase, macrophages stimulate proliferation of 
connective, endothelial and epithelial tissue directly and indirectly. 
Adipocytes make up the subcutaneous fat which is an active part of the endocrine 
system, secreting the hormones leptin and resistin.  
The interaction between different kinds of cells, structures, cytokines, growth 
factors and other large and small molecules in the skin is an extremely complex, and 
largely unknown part of the physiology and pathology of human skin. 
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Figure 1-1 The skin and its appendages 
The schematic illustrates the structure of the skin (Rook and Burns, 2010). The skin is 
composed of two layers: epidermis and dermis. The epidermis can be divided into 4 
layers: stratum corneum granular layer, spinous layer, basal layer and basement 
membrane. The dermis consists of connective tissues and is divided into two layers: 
papillary region and reticular dermis. 
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1.1.2 The function of skin 
The key role of the skin is to provide a barrier to the external environment, keeping 
certain elements either in or out of the body (e.g. keeping water in and bacteria out), 
whilst also acting as channel for environmental stimuli and for keeping the body in 
balance (e.g. thermoregulation).  
Water is the most important factor for all cell activity, and the cornified cell 
envelope and the stratum corneum prevent water loss through the skin. In the 
epidermis, there also are about 2×10
9
 Langerhans cells, which serve as sentinel cells 
whose primary function is to survey the epidermal environment and to initiate an 
immune response against microbial threats. 
Another important function of skin is thermoregulation. The networks of blood 
vessels in the deep or superficial plexuses help regulate heat loss through 
vasodilatation and vasoconstriction, and eccrine sweat glands excrete sweat to lower 
body temperature via evaporation. 
Subcutaneous fat has two main functions: trauma cushioning and calorie as 
reserves. In non-obese subjects, about 80% of the body’s total fat is found in 
subcutaneous tissue. Fat also has an endocrine function to regulate hunger and energy 
metabolism. 
1.2 The process of wound healing 
Wound healing is a complex and precisely controlled process where various 
intracellular and extracellular pathways are activated and coordinated to restore tissue 
integrity and homeostasis. Wound healing involves a complex interaction between 
epithelial and dermal cells, the extracellular matrix, and controlled angiogenesis and 
plasma derived proteins, which are coordinated by endogenous and exogenous stimuli. 
This dynamic process has been divided into three separate phases: inflammation, 
proliferation and maturation/remodelling (Harding et al., 2002). These different 
phases are not distinguished temporally as they overlap in time and therefore are 
distinguished by their separate functions. The entire process is summarised below in 
Figure 1-2. 
When tissue is first wounded, blood comes in contact with collagen, triggering 
blood platelets to begin secreting inflammatory factors; this is the start of the 
6 
 
inflammatory phase. Platelets also express glycoproteins on their cell membranes that 
allow them to stick to one another and to aggregate, forming a mass (Midwood et al., 
2004). Fibrin and fibronectin cross-link together and form a plug that traps proteins 
and particles and prevents further blood loss (Sandeman et al., 2000). Additionally, 
these activated platelets release a number of cytokines and growth factors which 
activate an inflammatory response (Werner and Grose, 2003). Neutrophils and 
macrophages respond to these chemicals by migrating to the wound site. Once there, 
they actively cleanse the wound of debris and bacteria by phagocytosis (Deodhar and 
Rana, 1997). Macrophages also secrete a number of growth factors and other 
cytokines, which attract cells involved in the proliferation stage of healing to the area 
(Werner and Grose, 2003). 
The beginning steps of proliferation are the migration of keratinocytes over the 
damaged dermis and the formation of new blood vessels. Angiogenesis increases the 
supply of oxygen and nutrients to the wound site, meeting the metabolic requirements 
of cells that are involved in wound repair. The sprouts of capillaries associated with 
fibroblasts and macrophages forms a new substrate for keratinocytes migration at later 
stages of repair process. The keratinocytes are behind the leading edge proliferate and 
mature and, finally, restore the barrier function of epithelium. Simultaneously with 
angiogenesis, fibroblasts begin accumulating in the wound site. Later, they become 
the main cell type that lays down the collagen matrix in the wound site (Stadelmann et 
al., 1998). Some parts of fibroblasts differentiate into myofibroblast which contract 
around cells that bring the edges of wound together and form granulation tissue which 
actually begins to appear in the wound already during the inflammatory phase, and 
continues growing until the wound bed is covered. 
The third stage is remodelling which normally lasts for a bit more time than the 
first two stages. During this stage all the process activated before gradually slow 
down and cease. Most of the macrophages, endothelial cells and myofibroblast move 
away from the wound or undergo apoptosis. The structure change of matrix from type 
III collagen to Type I is prevail at proliferation stage (Lovvorn et al., 1999). 
Metalloproteinases secreted by fibroblast, macrophages and endothelial cells is the 
main force of this process. This process strengths the repair tissue but the tissue never 
regains the properties of uninjured skin (Gurtner et al., 2008). 
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Figure 1-2 Phases of Wound Healing 
There are three classic stages of wound healing: inflammation (A), new tissue 
formation (B) and remodelling (C) (Gurtner et al., 2008). A. Inflammation. This stage 
starts immediately after injury and lasts about 2 days. The wound is characterised by a 
hypoxic environment in which a fibrin clot has formed. Bacteria, neutrophil and 
platelet appear in the wound. B. New tissue formation. This stage starts about 2days 
after injury and lasts one to two weeks. An eschar has formed on the surface of the 
wound; the new blood vessels populate the area. The immune cells start to migrate out 
from the skin and epithelia cells start to migrate into the wound. C. Remodelling. This 
stage lasts for a year or longer. Disorganized collagen has been laid down by 
fibroblasts that have migrated into the wound. The wound has contracted and the re-
epithelialized wound is slightly higher than the surrounding surface. 
1.3 The inflammatory response 
The inflammatory response is the first of a number of events that constitute wound 
healing and commences almost immediately after wounding. In skin repair, it begins 
with the passive leakage of circulating leukocytes (largely neutrophils) from damaged 
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blood vessels. They have multiple functions, not only defending against invading 
pathogens but also playing roles in tissue degradation and tissue formation. As such, 
the infiltration of leukocytes migrating into wound site may have profound effects on 
downstream cell migration, proliferation, differentiation, and ultimately the quality of 
healing process (Eming et al., 2007). The other types of immune cells which are 
already resident within the tissue such as mast cells, γδ T cells and Langerhans cells 
also become activated and in turn release a rapid pulse of chemokines and cytokines. 
Those cytokines, together with foreign epitopes such as lipopolysaccharides (LPS), 
actively recruit neutrophils and macrophages from nearby blood vessels into the 
wound site. Together, these activities promote local endothelial cell expression of 
selectins which induce leukocyte rolling and crossing of the endothelial barrier. This 
is enhanced by vessel dilation, which in turn is triggered by inflammation- associated 
nitric oxide, mast cell- derived histamine, tissue plasminogen activator and other 
factors (Shaw and Martin, 2009). 
 
 
 
The inflammatory response to wounding starts immediately with the leakage of 
circulating leukocytes. The resident immune cells also are activated and release a 
rapid pulse of cytokines and chemokines. Thus the neutrophils and macrophages are 
attracted by chemotaxis and migrate into wound bed (Shaw and Martin, 2009).  
 
 
Figure 1-3 Inflammatory response of skin wound 
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1.4 The role of immune cells 
In various experimental animal and human skin wounding models it has been 
demonstrated that the leukocyte subsets orchestrate the process spatially and 
temporally. The understanding of the interactions between the cells and well-defined 
chronology of the process is essential for artificial promotion of optimal wound repair. 
1.4.1 Neutrophil 
Neutrophils are immediately activated and recruited to a wound site by chemo-
attractant released from coagulation of the blood clot. Within a few hours after injury, 
the wound-released cytokines such as IL-1β, tumour necrosis factor-α (TNF-α) and 
interferon-γ (IFN-γ) trigger the activity of neutrophils and induce them to 
transmigrate across the endothelial cell wall of blood capillaries. In addition, those 
cytokines increase neutrophil expression of adhesion molecules, including endothelial 
P- and E-selectins and ICAM-1,-2. The adhesion molecules are crucial for neutrophil 
diapedesis because they interact with integrins present at the neutrophil cell surface 
and induce cell morphology transformation (Eming et al., 2007). The main function of 
neutrophils is to cleanse the wound site and kill invading microorganisms through 
several stratiges, including the release of proteolytic enzymes and bursts of reactive 
oxygen species (ROS) (Dovi et al., 2004; Shaw and Martin, 2009). Other studies 
suggest that these cells also influence many other aspects of repair, such as resolution 
of the fibrin clot and provisional ECM, promotion of angiogenesis, and re-
epithelialisation (Kim et al., 2008; Li et al., 2003b; Theilgaard-Monch et al., 2004). 
1.4.2 Monocyte 
Monocytes appear at the wound site from the circulation soon after neutrophils and 
their numbers peak at a day or so after injury (Shaw and Martin, 2009). The 
immigration of monocytes into the wound is regulated by the interaction of late 
antigen-4 (α4β1 integrin) and endothelial vascular cell adhesion molecule-1 (Eming et 
al., 2007). These cells mature into macrophages due to stimuli in the wound 
environment such as growth factors, cytokines and MCP-1. Thus their function can be 
separated into two phases during the wound healing process according to the 
concentration gradient of various chemotactic factors. In the earlier phase the 
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monocytes are recruited and play a major role in phagocytosis and clearance of 
infection (M1 pro-inflammatory). In the later phase, the monocytes mainly take part 
in repair and angiogenesis (M2 anti-inflammatory and pro-angiogenesis). These 
transformations imply major changes in the active phenotype of macrophages caused 
by significant alterations in gene expression. The membrane receptors of 
macrophages are thought to sense environmental change and therefore direct the 
transformation. Those receptors include Toll-like receptor, complement receptor and 
Fc receptor; however, the details of mutual interplay and the mechanisms of 
interaction between receptors and outside stimuli still remain unclear. In addition to 
their immunological function as phagocytes, macrophages possess other functions to 
facilitate wound repair by the synthesis of numerous potent growth factors, including 
TGF-β, TGF-α, basic fibroblast growth factor, platelet-derived growth factor and 
vascular endothelial growth factor, which promote cell proliferation and the synthesis 
of extracellular matrix molecules by resident skin cells (Eming et al., 2007; Lai et al., 
2009). 
1.4.3 Mast cell 
Mast cells arise from pluripotent hematopoietic progenitor cells present in bone 
marrow, and these progenitor cells are delivered to various tissues where they reside 
and terminally differentiate. Over the years, mast cells have been shown to be an 
important source of a variety of proinflammatory mediators and cytokines (Aller et al., 
2007; Bienenstock et al., 1987). Thus it has been widely accepted that they play an 
important role not only in wound repair but also in autoimmune disorders such as 
arthritis. In the immune response, mast cells release ROS and reactive nitrogen oxide 
species (RNOS), both of which are used at high levels to kill phagocytosed organisms. 
Low levels RNOS may diffuse outside cells to impact the vascular and nervous 
system. However, some studies of mast cell deficient mice have shown contradictory 
results concerning their function. Egozi reported that mast cell deficiency had no 
significant effect on epithelialisation, collagen synthesis or angiogenesis, but resulted 
in decreased number of neutrophils at a wound site (Egozi et al., 2003), this has been 
challenged by a report that mast cell deficiency led to a significant reduction in 
vascular permeability, neutrophil influx and wound closure (Eming et al., 2007). 
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However, further investigations are needed to better understand the impact of mast 
cells on the wound healing process. 
1.4.4 γδ T cells 
The γδ T cells are a unique T cell population resident in the epidermis. They arise 
from foetal thymic precursor cells and express a canonical γδ T cell receptor (TCR). 
These cells have a dendritic morphology and are strictly limited in their distribution to 
the epidermis, where they are thought to play an important role in mediating wound 
healing. Upon wounding, they recognize an unknown antigen expressed by damaged 
keratinocytes and then produce epithelial growth factors and inflammatory cytokines. 
The study on γδ T cell-deficient mice reveals that the deficiency of γδ T led to 
delayed wound healing (Eming et al., 2007). Similar findings in the clinic revealed 
that γδ T cells from patients with healing wounds were activated and secreting growth 
factors, and conversely, γδ T cells had an impaired response in non-healing patients 
(Havran and Jameson, 2010). In addition, this population of T cells has recently been 
shown to participate in EMC deposition and macrophage infiltration. Taken together, 
these results demonstrate a novel function of γδ T cells and provide a new perspective 
of T cells on skin wound healing. 
Table 1-1 Inflammatory cells, their functions and mediators (Eming et al., 2007) 
Cell type Funciton mediators 
PMN 
Phagocytosis of infectious 
agent ROS, cationic peptides, proteases 
 
Macrophage activation 
through phagocytosis  
 
Amplify inflammatory 
response TNF-alpha, IL-1beta, and IL-6 
 Stimulate repair response  
Macrophages 
Phagocytosis of PMN and 
fragments of 
tissuedegradation  
 
Amplify inflammatory 
response TNF-alpha, IL-1beta, and IL-6 
 Anti-inflammatory function IL-10, TGF-beta1 
 
Stimulate repair response: 
angiogenesis, fibroplasia  
 fibrolysis t-PA, uPA, u-PAR, and PAI-1/-2 
monocytes Control vascular Histamine 
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permeability 
 control influx of PMN Chymase, tryptase 
 regulate tissue remodelling  
T cell; Th1/Th2 regulate tissue remodelling Cd40l ligand; IL-2, TNF-alpha/IL-4,-5,-10 
γδT cells 
Keratinocyte proliferation, 
differentiation, hyaluronan 
synthesis in Keratinocytes FGF-7, -10 and IGF-1 
bGFG, basic fibroblast growth factor; FGF, fibroblast growth factor;PDGF, platelet-
derived groth factor; PMN, polymorphonuclear leukocyte; ROS, reactive oxygen 
species; TGF, transforming growth factor; TNF, tumor necrosis factor, uPA, 
urokinase-type plasminogen activator; VEGF, vascular endothelial growth factor 
1.5 The roles of growth factors 
Platelet-derived growth factor (PDGF) is a major mitogen for a number of different 
cells, including fibroblasts and vascular smooth muscle cells. It has a crucial role in 
development and is involved in the initiation of wound healing events. The main 
cellular effects of PDGF are to promote growth and reorganisation of the actin 
cytoskeleton, initiate chemotaxis, and prevent apoptosis.  
The main signal transducers that bind to activated PDGF receptors include 
phosphatidylinositol 3’-kinase (PI3K), phospholipase C-γ, tyrosine phosphatase SHP-
2 and activating proteins for the Rho family of small GTPases. PI3K is able to interact 
with a number of different downstream effectors to promote actin reorganisation, 
chemotaxis, growth and protection against apoptosis. Phospholipase C-γ induces 
mobilisation of intracellular calcium stores and contributes to proliferation and 
motility of some cell types. Dephosphorylation of tyrosine residues by PDGF-
activated SHP-2 serves as a negative feedback mechanism of receptor activation. The 
mitogen-activated protein kinase (MAPK) cascade can be initiated by a number of 
PDGFR signal transducers to result in the transcription of genes that are required for 
cell proliferation, differentiation and migration (Andrae et al., 2008). There is a 
significant degree of cross-talk between the different transduction mechanisms which 
can help to amplify signals. For example, PI3K products can serve to increase 
phospholipase C-γ activity. 
Hepatocyte growth factor (HGF), through binding to its receptor (Met), exerts 
important function in re-epithelialization. Met gene knockdown mice showed strongly 
delayed re-epithelialization in response to skin wounding (Chmielowiec et al., 2007). 
Though it was thought that other growth factors are involved in this process, it is clear 
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that they cannot compensate for the absence of HGF signalling. HGF/c-Met trans-
activates epidermal growth factor receptor (EGFR) and then enhances activation of 
downstream kinases PI3K and ERK. The cross-talk between EFGF and HGF/c-Met 
may play a key role in regulating retinal pigment epithelial cell migration, 
proliferation, and wound healing (Xu and Yu, 2007). Mesenchymal stem cells can 
enhance the quality of wound healing, and may generate de novo intact skin. It has 
been reported that HGF can induce human MSC migration and plays an important 
role in hMSC recruitment to wound site (Neuss et al., 2004). 
Ligands for the Шb variant of FGF receptor 2 (FGFR2- Шb), in particular, 
contribute to wound repair. This was shown in a transgenic mouse experiment in 
which keratinocytes expressing a dominant-negative mutant of FGFR2- Шb showed a 
strong inactivation in re-epithelialization. The mutant receptor binds to FGF but 
cannot transduce the signal (Werner et al., 1994). FGF7 and FGF 10 are likely to be 
the most efficient FGFR2- Шb ligands (Braun et al., 2004). The mice that lack 
dendritic epidermal T cells, which are a potent source of FGF7 and FGF10, show 
decreased keratinocyte proliferation and wound closure after injury (Jameson et al., 
2002).   
Epidermal growth factor (EGF) is believed to play an important role in normal 
wound healing in tissues such as skin, cornea and gastrointestinal tract. In addition 
heparin-binding EGF has been shown to have a functional role in keratinocyte 
migration and accelerates wound healing (Shirakata et al., 2005).Those positive re-
epithelialization growth factors such as FGFs, HGFs and EGFs are ligands of receptor 
tyrosine kinase, the activation of which will stimulate fibroblast and keratinocyte 
migration and proliferation and lead to wound closure. Some of those processes are 
mediated by Signal Transducer and Activator of Transcription 3 (STAT3) which 
responds to a number of growth factors and cytokines. STAT3 is phosphorylated by 
receptor associated kinases and then forms homo- or heterodimers that translocate 
into the cell nucleus, where they stimulate gene expression. Another transcription 
activator, Activator Protein 1 (AP1), is thought to play a similar role to STAT3 in 
response to cytokines and increases wound closure (Li et al., 2003a). 
In contrast to these mitogenic growth factors, TGF- is a negative regulator of re-
epithelialization. It was demonstrated that loss of TGF- signalling leads to an 
accelerated re-epithelialization and an increased proliferation of keratinocytes at the 
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wound edge (Amendt et al., 2002). This finding is supported by studies in mice 
lacking transcriptional regulator SMAD3, one of the main targets of TGF- mediated 
signalling. Smad3 null mice show accelerated cutaneous wound healing, characterized 
by an increased rate of re-epithelialization (Ashcroft et al., 1999).  
1.6 Chronic wounds 
Chronic wounds are a major global health problem resulting not only in distress 
and disability to patients but also enormous economic burden to health care providers 
(Nwomeh et al., 1998). Chronic wounds encompass a spectrum of disease and can be 
divided into three main forms: chronic venous leg ulcers, pressure ulcers, and diabetic 
ulcers. Generally, the normal wound healing responses described above are altered in 
chronic wounds, with prolonged inflammation, a defective cell activity and a failure 
of response to cytokines. 
1.6.1 Growth factors in chronic wounds 
Growth factors are soluble signalling proteins and play essential roles in mediating 
the process of normal wound healing. Thus the defective function of growth factors 
always leads to chronic wounds. It has been demonstrated that there is no active 
PDGF-BB in chronic wound fluid (Castronuovo et al., 1998); and decreased 
expression of TGF-β in chronic wound fibroblast (Cha et al., 2008a). In addition, EGF 
and TGF-β were reported to increase fibroblast migration in a chronic wound model 
in vitro (Cooper et al., 1994). Moreover, topical treatment with basic fibroblast 
growth factor has been showed to effectively heal the chronic cutaneous wounds (Fu 
et al., 2002).  
1.6.2 Skin cells in chronic wounds 
The properties of skin cells have been altered by the microenvironment of chronic 
wound. It has been reported that keratinocytes at the chronic ulcer edge are highly 
proliferative and have an activated phenotype (K16), but show a reduced expression 
of LM-3A32 – a key molecule present on migrating epithelium (Usui et al., 2008). 
Additionally, the fibroblasts from chronic wound showed slow proliferation, impaired 
response to TGF-β stimulation and collagen disposal capacity (Cha et al., 2008a; 
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Loots et al., 1999; Stephens et al., 2003). The dysfunction of leukocytes cells was also 
reported to contribute to chronic wounds (De Ugarte et al., 2002). 
1.6.3 The perspective of chronic wound treatment  
PDGF-BB shows promise in the treatment of complex wounds with exposed 
tendon or fascia, but there are still several clinical studies that could not replicate the 
result (De Ugarte et al., 2002). It has been suggested that the treatment of complex 
intractable wounds requires consideration of growth factors in combination with 
adjunctive modalities (Martin, 1997). Adjunctive modalities, including electrical 
stimulation, hyper baric oxygen, immunomodulatory reagents may enhance the 
wound healing efficiency (Goldman, 2004). 
1.7 Bioelectric signals in biology 
In addition to biological factors there are several physical ones; for example 
electrical signals are also found to regulate wound healing. The detail of how 
electrical signals control cell behaviour in wound repair will be discussed below in 
section 1.8. 
The first definitive evidence for electric signals being involved in biological 
activity was discovered by Galvani in the 1790s. His fundamental work proved that it 
is electricity that causes frog leg muscle to twitch. Evidence has accumulated in 
nearly every aspect of bioelectrical study with major developments in this field over 
the last hundred years. Through the 1920s and 1930s Lund found the polarity of cells 
was somehow controlled by the bioelectric polarity of ion flows in vivo. In the 1930s 
and 1940s, Burr discovered that the there was a correlation between the voltage 
gradient and developmental pattern in a wide range of species and organs (Burr, 1941; 
Lund, 1928). The main breakthroughs which demonstrated the electrical properties of 
individual cells, epithelia, neural structures and limb regeneration were based on 
works by McCaig and his colleagues (McCaig, 1986, 1987, 1989; McCaig and Dover, 
1993).   
This fascinating research field has shown that endogenous electric signals control 
limb and spinal cord regeneration, cell and embryonic polarity, growth control, and 
migration guidance of numerous cell types (Levin, 2009; McCaig et al., 2005). These 
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endogenous currents and fields were found widely distributed in biological systems 
(Table 1-2 ). 
 
Table 1-2 Electrical signals in different biological system (Levin, 2009) 
Role species/Syetem 
Cellular polarization (anatomical asymmetry of cell or 
epithelium) Alga Fucus 
Patterning in gastrulation, neurulation,and 
organogenesis Chick, axolotl, frog 
directional transport of maternal components into the 
oocyte Moth, Drosophila 
Growth control and size determination Segmented worms 
Neural differentiation Xenopus embryo 
Polarity during regeneration Plannaria and annelids 
 
1.7.1 The basis of bioelectrical signals 
Electric current is commonly referred as the movement of ions. There is a direct 
relationship between the voltage, resistance and current. This is known as Ohm’s law: 
V=I×R, where V is the Voltage of the battery, I is the current (in amps), and R is the 
resistance (in ohms). In physiological environments such as the cell membrane, 
cytoplasm or the fluids of extracellular spaces charge, is carried not by electrons but 
by charged ions like Na
+ 
and Cl
-
. Current is generated by the movement of the ions 
through specific ion channels and pumps within the cell membrane. The bulk 
resistivity of a physiological solution is about 100 Ω·cm with some exceptions e.g. a 
single human red cell has a resistivity of only 10 Ω·cm2 (Johnson and Woodbury, 
1964).  
Current will flow if a voltage difference exists between any two points in a 
conductive medium. The electric field (EF) is expressed as the voltage difference per 
unit distance. The relationship between the current density and electric field is E = 
J×ρ, where E is the electric field, J is the current density and ρ is the resistivity of the 
medium. Importantly, all voltage differences, currents and electric fields have 
directions which are inevitably interdependent. The direction of the EF thus makes it a 
potential mediator for spatial organization, because it can impose directional 
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movement on chemicals in the extracellular environment, receptor molecules, cells 
and tissues (McCaig et al., 2005). 
 
Figure 1-4 Electrical properties of wounded epithelia and surrounding tissue 
A: a sample of electric circuit physics. Wires connect a battery (V) to a resistor (R). 
Electrons, which are negatively charged, carry the current (I, arrows) within the wire 
move from negative pole (low potential) to positive pole (high potential). The 
relationship between the voltage difference across the resistor and the current ﬂowing 
through it is described by Ohm’s law: V= I ×R. B: In an ion-transporting epithelium, 
the transepithelial potential difference (TEP) of several tens of millivolts acts as a 
“skin battery” (V). In biological systems the current (I) is carried by charged ions, 
such as Na
+
 and Cl
-
. The ions leak out when there is an injury to the epithelium which 
produces a low resistance. The total resistances include the wound (Rw) the inner 
tissue (Rt) and outside fluid (Rf). Because the direction of current ﬂow is taken to be 
the direction of ﬂow of positive ions (arrows), the wound is more negative than distal 
regions within the tissue. The wound therefore represents the cathode of the naturally 
occurring subepidermal electric ﬁeld. (McCaig, et al. 2005) 
An EF in the context of development and regeneration is distinct from those found 
in the electrophysiology in neurons/cardiomyocytes and electroporation due to the 
electrical magnitude. To depolarize a neuron and start an action potential require an 
EF strength of 1-2 V/mm; the common electroporation method to deliver drugs or 
genes into cells uses an extremely high strength EF, roughly 100-500 V/mm; the EF 
that plays physiological roles in development and regeneration is between 1-100 
mV/mm, three or four orders of magnitude less than electroporation. 
With the development of molecular genetics and other state-of-the-art techniques 
during the last few decades detailed studies of the proteins responsible for 
bioelectrical signals, the genetic networks that shape them, and the mechanisms that 
allow cells to convert the information into growth control decisions have been widely 
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carried out. Several research areas have made tremendous progress in understanding 
biological events controlled by bioelectrical signals, such as wound healing, neural 
guidance and cell orientation responses (McCaig et al., 2005; Zhao, 2009). 
1.7.2 EFs and wound healing 
Though the naturally occurring electric current present in human skin wounds were 
measured 150 years ago, the confirmation and further understanding of its biological 
function wasn’t gained until the application of modern technologies such as the 
vibrating probe, and glass and platinum microelectrodes in the last decades. 
Epithelial cells are organized in apical-basal pattern which segregate the charges 
achieved by ion flux, giving rise to a trans-epithelia potential (TEP). The mammalian 
skin epithelia support a TEP around +70 mV, internally positive. The top layer of 
cells- the stratum corneum is connected by tight junctions and this forms the major 
resistive barrier. Intact mammalian epithelial cells transport Na
+
 and K
+
 inwards from 
the extracellular fluid and Cl
-
 in the opposite direction. Upon wounding which 
disrupts the epithelia barrier the TEP is short-circuited. The voltage potential at the 
wound thus drops to zero. However, normal ion transport maintains the original 
potential in unwounded epithelial cells 500-1000 μm away to the wound edge. The 
resulting gradient of electrical potential, from 0 mV at the wound bed to +70 mV at 
500-1000 μm away from the wound, thus establishes a steady, laterally oriented EF 
with the cathode at the wound (Figure 1-5). 
 
 
 
 
Figure 1-5 Wound generated EFs in epithelia 
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Mammalian skin keeps a substantial TEP. Wounding collapses the TEP locally thus 
generates a wound current and an electric field within the sub-epithelium. This 
wound-induced EF persists until the migrating epithelium reseals the wound and re-
establishes a uniformly high electrical resistance (McCaig et al., 2005). 
Several studies have investigated these steady wound-induced EFs in a number of 
tissues. In a cornea wound there is an EF of about 42 mV/mm, whereas in guinea pig 
skin the wound generates a steep, lateral EF of about 140 mV/mm. The similar 
strength endogenous EFs have been detected at human skin wounds by using a bio-
electric imager (Nuccitelli et al., 2008). In both tissues the voltage gradient dropped 
off exponentially from the wound edge with a profile that was equivalent to that of a 
uniform cable that has been disrupted at one point (McCaig et al., 2005). In skin 
wounds, the distance was about 330 μm, which means that at 330 μm away from the 
wound bed the voltage gradient would have decayed to 37% of its maximum value at 
the wound edge. It is similar in human skin wound that the voltage gradient was 140 
mV/mm at 250 μm away from the wound bed, 40 mV/mm at 300-500 μm, and about 
10 mV/mm at 500-1000 μm. 
1.7.3 The endogenous EFs are regulated spatially and temporally  
The endogenous current can be tightly regulated in space and in time. Spatially, in 
different organ or at different distance to wound bed of the same tissue, the current 
strengths are variable. Amphibian neural tube establishes a potential difference across 
the tube wall. There is about 90 mV in axolotl at stage 28 and this voltage difference 
would create a steady voltage gradient across cells in the neural tube wall of 
remarkable 1800 mV/mm. Levin and his colleagues found H
+
 flux might be crucial 
for creating voltage gradient that drive directed regeneration of spinal-cord axons and 
tadpole-tail (Adams et al., 2007). On the other hand, in the mammalian skin wound, 
the strongest currents are found at the wound edge; wound centres have much lower 
current flow. 
The EF at a wound site varies temporally; the EF at a skin wound is around 140 
mV/mm immediately after wounding. This gradually increases to a maximum value 
of about 250 mV/mm 24 hours after wounding, and then gradually decreasing over 
about one week until returning to rest the resting TEP of 70 mV/mm (Nuccitelli et al., 
2008). Cornea wounds have similar currents that flow out of the wound and rise to a 
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peak within one hour and persist for several days (Song et al., 2004). During limb 
development in embryos, current flows out of a precise point on the skin flanking the 
area from which the limb bud will appear a day or so after the current begins flowing. 
Injecting a fluorescently tagged charged protein into the extracellular space of non-
bud flank skin resulted in radial diffusion. However, the injection into the limb bud 
resulted in limb development disruption (McCaig et al., 2009). This current also 
appears in chicken and mouse, which indicates the currents are the guidance of tail 
regeneration.  
1.7.4 Manipulation of epithelial transportation of ions and the effects on wound 
electric fields 
The polarized distribution of ion channels and pumps and segregation of free 
charges by tight junctions maintain vectorial ion transport (Kucerova et al., 2011; 
McCaig et al., 2002; Zhao, 2009). The Na
+
 channel and Cl
-
 channel on the cornea 
epithelium consistently pump Na
+
 out of and Cl
-
 into the tear film, respectively 
(Figure1-6). The relative magnitudes of net Cl
-
 secretion and Na
+
 absorption largely 
decide the electrogenic transporting system and potential differences. 
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Figure 1-6 Molecular basis of ion channels generate electric potential difference 
A: skin is like a battery and maintains an electric difference across the whole layer 
due to the ions exchange B; An electric potential difference, positive at the basal side 
relative to the apical side is generated and maintained by net directional ions 
movement (Zhao, 2009). 
Several experiments have proved that a reduction in Cl
-
 in the bathing solution at 
the topical side of cornea increases both the electric and chemical forces that drive Cl
-
 
to move to the tear side, therefore the movement of Cl
-
 is significantly increased and 
the voltage difference has been doubled. Oppositely, a decrease of Na
+
 in the bathing 
solution decreases both electric and chemical forces of Na
+
 movement and reduces the 
voltage difference. 
Pharmacological manipulation of ion channels or pumps- especially Cl
-
 and Na
+
 
channels- has a large effect on wound electric fields. The application of Cl
-
 channel 
activators PGE2 (prostaglandin E2), Aminophylline or Na
+
 channel activators 
ascorbic acid and AgNO3 have been proven to achieve an increase of wound TEP 
(Nuccitelli et al., 2008; Song et al., 2004; Zhao et al., 2006). Conversely, inhibition of 
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Cl
-
 or/and Na
+
 channel decreases wound TEP. Na
+
-K
+
-ATPase, Na
+
 channel, and 
Na
+
-K
+
-Cl
-
 transporter can be inhibited by ouabain, benzamic and furosemide 
respectively, and those inhibitors have been experimentally confirmed to reduce 
wound TEP (Nuccitelli et al., 2008; Song et al., 2004; Zhao, 2007). Though these ion 
channel activators or inhibitors have different pharmacological or physiological 
effects, their applications all converge on one common denominator- the increase or 
decrease of wound-induced EFs, respectively (McCaig et al., 2005; Song et al., 2004; 
Zhao et al., 2004; Zhao et al., 2006). The latest investigations imply that wound-
induced EFs have major effects on directional cell migration and open another 
window for wound management (Zhao, 2009). 
1.8 Electric fields are an overriding guidance cue that 
directs cell migration in wound healing 
During the wound healing process, endogenous or exogenously applied EFs have 
been shown to be an overriding mediator for directional cell migration. Many types of 
cells respond to applied EFs by directional migration. Although EFs are applied 
experimentally, the same EFs occur naturally in vivo.  
Cells involved in wound healing must acquire a spatial asymmetry polarization, 
protrusion towards the wound bed which enables translocation of cells and wound 
closure. The Golgi apparatus is one of the important elements in mediating cell 
polarization and protrusion. In detail, Golgi apparatus reorganize the cytoskeleton to 
direct secretory traffic and recycle the endosomes to the leading edge of the migrating 
cell (Zhao, 2009). This redistribution of traffic and re-organization of cytoskeleton 
leads to the enrichment of cell-surface receptors and adhesive molecules at the “front” 
of the cell that are required for cell protrusion. The movement of the Golgi apparatus 
to the anterior side of the nucleus decides the direction of migration, thus the cell 
organizes into a “head-tail” polarization. Pu and colleagues found that Golgi 
apparatus could be polarized toward the cathode by EFs and disruption which 
inhibited the directional cell migration. Remarkably, when an EF was applied against 
the default polarization of cells in a scratched wound (toward wound bed), the Golgi 
polarization and cell migration followed the direction of EF and ignored the other co-
existing directional cues (Pu and Zhao, 2005). 
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1.8.1 Electric signals in inflammation 
As with epithelial cells in wounds an applied EF of physiologic strength can induce 
directional migration of immune cells such as neutrophils, dendritic cells and 
lymphocytes. Both freshly isolated neutrophils and HL-60 cell line-differentiated 
neutrophils showed a strong response to applied EFs. The migration speed and 
directedness appeared to follow a dose-dependent pattern based on the strength of the 
EFs. The threshold voltage to induce directional migration was around 200 mV/mm 
(Zhao et al., 2006). I found applied EFs increased the expression of interferon γ (IFN-
γ) in KG-1 cells and induced directional migration in KG-1-derived dendritic cells in 
3D culture. I also found EFs could increase the response of dendritic cells to 
stimulation by IL18 by increasing co-localization of IL18 receptors. Human 
peripheral blood had previously been investigated to determine whether any subset of 
cells response to applied EF. Compared with spontaneous migration in the absence of 
EFs, there was a significant increase in migration of all lymphocyte subsets except 
NK cells when the EF was applied. In addition, the magnitude of the effects was 
similar for CD4 T cells, CD8 T cells, naïve T cells, memory T cells, B cells and for 
monocytes. This observation is in contrast to the chemotactic receptor-driven 
responses, which are characteristically subset-selective; the electrotaxis response is 
remarkably uniform among the major lymphocyte classes (Lin et al., 2008). 
1.8.2 Electric signals control cell behaviours in proliferation phase of wound 
healing 
During the proliferation phage of wound healing there are mainly two cell types 
playing the central role. Keratinocytes are the main force for re-epithelialization and 
are a good model for chemotaxis studies. To study how keratinocytes would respond 
when both EFs and cytokines are present, the cross flow experiment was used as the 
method excludes indirect effects of chemoattractant gradients in an electric field. The 
culture medium containing chemoattractant was circulated through the electrotactic 
chamber perpendicularly to the field vector at a rate of 20 ml/h, thus eliminating 
build-up of chemoattractant gradients. The directedness of keratinocyte migration was 
exactly the same at that of the cells in the same strength EF but absence of medium 
flow (Zhao et al., 2006).  
24 
 
Fibroblasts in close proximity to a wound respond by forming stress fibres, which 
enable connective tissue contraction, and also migrate and proliferate to form 
granulation tissue. Freshly isolated human dermal fibroblast showed a response to 
applied EFs as low as 100 mV/mm, and the stronger EFs (200-400 mV/mm) had more 
prominent effects to induce directional cell migration. From the scratch wound 
experiment, EF stimulation for 6 hours significantly increased wound closure (Guo et 
al., 2010; Zhao et al., 2006).This evidence clearly verifies that EFs are the overriding 
signals during wound closure. 
1.9 The hypothesis of how cells sense the EFs 
The molecular mechanism by which cells detect and migrate directionally in 
response to an EF remains vague. The early theory that the EF redistributed molecules 
in the extracellular medium, thus creating a chemical gradient which guides cell 
response, is not entirely true. This is because cells retain their characteristic 
electrotropic response to EFs with perfusion of fresh medium orthogonal to the vector 
of the EFs (Patel and Poo, 1982; Patel and Poo, 1984). Another proposal was that a 
direct voltage difference across a cell might produce a cytoplasmic voltage gradient 
which means the cell has positively and negatively charged ends. However, because 
of the very high resistance of the plasma membrane, the vast majority of the voltage 
drop remains outside the cells, with almost no internal gradient arising (Betz et al., 
1980). The focus then changed to examining which molecular elements of the cells 
might be asymmetrically affected on the exposure to an EF. 
1.9.1 Nerve Cells 
It was very controversial finding that showed that growing nerve cell processes 
(neurites) respond to an electric field; Jaffe and Poo found that neurites grew faster 
toward the cathode than toward the anode by using embryonic chicken dorsal root 
ganglia (Jaffe and Poo, 1979). But continued research revealed that it was indeed an 
electrotactic response, and neurites even turned 180 degree in order to move to the 
cathode. Further study discovered that EFs also increased total neurite production, and 
what’s more, there were more neurites initiating on the cathode-facing side of the cell 
body than the anodal side. 
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Rajnicek and Mccaig first tried to explain the molecular mechanism behind the EF-
induced neurite migration (Rajnicek et al., 2006a, b). They found that dynamic 
microfilaments and microtubules are very important for EF-induced growth cone 
migration. Further, growth cone turning can be divided into two stages: filopodia 
reorientation is in advance of turning and lamellipodia reorientation is coincident with 
the turning. Finally they suggested that Rac/Cdc42-mediated dynamics of 
microfilaments and microtubules act cooperatively to generate cathodal steering. 
1.9.2 Muscle Cells 
Myoblast cells from frog embryos were aligned perpendicularly to the vector of an 
applied EF. The threshold to induce the alignment of myoblasts was as low as 0.3 
mV/mm. Mccaig and Dover (McCaig and Dover, 1991) found that calcium 
potentially contributed to the EF-induced orientation change, because a calcium 
inhibitor blocked the perpendicular orientation of myoblasts. Calcium entry is 
essential for EF-induced perpendicular orientation of mouse embryonic fibroblasts as 
well (McCaig and Dover, 1991). Further experiments indicated that L-type calcium 
channels might not be as important as T and N type calcium channels in this effect. 
Another factor which affected the EF-induced orientation change was recognized to 
be cytoskeleton proteins, and pharmacological inhibitor studies implied that the 
limited amount of F-actin present played a more important role than microtubules in 
the morphology transformation. 
1.9.3 Neural Crest Cells 
Neural crest cells are a transient, multipotent migratory cell population that first 
accumulates on the dorsal side of the vertebrate neural tube, and then disperses as 
these cells follow a characteristic pathway to form a remarkable number of derivatives, 
including melanocytes, craniofacial cartilage and bone, smooth muscle, peripheral and 
enteric neurons and glia.  A number of studies were carried out mainly on amphibian 
and quail material, and the results were consistent, which were that the cells 
responded directionally to a transcellular voltage difference of 0.7 mV. In agreement 
with muscle cells, the neural crest cells have similar morphology transformations in 
applied EFs, which is difficult to explain because any asymmetries induced by the 
field will be parallel to the field. Cooper and Keller (Cooper and Keller, 1984) have 
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explained that the perpendicular alignment minimizes the perturbing effect of the field 
on the membrane potential and suggest that cells respond in such a way as to achieve 
this minimization. 
1.9.4 Epithelial Cells and Fibroblasts 
There are a quite a number studies discussing how epithelial cells and fibroblasts 
respond to an applied EF. The threshold of the field able to induce directional 
migration in these two cell types is around 100 mV/mm. Cornea epithelia cells in an 
EF of this magnitude have a migration speed of 10 μm/hour with directedness of 0.6, 
and fibroblasts appear to have a similar response. However, most of the fibroblasts 
studied have shown migration towards the anode, which is contrary to the response of 
the majority of other types of cells (Guo et al., 2010; McCaig et al., 2005). The 
mechanism of the difference is largely unknown so far. 
1.9.5 Mechanism of interaction with electric fields 
Although it is still unclear how cells sense and respond to an electric field as small 
as 0.1 mV, their responses to larger voltage gradients are partially due to the influence 
of the difference between calcium entry into the cathode-facing sides and anode- 
facing sides of the cells. The symmetric zygotes of the brown algae focus and pelvetia 
will polarize and develop their rhizoides on the anodal side in an electric field; the 
argument is that the imposed electric fields polarize the zygotes by driving in calcium 
on the anodal side, which mimics the normal physiological calcium drive process 
(Figure 1-7).  
However, this straight-forward explanation with perturbation of calcium flux 
cannot explain all observed scenarios. An alternative mechanism whereby an applied 
electric field might induce asymmetric distribution of membrane proteins is by 
electrophoresis or electroosmosis. 
In the case of ion channels on the cell membrane, it has been proposed that an 
electric field might redistribute and polarize charged and mobile components in the 
cell membrane. The degree of redistribution a molecule achieves in a given electric 
field has been shown to be dependent on the diffusion coefficient of the 
electrophoretic mobility and the voltage drop per cell required to produce asymmetry 
of 0.1 (0 representing uniform distribution and -1 or +1 representing completely 
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redistribution of the component to the one pole or the other). A variety of membrane 
receptors has been shown to be redistributed to the cathode side of the cell in an 
applied EF (McCaig et al., 2005; Robinson, 1985), including the Con A receptor, 
acetylcholine receptor, and the Fcε receptor.  
 
Surprisingly most of the studied receptors with a high degree of redistribution were 
 
Figure 1-7 Electric Fields interact with a cell by changing calcium uptake 
(a) A spherical cell with a membrane potential of -70 mV. (b) The effect of a 
uniform applied electric field. The electric field is distorted by the highly 
resistive cell as shown. The potential outside the cell will vary sinusoidally and 
thus the transmembrane potential, will vary as well so that the anode-facing 
side is hyper polarized and cathode facing side depolarized. (c) The effects of a 
field on one voltage gated calcium channel. Because the anodal side is hyper-
polarized meaning cytoplasm is more negative, the force driving calcium 
inwards is increased, while the calcium driving force on the other side is 
decreased. (d) The effects of the field on calcium flux through voltage-gated 
channels. The calcium channels on the cathodal side are open due to 
depolarization, while anodal side channels remain closed. (e) Electrophoretic 
redistribution of calcium channels. The other proteins studied have been shown 
to be redistributed by the field. Calcium channels here are only for illustrative 
purposes, similar consideration applies to other ion channels or protein 
(Robinson, 1985).  
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glycoproteins which have a net negative charge at physiological pH. This observation 
has led to the suggestion that the mechanism of electric field-induced receptor 
redistribution is due to electroosmotic water flow near the surface of the cell, 
produced by the immobile negative charge on the surface (Robinson, 1985). The 
evidence has come from Poo’s experiment that showed the direction of migration of 
the Con A receptor was reversed following the treatment of the cells with 
neuraminidase, which would be expected to remove much of fixed negative charge, 
allowing a direct electrophoretic response by the receptors (McLaughlin and Poo, 
1981).  
Another model is cornea epithelia cells as wounds in the cornea epithelium 
generate endogenous currents that control the process of reepithelialization. This 
small wound-induced electric field can affect both cell migration and division. During 
electrotaxis, several growth factors have also been found to act together, perhaps 
using parallel signalling pathways to transduce the effect of EF. Most electrotaxis 
work has concentrated on EGF, because during cornea wound healing EGF is 
upregulated and EGF receptor is activated at the leading edge, which experiences the 
strongest electric field. Flow cytometry results have confirmed that applying EF 
increases the expression of EGF receptors and resulted in redistribution of EGF 
receptors and F-actin to the cathodal side of the cells. 
EF-induced asymmetry of EGFRs also induced asymmetric intracellular signalling 
through the mitogen-activated protein (MAP) kinase signalling cascade. Western blot 
results have shown increased activation of dual phosphorylated ERK1/2 distributed at 
the cathodal side. Moreover, activated ERK1/2 and F-actin have become colocalized 
at the leading lamellae in CECs migration.   
In short, the mechanisms driving EF-induced cell directional migration in different 
kinds of cells share several elements in common. They all can be transduced by an 
induced asymmetry of membrane receptors which interact with the chemical gradient. 
They all involve signal transmission at the leading edge by second messenger 
pathways and eventually connect to cytoskeleton proteins. Figure Figure1-8 compares 
and contrasts the mechanisms that control electrically and chemically directed cell 
movement (McCaig et al., 2005). 
29 
 
 
1.10 Cell migration 
Cell migration is an important biological process and plays a key role in 
physiological and pathological processes. During embryonic development, cell 
migration is required for morphogenesis ranging from gastrulation to development of 
the nerve system. Migration remains prominent in the adult organism, in physiology 
as well as in pathology. In the inflammatory response, for instance, leukocytes 
migrate into areas of insult, where they mediate phagocytic and immune function 
(Lauffenburger and Horwitz, 1996). In wound healing, migration of epithelial cells, 
fibroblasts and vascular endothelial cells is essential. In cancers, abnormal cells can 
migrate from initial tumour mass into the circulatory system. Finally, cell migration is 
 
Figure1-8 Model proposed for chemotaxis (A) and electrotaxis (B) 
(A) In chemotaxis, a gradient of ligand concentration stimulates activation of 
more receptors on one side the cell than the other. This results in increasing 
intracellular signalling pathway activation on one side of the cell even if the 
receptor density is evenly distributed on both sides of the cells. Therefore, cells 
migrate toward the high concentration of ligand. (B) In electrotaxis, asymmetric 
signalling comes from EF-induced polarized receptor distribution, mainly on 
the cathodal side. Thus, cells migrate towards the side with more polarized 
receptors (McCaig et al., 2005). 
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also crucial to technological application or engineering such as tissue regeneration, 
tissue engineering and biomaterial scaffolding. 
Over the past few years, immense work has been done in order to understand the 
various aspects of cell migration, including the establishment of polar structures, the 
regulation of dynamic process of actin, microtubule polarization, and regulation of 
spatial and temporal signal transduction. Cell migration is a precisely controlled and 
highly orchestrated multistep process. Migration varies from one cell type to another. 
For example, the fibroblast is a very typical cell type used for cell migration study. It 
exhibits relatively slow and uncoordinated movement with protruding and retracting 
lamellipodia, and they contain many stress fibres connected to large focal adhesion. In 
contrast, fish keratinocytes move faster and have characteristic unique persistent 
lamellipodia, small areas of adhesion and absence of stress fibres and filopodia (Le 
Clainche, 2008). Nevertheless, different types of cells share some common features of 
cell migration: cells need to establish morphological polarization in response to an 
extracellular response. At the “front”, cells form lamellipodia which connect to the 
adhesions; at the “rear” cells retract by combining actomyosin and disassembly of 
adhesions (Figure 1-9).  
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1.10.1 Actin-based directional cell migration 
The actin network is the most important component of lamellipodia formation and 
protrusion. The constant and rapid actin assembly maintains the cell lamellipodium 
and migration direction. Moreover, actin assembly also initiates, regulates and 
mechanically couples to adhesion to enable protrusion and traction of the cell body. 
How actin assembly is converted into a protrusive force to enable cell migration is 
the basic question in understanding cell migration. Based on seminal experiments, the 
actin network in cell protrusion is summarised in Figure 1-10, showing that actin is 
organized in a bidimensional dendritic array of branched filaments. 
 
Figure 1-9 Illustration of Cell Migration 
Protrusion of membrane lamellipodia is achieved by actin polymerization. Cell 
starts to move forward once the membrane protrusion has become adherent to 
the substratum; this may occur by myosin interactions with actin filaments. The 
rear of the cell follows, detaching and contracting (Lauffenburger and Horwitz, 
1996). 
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Lamellipodia are broad, flat, sheet-like structures whereas filopodia are thin, 
fingerlike projections. Both can extend into 3D dimensions around the cell in steady 
or motile states. FRAP (fluorescence recovery after photo bleaching) experiments in 
lamellipodia using microinjected fluorescent actin has demonstrated that actin 
filaments polymerise at the leading edge and depolymerise at the rear. The movement 
speed of the cell correlates with the rate of actin assembly; the movement of 
fluorescent actin is at the same relative speed as cell migration. The constant actin 
nucleation and depolymerisation at front edge of lamellipodia is described as 
“treadmilling”. Recent discoveries indicate that treadmilling of actin filaments was 
 
Figure 1-10 Schematic illustration of actin skeleton in a migrating cells 
This schematic cell shows the major structures containing actin in migrating 
cells but does not correspond to a precise cell type. A. In lamellipodia, 
branched actin filaments are generated at the plasma membrane in response to 
WASP-Arp2/3 signalling and are maintained in fast treadmilling by a set of 
regulatory proteins (profillin, ADF). B. During cell migration, cells extend 
finger-like protrusions called filopodia beyond the leading edge of the 
protruding lamellipodia to sense the environment. C. Slow moving cells 
forming focal adhesion in response to RhoA signalling. Focal adhesion 
connects the extracellular matrix to contractile bundles made by actin filaments, 
myosin II and bundling proteins like α-actinlin. D. The lamella is characterized 
by a slow actin turnover and contains the signature proteins tropmyosin and 
myosin II (Le Clainche and Carlier, 2008). 
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sufficient to support the protrusion of the leading edge. Moreover, there are two 
different types of actin network involved in the process: fast-moving speckles in the 
lamellipodia and slow-lived speckles in lamella (Ponti et al., 2004). The lamella is 
behind the lamellipodia and is characterized by a loose array of unbranched actin 
filaments that is enriched with tropomyosin and myosin II (Svitkina and Borisy, 1999; 
Svitkina et al., 1997). Microinjection of tropomyosin to replace the lamellipodium-
forming components Arp2/3 and actin depolymerising factor (ADF) results in the loss 
of lamellipodia but also an increase in the level of protrusion and in migration speed 
(Gupton et al., 2005). This indicates that lamella play a major role in protrusion and 
the lamellipodia is dispensable. Lamellipodia may serve other functions such as 
sensing the environment; another possibility is that lamellipodia and lamella may 
have redundant function in cell migration (Le Clainche and Carlier, 2008). 
1.10.2 Molecular basis of actin treadmilling 
Actin assembly is a dissipative biochemical process where actin polymerization 
costs ATP, thereby forming two types of actin formats: ATP-bounded barbed end and 
ADP-bounded pointed end. Therefore the balance between depolymerisation and 
polymerisation which reflected by the ratio of pointed-end and barbed-end actin 
determines the protrusion force. It has been discovered that a set of proteins- ADF, 
profilin and capping proteins- cooperate to accelerate treadmilling of actin. 
ADF binds to pointed end actin and changes its structure to enhance 
depolymerisation in vitro (Carlier et al., 1997). As a result, the concentration of G-
actin (monomeric actin) increases up to a level that allows G-actin to bind to barbed 
end actin, thus keeping the concentration of G-actin in balance. ADF therefore 
promotes barbed end growth and potentially fosters actin-based motility. In good 
agreement with its biochemical function, ADF increased the velocity of listeria and 
N-WASP-coated beads in reconstituted motility assays, but decreased the length of 
the tails (Wiesner et al., 2003). Identified effects have been discovered in Drosophila 
where the RNAi knockdown of ADF leads to an increase in the width of the 
lamellipodia of cells.  
Profilin is another regulative protein of the treadmilling process and it is abundant 
at lamellipodia. Profilin binds to monomeric actin and forms a profilin-actin complex 
which exclusively binds to barbed end actin; thus it enhances directional treadmilling 
34 
 
(Didry et al., 1998). Recent studies have revealed that the WH2 domain (WASP 
homology 2) protein shares similar functions with profilin in promoting barbed end 
assembly (Co et al., 2007; Hertzog et al., 2002). 
There are also a group of proteins named capping proteins which have high affinity 
to barbed end actin. However, this group of proteins is also involved in other cellular 
functions and controlled by distinct signalling pathways. The dynamics of capping 
protein interaction with barbed end actin have been addressed in vitro and in vivo. 
Surprisingly, the kinetics in the two situations show huge differences, with the 
dissociation constant in vivo being 3 orders magnitude longer than in vitro (Iwasa and 
Mullins, 2007; Miyoshi et al., 2006).  
1.10.3 Nucleation of actin filaments by the Arp2/3 complex in response to 
signaling  
During migration cells need to keep a balance between the nucleation and 
depolymerisation of actin filaments. In the lamellipodia of migrating cell, the 
nucleating factor is the Arp2/3 complex activated by the signalling WASP proteins 
(Gournier et al., 2001).  The Arp2/3 complex acts as an accelerator for actin 
treadmilling and therefore the localized activation of Arp2/3 determines the direction 
of protrusion. Arp2/3 localizes at the leading edge of lamellipodia, where it nucleates 
branched actin filaments. Arp2/3 contains seven conserved subunits including the two 
actin-related proteins Arp2 and Arp3 and ARPC1-5. Arp2/3 complex can be activated 
by WASP proteins and then nucleates actin filaments by branching the side of 
preexisting filaments (Amann and Pollard, 2001; Blanchoin et al., 2000). 
Actin treadmilling is an energy consuming process, in which ATP exchange and 
hydrolysis play a critical role. It has been reported that inactive Arp2/3 complex has a 
high affinity with ATP (Le Clainche et al., 2001). Whilst both the Arp2 and Arp3 
subunits have an ATP binding site, those sites are quite different. Arp3 has a high 
affinity binding site whereas Arp2 has a low affinity site. ATP is hydrolysed at Arp2 
without affecting the branched nucleation but strongly inhibits debranching. 
The Arp2/3 complex must be activated before initiating lamellipodia protrusion. 
There are several Arp2/3 activators: WASP/N-WASP, SCAR/WAVE and cortactin 
(Le Clainche and Carlier, 2008). The WASP (Wiskott Aldrich syndrome proteins) and 
N-WASP (Neuronal WASP) share the several domains: The NH2-terminal WASP 
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homology 1 domain, a GTP binding domain, and a COOH-terminal catalytic domain. 
Both WASP and N-WASP can be activated by Cdc42 and PIP2, whereby their C-
terminal conformations are changed and bind to Arp2/3 complex (Stradal and Scita, 
2006; Takenawa and Suetsugu, 2007). SCAR (Suppressor of cAMP Receptor) and 
WAVE (WASP-family Verprolin homology protein) were identified as WASP related 
proteins. WAVE/SCAR activates Arp2/3 in quite a different way in comparison with 
WASP/N-WASP. Neither can be activated by Rho-GTPase due to the lack of GBD 
domain. However, WAVE/SCAR activates Arp2/3 followed by binding to Rac1, 
which induces membrane ruffling (Eden et al., 2002). Another candidate as an 
activator of Arp2/3 is cortactin, because it is enriched at the leading edge of the 
lamellipodia where it colocalized with actin and Arp2/3 (Cantarelli et al., 2006; Weed 
et al., 2000). However its role in the dynamics of lamellipodia is still unclear. 
A detailed description of the interaction of these molecules and their signalling 
pathways will require an in-depth investigation and biological dissection of the spatial 
and temporal regulators. The new high throughput model in yeast and newly designed 
fluorescence probe probably will help to establish the specificity of these different 
pathways (Lorenz et al., 2004; Sun et al., 2006). 
1.10.4 Integrin signaling during cell migration 
For the migration to occur, a protrusion must be stabilized and attached to its 
surroundings. Although many different receptors are involved in this process in 
different cell types, the integrins are a major family of migration-promoting receptors 
(Ridley et al., 2003). These receptors act as the “feet” of migrating cells by supporting 
the adhesion to the ECM or by linking via adapters of actin filaments inside of the 
cells. 
Integrin and adhesion types 
The adhesion is like a “hub” to cell migration and at the centre of the migration 
cycle. It is involved in leading edge protrusion, adhesion to the ECM, contraction of 
the cell body and release of the adhesions at the rear. In mammalian cells, there are 18 
α subunits and 8 β subunits that can bind as about 24 different heterodimers to 
determine ligand specificity. Structurally, integrins contain three domains: a ligand 
binding extracellular globular head, a hydrophobic transmembrane domain and 
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cytoplasmic tail. There are two conformations of integrins: extended and intermediate 
in accord with if interacting to extracellular ligand (Askari et al., 2009). Those two 
statuses are reversible and are vital for signalling transduction. Integrin can also be 
activated by intracellular molecules which bind to the cytoplasmic tail of the β subunit 
(Zaidel-Bar et al., 2007).  
Integrin-based adhesions have been broadly classified into four groups based on 
their location, lifetime and protein composition (See Figure 1-11). They are: nascent 
adhesions (NAs), focal complexes (FCs), focal adhesions (FAs), and fibrillar 
adhesions (FBs) (summarized in Figure). NAs are very small and punctuate structures 
at the leading edge of lamella with a very short turn over time (less than 1 minute). If 
NAs remain stable (for more than 5 minutes), they mature into FCs. If FCs become 
bigger and stable for a further 10+ minutes, they change into FAs and can interact 
with zyxin and focal adhesion kinase (FAK). FBs are stable contacts found parallel to 
bundles of fibronectin (Mercurio et al., 2001). While the turn-over process of 
transformation and identity of recruited proteins are still not very clear, super-
resolution imaging technology and high through-put proteomics may help to reveal 
more details. 
Integrin signalling in adhesion dynamics 
Talin is a ubiquitous cytosolic protein with a high concentration in the focal 
adhesion area, thus it is suggested as a linker between integrin and actin. Recent 
studies discovered that talin activated integrin by binding the cytoplasmic tail of 
integrin β-subunits (Anthis et al., 2009). The interaction between talin and integrin 
has two stages; reversible loose interaction and high affinity binding. It has also been 
suggested that integrin might dictate talin mobility, because β1 and β3 integrins could 
lead to changes in talin (Himmel et al., 2009).The other β integrin activators are 
kindlin family proteins, which bind at a site distal to that of talin. It is hypothesized 
that kindlin synergistically active β integrin with talin due to an effect of stabilizing 
talin or preventing binding of talin competitors (Ma et al., 2008). 
In addition to integrin activators, the molecules that maintain integrin in an inactive 
state also play a very important role in coordinating adhesion dynamics (Scales and 
Parsons, 2011). The typical example is filamin which binds directly to the 
cytoplasmic tail of integrin and competes with talin to limit integrin activation (Xu et 
37 
 
al., 2010). Other proteins like Dok1 and ICAP1 may also play similar roles 
(Calderwood et al., 2003). 
The adhesion complex is formed by a variety of proteins, in which α-actinin acts as 
an organizer by linking integrins, actin and vinculin systematically (von Wichert et al., 
2003). Knockdown of α-actinin prevents nascent adhesions (NAs) becoming mature 
(Choi et al., 2008). Paxillin and vinculin are the key proteins in stabilizing adhesion.  
Paxillin is rich in of protein-protein interaction sites at its N-terminal. The proteins 
binding to paxillin are diverse and include protein tyrosine kinases, such as Src and 
FAK, and structural proteins such as vinculin. Vinculin links integrin, paxillin, F-actin, 
α-actinin and Arp2/3 complex, thus strengthening adhesions. Vinculin knockout 
mouse fibroblasts showed reduced adhesion and increased random migration rate, 
potentially because of a reduction of adhesion stability (Xu et al., 1998).  
There are other molecules which also interact with adhesions, such as FAK and 
small G proteins. By coordinating temporally and spatially, all these molecules 
together regulate cell adhesion and migration. However, the details of physiology and 
pathology should be investigated further. 
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Figure 1-11 Schematic illustration of classic integrin-based adhesions 
Shown are the typical localizations of nascent adhesions (NAs), focal 
complexes (FCs), focal adhesion (FAs), and fibrillar adhesions (FBs) and the 
hierarchy of their maturation (green arrows) and turn over (red arrows) (Scales 
and Parsons, 2011).  
 
1.10.5 The roles of Rho-family GTPases in cell migration 
Rho-family GTPases, including Cdc42, Rac1 and RhoA, mediate the interaction of 
cytoskeleton proteins during cell adhesion and migration. These GTPases have been 
implicated in several different cell types: fibroblasts, T cells, macrophages, astrocytes, 
epithelial cells and neuronal cells (Fukata et al., 2003). Recent intensive analyses have 
started to clarify how Rho-family GTPases regulate cell migration: basically they re-
organise the cytoskeleton by producing a gradient of signalling molecules (Fukata et 
al., 2003; Raftopoulou and Hall, 2004; Scales and Parsons, 2011).  
The Rho GTPase switch 
Rho-family GTPases are ubiquitously expressed and 20 members have been 
identified in mammals. The Rho-family GTPases cycle between a GDP-bound 
inactive form and a GTP-bound active form (Fukata et al., 2003). This process is 
regulated by three factors: guanine nucleotide exchange factors (GEF), Rho GDP 
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dissociation inhibitor (GDIs), and GTPase-activating proteins (GAPs). Their best-
characterised function is to regulate actin dynamics in the lamellipodium. The in vitro 
analyses focused mainly on fibroblasts have clarified that Rho regulates the assembly 
of actin and myosin filaments, while Rac1 and Cdc42 organize polymerization of 
actin to form peripheral lamellipodia and filopodia protrusions, respectively 
(Raftopoulou and Hall, 2004). Moreover, these three GTPases are all involved in the 
assembly of integrin-based adhesions (Nobes and Hall, 1995). 
Regulation of Rho GTPase during cell migration 
High resolution fluorescence images have shown that Rac is found at the front of 
lamellipodia and regulates actin polymerization during cell migration (Chen et al., 
2008). Rho, on the other hand, is thought to regulate the contraction and retraction at 
the rear of cell body, and would be expected to follow an inverse distribution to Rac. 
For example, by using FLAIR technology, Rac can be visualized in migrating 
fibroblasts with a high concentration at leading edge and Rho at the rear (Kraynov et 
al., 2000; Stuart et al., 2008). Cdc42, unlike Rac and Rho, is thought to establish cell 
polarity in order to initiate migration as live fluorescence imaging showed that Cdc42 
was located in the Golgi apparatus where it mediated secretion in endocytic transport 
(Kroschewski et al., 1999). In the 3T3 fibroblast scratch wound model, a gradient of 
Rac1 activity exists across the flank of the wound with highest concentration at the 
leading edge of the wound. A comparison of localization between Rac1 and Cdc42 
showed that the highest concentration of Rac is closer to the leading edge than that of 
Cdc42 (Itoh et al., 2002). 
PI3-Kinase and PIP3 in regulation of Rho GTPases activity 
PI3K and its product PIP3 have been widely implicated in a pivotal role in 
regulating cell polarity and migration in physiological and pathological conditions 
(Stephens et al., 2002). During chemotaxis, PI3K is required for lamellipodium 
extension and migration via signalling from G-coupled receptors (Li et al., 2000). 
Fluorescence imaging of GFP-tagged PIP3 has shown that extracellular stimuli induce 
their redistribution to the leading edge of migrating cells and co-localize with centres 
of actin polymerisation (Haugh et al., 2000; Servant et al., 2000). 
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But how does the PI3K signalling pathway interact with Rho-family GTPase 
activation? It has been found that both regulatory and catalytic subunits (p85 and 
p110, respectively) of PI3k are present in the eluates of GTPγS-bound affinity column 
chromatographs (Kobayashi et al., 1998; Raftopoulou and Hall, 2004). In addition 
GTP-bound Rac1 and Cdc42 can enhance PI3K activity and work as the upstream 
signals of PI3K (van Leeuwen et al., 1999). Due to the evidence that Rac1 GEFs are 
activated by PIP3, a positive feedback loop for cell migration is proposed for the 
PI3K signalling pathway: PIP3—GEFs—Rho GTPases—PI3K—PIP3 (Raftopoulou 
and Hall, 2004). Recently, PTEN, a lipid phosphatase and a negative regulator of cell 
survival mediated by the PI3k-Akt pathway, exhibits reciprocal localization to PI3K 
in Dictyostelium (Funamoto et al., 2002).  
Downstream effects of Rho family GTPases during cell migration 
Rac and Cdc42 are both required for cell migration, with Rac needed for the 
generation of protrusion force and Cdc42 for polymerisation of actin in filopodia. 
Recent studies on Drosophila have shown that Cdc42 loss of function mutations do 
not affect the migration speed of peripheral glial cells but instead reduce the 
directedness of migration (Sepp and Auld, 2003). The interactions between 
Rac/Cdc42 and actin dynamics have been intensely investigated. The Ser/Thr kinase 
PAK is commonly activated upon Rac or Cdc42 activation and is believed to play a 
role in regulating actin dynamics and adhesions. In addition, PAK phosphorylates and 
activates LIM kinase, which in turn inactivates cofilin. Cofilin is crucial for actin 
treadmilling at the front of migrating cells by dissociating actin subunits from 
pointed-end actin filaments (Arber et al., 1998) (Figure 1-12). 
The WASP/SCAR/WAVE family of scaffold proteins are the essential regulators 
of actin dynamics. They are able to stimulate the Arp2/3 complex, which can initiate 
actin polymerisation either de novo or at the barbed end or sides of pre-existing 
filaments (Amann and Pollard, 2001). Cdc42 activates WASP/N-WASP directly and 
PIP3 is an important cofactor (Rohatgi et al., 2001), whereas Rac1 activates 
SCAR/WAVE family members indirectly (Eden et al., 2002). Rho activity is 
responsible for focal adhesion assembly and cell contractility. In addition, Rho 
activity is associated with actin and myosin interaction and therefore induces the 
contraction of the rear of the cell body via ROCK (Alblas et al., 2001) (Figure 1-12). 
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Clearly, if Rho activity is at the front of a migrating cell this will block membrane 
protrusion, hence mechanisms must be in place to inhibit its activity at the leading 
edge. Rac may have this function because expression activated Rac has been shown to 
inhibit Rho activity in many cell types, ranging from fibroblast to neurons 
(Raftopoulou and Hall, 2004).   
Rho-family GTPase and polarity 
Although Rho-family GTPases have received attention mainly for their actin 
modification effects, it is now clear they also possess functions for the regulation of 
microtubules and cell polarity (Wittmann and Waterman-Storer, 2001). While it 
seems that microtubules are not involved in lamellipodium dynamics and chemotaxis 
over a short distance, long distance migration and the persistence of cell polarity are 
achieved by the microtubule cytoskeleton. Rho was shown to promote the 
stabilization of microtubules by mDia, which is involved with microtubule capping 
(Ishizaki et al., 2001). Rac, on the other hand, may elongate microtubules through 
PAK and the inactivation of the microtubule destabilizing protein, stathmin (Daub et 
al., 2001).  
Cdc42 plays an essential role in defining cell polarity in response to external 
environmental stimuli. Inhibition of Cdc42 blocked macrophage chemotaxis to CSF 
without impairing their motility (Ridley, 2001). The polarized migration in many cells 
is reflected in the reorganization of the microtubule skeleton and centrosome, which 
usually face the direction of migration (Raftopoulou and Hall, 2004). Cdc42 has been 
shown to regulate reorientation of the microtubule skeleton and centrosome in 
migrating astrocytes and fibroblasts. The mechanism involves GTP-bound Cdc42 
activating Par6 and PKCζ at the leading edge of cells, which is essential for 
determining the orientation of cell migration (Etienne-Manneville and Hall, 2001). 
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Figure 1-12 Rho-family GTPases regulated pathways affect actin filaments 
organization 
Rho promotes contractile actin:myosin filament assembly through two 
effectors, mDia and ROCK. Rac and Cdc42 both regulate actin polymerization 
through the WASP/SCAR/WAVE family of proteins acting on Arp2/3 complex 
(Alblas et al., 2001). 
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1.11 Mechanisms of dendritic cell migration 
Dendritic cells (DCs) are professional antigen-presenting cells that initiate adaptive 
immune responses against foreign antigens and maintaining T cell tolerance to self 
(Steinman and Banchereau, 2007). DCs consist of several subsets which can be 
distinguished by surface and intracellular phenotypic markers, immunological 
function and anatomic distribution. In mice all DCs express CD11c integrin and MHC 
class-II (MHC-II) molecules; by combining tests for these with those looking at the 
expression of CD8α, CD4, CD11b, Langerin, PDCA-1 and other markers they can be 
further distinguished (Shortman and Naik, 2007). When DCs become activated, they 
normally exert their function in discrete locations remote from their place of origin, 
which implies that DCs possess migratory capacity to navigate through the body 
(Alvarez et al., 2008).  
All DCs have been found to be derived from hematopoietic stem cells in the bone 
marrow. However, the facultative DC progenitors are also found in multiple locations 
other than bone marrow, such as the thymus, blood, lymph and in most visceral 
organs (Liu et al., 2007). These progenitor cells differentiate into DCs upon challenge 
of peripheral tissues. The immature DCs in healthy organs are characterised by having 
highly active endocytic machinery of sampling of foreign antigens but without the full 
capacity for priming naïve T cells (Banchereau et al., 2000). The most enriched sites 
of DCs are skin and lymphoid organs where the first entrance of microbial pathogens 
and adaptive immune response initiates. Indeed their migratory ability allows the DCs 
in non-lymphoid tissues to transport and present antigenic cargo into and within 
lymphoid organs. The antigen-bearing DCs become mature with increased expression 
of MHC complexes and up-regulation of co-stimulatory molecules and cytokines. 
Clearly, the ability of DCs to migrate through the body is a critical prerequisite of 
its immunological function. The “migration” continues throughout the whole lifespan 
of the DC under different biophysical conditions. Specifically, DC migration 
encompasses the following events: 1) newly formed DCs or their progenitors exit 
their place of birth and enter the blood, 2) recruitment of the circulating cells into 
target tissues; 3) extravascular lodging and interstitial motility to sample antigens; 4) 
the capacity to access lymph vessels to travel either to lymph nodes (LN) or back to 
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blood; and 5) the ability to interact with migrating lymphocytes and other immune 
cells (Alvarez et al., 2008) (Figure 1-13). 
  
 
Figure 1-13 DC trafficking in peripheral tissues 
This schematic illustrates a proposed model for the interstitial migration of skin DCs 
from the cutaneous microenvironment to the afferent lymphatics en route to the LN. 
The migratory cascade is divided into five discrete steps (clockwise from top left), 
starting with recognition of a mobilizing signal (inset 1), detachment from structural 
tissue elements (inset 2), trafficking through interstitial space (inset 3), transit through 
the afferent lymphatic endothelium (inset 4), and transit through the afferent lymph 
vessels (inset 5). Major chemokine-chemokine receptor (CKRs) pathways and other 
trafficking molecules controlling DC migration are highlighted (Alvarez et al., 2008). 
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1.11.1 Dendritic cells in the skin 
The skin can be divided into two areas: epidermis and dermis. DCs can be found in 
both as Langerhans cells (LCs) in the epidermis and dermal DCs (DDCs) in the 
dermis. 
Langerhans cells, the first type of DCs to be identified and characterised, are a 
homogenous population of cells typically found in tight association with the 
surrounding keratinocytes. They can also be found in the papillary dermis, 
particularly around blood vessels, as well as in the mucosa of the mouth, foreskin and 
vagina (Roediger et al., 2008). LCs exhibit stellate morphology with long branches. 
Dermal DCs are a heterogeneous cell population, both in human and mouse. In 
contrast to LCs, DDCs display an amoeboid shape and show a stronger ability to 
migrate (Ng et al., 2008). In terms of function, both LCs and DDCs are capable of 
capturing and presenting both foreign and self antigens to naïve T cells in vivo. 
However, it is still not clear whether antigen presentation to T cells by the different 
dendritic cell subsets leads to distinct functional outcomes during the immune 
response (Ng et al., 2008). 
1.11.2 Traffic molecules in DC migration 
Circulating DCs and their progenitors can be recruited by attractive signals 
displayed on vascular walls and exit into specific tissue. The majority of these signals 
are inflammatory chemokines with rare exceptions, such as the recruitment of 
progenitors for DC renewal (Elbe et al., 1989). In response to these chemokines, DCs 
express specific adhesion molecules and chemoattractant receptors that allow them to 
traffic into target tissues (Sozzani et al., 1997). For instance, relying on chemokine-
ligand pathways, such as CCR2-CCL2, CCR5-CCL5 and CCR6-CCL20, immature 
DCs can access non-lymphoid peripheral tissues and navigate within them 
(Banchereau et al., 2000). When DCs become mature, they down-regulate their 
previous level responsiveness to these inflammatory chemokine pathways and up-
regulate CCR7, which induces them to traffic to draining lymph nodes (Dieu et al., 
1998). During DC rolling and tethering on their journey three members of the selectin 
family and occasionally α4 integrin mediate the migration (Vestweber and Blanks, 
1999). 
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The combinational use of selectins, chemoattractant receptors, integrins, and their 
respective ligands results in a great deal of diversity and selectivity in regulating DC 
migration to different tissue (Springer, 1994). 
1.11.3 Lymphatic Vessels 
Lymphatic vessels are thin walled, valved structures through which lymph material 
including soluble protein, antigens, migratory DCs and recruiting T cells travel to 
lymph nodes (LNs). The Lymphatic system is very important for the maintenance of 
normal tissue homeostasis, as well as in inflammatory situations (Ryan, 1989). In the 
skin, afferent lymphatic vessels begin as a plexus of lymphatic capillaries that drain 
interstitial fluid. These initial absorbing lymphatic vessels ultimately converge in 
large collecting ducts, such that only a few vessels enter and terminate in the 
subcapsular sinus of the draining LNs (Roediger et al., 2008). 
DCs migration into lymphatic vessels is dependent upon CCR7 mediated 
chemotaxis. In CCR7-deficient mice it has been shown that CCR7 is essential for DC 
mobilization to LNs from peripheral tissues (Forster et al., 1999). CCR7 recognizes 
the ligands CCL19 and CCL21, which together coordinate the traffic of both DCs and 
T cells to secondary draining LNs under both steady-state and inflammatory 
conditions (Roediger et al., 2008). However, the function of CCR7 is dependent upon 
the intracellular calcium concentration, and therefore relies on additional molecules 
controlling calcium levels. Prostaglandins, particularly PGE2, have been shown to 
influence CCR responsiveness by controlling intracellular cAMP, an important 
intracellular calcium concentration regulator (Scandella et al., 2002). In agreement 
with this, the ADP-ribosyl cyclase CD38 and the Ca
2+
-activated non-selective channel
 
TRPM4 have been shown to promote DC migration through modulation of 
intracellular Ca
2+ 
influx (Barbet et al., 2008). In addition to CCR7, other cytokines 
such as IL18 or cytokine receptors like CXCR4 may further facilitate DC migration, 
particularly in inflammatory conditions (Kabashima et al., 2007). 
1.11.4 Mobilization signals 
It is firmly established that DCs are mobilised in response to a large variety of pro-
inflammatory stimuli, including chemicals (contact sensitizers and irritants), physical 
ones (UV radiation or trauma), and biological ones (microbial, or tissue necrosis). The 
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initial exposure to such inflammatory stimuli induces the mobility and antigen uptake 
of DCs and thus enhances DC maturation. During maturation, DCs start to upregulate 
their motility, re-arrange their repertoire of chemokine receptors, upregulate their 
antigen presentation machinery, and eventually migrate to LNs (Granucci et al., 1999). 
Although DCs respond to a diverse number of signals TNF-α and IL-1β are the most 
common intermediate messengers to their mobilization. The importance of IL-1β and 
TNF-α in contact hypersensitivity and DC migration has been substantially validated 
by experiments involving cytokine neutralization, and in mice deficient in the TNFα 
receptor, the IL-1 receptor, and caspase-1, a protease is required for the release of 
active IL-1β (Alvarez et al., 2008). In addition to these findings, Cumberbatch 
(Cumberbatch et al., 1997a, b) found that subcutaneous administration of either IL-1β 
or TNF-a was sufficient to promote DC migration. The mechanisms by which these 
cytokines promote DC migration probably include altered expression of adhesion 
molecules and chemokine receptors or the changes of local environment. 
1.12 IL-18 and IL-18 receptors 
 Cytokines are the key mediators of the immune system; the IL-1 family may have 
been the most thoroughly studied of the cytokines. IL-1β and IL-18 contribute to host 
defence against infection by augmenting phagocytosis, promoting DC migration and 
initiating Th1 and Th17 adaptive immune responses (Li et al., 2004a; Smith, 2011; 
van de Veerdonk et al., 2011).  
IL-18 was found in 1995 to be a strong stimulator of the production of gamma 
interferon (INF-γ) in Th1 cells (Dinarello, 1999). IL-18 is constitutively expressed as 
an inactive precursor and can be activated by caspase 1 in response to inflammatory 
and infection stimuli. In addition, IL-18 is a strong stimulator of the activity of natural 
killer cells alone or with IL-15. Together with IL-2, IL-18 also stimulates the 
production of other Th2 cytokines such as IL-13. Now, it is clear that IL-18 is 
associated with or demonstrated to contribute to numerous inflammatory disorders 
including infections, autoimmune diseases, rheumatoid arthritis, and metabolic 
syndrome (Alboni et al., 2010; Bachmann et al., 2007a; St Louis et al., 1999). 
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Figure 1-14 IL-18 system 
Schematic illustrates the inflammasome components on the activation of IL-18 
singling pathways. Recent evidence suggests that Caspase I is responsible for 
IL-18 maturation. It also has been demonstrated that IL-18 binds to its receptors 
thus forming a trimmer to initiate downstream cascade, which leads to the 
activation of a panel adaptor proteins such as MyD88. MyD88, IRAK and 
TRAF-6 have also been shown to influence the activation of NF-κB and 
subsequent activation of cytokine transcription (Novick et al., 1999).  
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1.12.1 Components of IL-18 system 
Pro-IL-18 commonly exists as a 24-kDa precursor protein and becomes an 18-kDa 
secretable mature form after caspase-1 cleavage. Pro-IL-18 can also be processed into 
its active form by various extracellular enzymes such as protease 3, serine protease, 
elastase and cathepsin G (Arend et al., 2008). It has been found in an alternatively 
spliced form during IL-18 gene expression in rat adrenal glands as a shorter IL18 
form lacking 57bp/19 aa (Conti et al., 1997). 
The IL-18 receptor belongs to the interleukin 1 receptor/Toll like receptor 
superfamily. There are two subsets: IL-18Rα and IL-18Rβ, both with three 
extracellular immunoglobulin-like domains and one intracellular Toll/IL-1 receptor 
(TIR) domain (Smith, 2011). IL-18 is supposed to directly bind IL-18Rα and then 
recruit IL18Rβ to form a high-affinity heterotrimeric complex, thus inducing 
downstream signals (Thomassen et al., 1998). IL-18R shares the same adaptor 
molecules as MyD88, IRAK and TRAF6 and results in similar responses: activation 
of NFκB, JNK and P38 MAP kinase as IL1R. Although the IL-18R complex is 
remarkably similar to IL-1R complex, regulation of IL-18 action is different from IL-
1 regulation. It has been claimed that IL18-binding protein (IL-18BP) can bind IL-18 
and prevent IL-18 and IL-18R interaction (Novick et al., 1999). 
Another negative regulator of IL-18 activity is IL-1F7 a different member of the 
IL-1 family. IL-1F7 can bind IL-18BP and the IL-1F7/IL-18BP complex is able to 
interact with IL-18Rβ, preventing IL-18 signal transduction (Bufler et al., 2002).  
1.12.2 IL-18 signaling 
Canonical IL-18 acts similarly to IL-1β via the recruitment of adaptor myeloid 
differentiation factor (MyD88). The sequence of events starts with the activation of 
the IL-1R-associated kinase (IRAK)/tumour necrosis factor receptor-associated factor 
6 (TRAF6) pathway, leading to NFκB-modulated gene expression (Gracie et al., 2003) 
(See Figure 1-14). In addition, IL-18 has also been reported to activate the 
transcription factors tyk-2, STAT3 and NFATc4, and promotes mitogen-activated 
protein kinases pathways including ERK1/2 and P38 MAP kinase (Alboni et al., 
2010). Recently, use of PI3k and NFκB inhibitors implicated that both were required 
for IL-18 induction of vascular cell adhesion molecule-1 (VCAM-1) in fibroblasts 
(Perejaslov et al., 2008). 
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1.12.3 Functional effects of IL-18 
Although the first discovery pertaining to IL-18 was its strong capability of 
inducing INF-γ production in mice, the effector role of IL-18 is rapidly expanding. 
IL-18 enhances T and NK cell maturation, cytokine production and cytotoxicity via 
the FasL pathway (Dao et al., 1996). IL-18-deficient mice have shown a reduced 
cytolytic ability in NK cells which can be rescued by exogenous IL-18 (Takeda et al., 
1998). IL-18 has also been found to induce murine T cell Th2 differentiation alone or 
in combination with IL-4. Thus, IL-18 can promote Th1 and Th2 lineage maturation 
based on underlying genetic influence and ambient cytokine stimulation (Takeda et al., 
1998). 
On non-T cell populations, IL-18 has shown direct effects on macrophages and 
DCs (Li et al., 2004a). IL-18 and IL-12 have been shown to synergistically induce 
INF-γ production by bone-marrow derived macrophage and splenic DCs (Munder et 
al., 1998). Studies of knockout mice also revealed that IL-18-induced IL-6 production 
of macrophages is independent of TNF-α and IL-1β (Munder et al., 1998). Similarly, 
IL-18 promotes neutrophil activation, reactive oxygen intermediate synthesis, 
cytokine release, and degranulation (Leung et al., 2001).  
In addition, other non-haemopoietic cell responses to IL-18 are likely with direct 
effects on chondrocytes and cartilage matrix degradation (Smith, 2011). Keratinocytes 
have been shown to not only produce but process IL-18 when treated with pro-
inflammatory mediators such as LPS (Mee et al., 2000). In addition to keratinocytes, 
LCs also produce IL-18, which in turn contributes to the regulation of LC migration 
(Antonopoulos et al., 2008; Cumberbatch et al., 2001; Wang et al., 2002). 
Based on the previous investigations, I postulate that electric signals may modulate 
the response of DC to cytokines and then mediate its maturation/migration. First, EFs 
generation and DC maturation/migration take place in peripheral organs 
simultaneously, which provides the spatial and temporal precondition for the 
interaction. Secondly, it has been proved that cytokines and their receptors decisively 
mediate the fat, development and function of DCs (Merad et al., 2008; Takashima and 
Bergstresser, 1996). Thirdly, one mechanism that EFs regulate cells behaviour is 
through modification of cytokine/ growth factors receptors (McCaig et al., 2005; Zhao 
et al., 2006). 
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Above all, I hypothesize that electric signals may regulate DC functions 
(migration/maturation) in response to cytokines during inflammation or wound 
healing. 
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CHAPTER 2 MATERIAL AND METHODS 
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2.1 Chemicals and reagents 
Table 2-1 Chemicals and reagents used in this study 
Name Catalogue No. Manufacturer 
L-glutathione, reduced (GSH) G6013 Sigma-Aldrich 
Tyrphostin AG1296  Sigma-Aldrich 
Protease inhibitor cocktail P2714 Sigma-Aldrich 
Phosphatase inhibitor cocktail P5726 Sigma-Aldrich 
Y27632 (Rho-associated protein kinase 
inhibitor) 
688000 Calbiochem 
LY294002 440202 Calbiochem 
phalloidin, rhodamine-labelled   R415 Invitrogen 
TRIzol reagent 15596-026 Invitrogen 
Promega Reverse Transcription  A3500 Promega, UK 
DMEM:F12+GlutaMAX-1 31331 Invitrogen 
dispase II D4693 Sigma-Aldrich 
1M HEPES buffer 15630 
H0887 
Invitrogen 
Sigma-Aldrich 
Human Platelet derived growth factor 
(PDGF)  
PHG0043 Invitrogen 
Competent subcloning E.Coli 18265017 Invitrogen 
LB ager powder 684295 
 
Sigma-Aldrich 
Ampicillin 11593027 Invitrogen 
SOB medium,  Invitrogen 
SOC medium 15544034 Invitrogen 
T4 ligase 15224041 Promega 
GoTaq PCR kit M7650 Promega 
DEPC-treated water D5758 Sigma-Aldrich 
Ethanol E7023 Sigma-Aldrich 
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Isopropyl alcohol  I9030 Sigma-Aldrich 
25X TAE buffer AM9870 Invitrogen 
Taqman qPCR kit 4391848 Invitrogen 
2.2 Cell and tissue culture and gene expression 
2.2.1 KG-1 cell culture  
KG-1 cell is human myeloid cell line and considered to be progenitor of dendritic cell. 
In this research, KG-1 cells were taken from liquid nitrogen storage and quickly thawed 
at 37°C in a water bath. Cells were transferred to 37°C RPMI-1640 medium (Nonza, 
Germany) containing 10% FBS (Invitrogen) and 100 U/ml penicillin, 100 μg/ml 
streptomycin and spun down at 1500 rpm for 5 min.  Supernatant was aspirated and pellet 
was re-suspended with ~1 ml RPMI-1640 medium. Cell number was counted using a 
haemocytometer and ~5×105 cells were inoculated into a T75 culture flask (Greiner, 
Germany). Medium was changed every other day and cells were split from 1 flask into 2 
flasks every 4 days. 
In vitro generation of KG-1 cell-derived DCs 
KG-1cell-derived DCs were generated under the conditions essentially as described 
(Teobald et al., 2008). Briefly, KG-1 cells were stimulated under two different conditions 
for comparison study. The first condition was Phorbol 12-myristate 13-acetate (PMA) (10 
ng/ml) plus ionomycin (500 ng/ml) (sigma-aldrich); the second condition was GM-CSF 
(50 μg/ml) plus IL-4 (50 μg/ml). KG-1 cells were kept in these two conditional media for 
10 days. 
2.2.2 Mouse epidermal Langerhans cells isolation and culture 
Mouse ear skin digestion 
Mouse epidermal Langerhans cells were isolated by using the positive-selection 
microbead method according to the kit manual (Miltenyi Biotec, UK). Mouse (C57BL/6) 
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ear skin was cut into ~5 mm
2
 pieces, washed with PBS, and incubated at 4ºC overnight in 
dispase I (5U/ml) ( Roche, Switzerland) in PBS. The next morning the epidermis was 
removed from underlying dermis with fine forceps and incubated at 37 ºC for 15 minutes 
in trypsin (0.05%)/EDTA (Invitrogen). The single cell suspension was obtained by 
agitation and aspiration using 1ml pipette. The cells were then washed with RPMI 1640 
full medium. 
Separation of Langerhans cells using microbeads 
The cell suspension was centrifuged at 300×g for 10 minutes and re-suspended in 80 
µL of buffer per 10
7
 cells. The cell suspension was then blocked with 10 µL FcR 
(Fragment crystallisable region receptor) blocking reagent at 4 ºC for 10 minutes. 10 µL 
Langerhans cell microbeads were then added. The mixture was incubated at 4 ºC for 
another 15 minutes, followed by 2 buffer washes. The cells were then re-suspended up to 
5 × 10
7 
cells in 500 µL buffer prior to magnetic separation. 
A suitable MACS column was washed 2-3 times in buffer to eliminate unspecific 
binding and then the final cell suspension was passed through. The column was removed 
from the MACS separator and the Langerhans cells washed out. The detached beads were 
removed after 2 or 3 times medium change. 
Langerhans cell culture 
The freshly isolated Langerhans cells were cultured with RPMI 1640 medium with 10% 
FBS, 50 U/ml penicillin, 50 μg/ml streptomycin and 2 mM L-glutamine. Culture medium 
was changed every two days and cells were incubated at 37 ºC with 5% CO2 up to a 
maximum of 7 days. 
2.2.3 Coating 
A variety of extracellular matrix components have been used for coating in order to 
induce cell adhesion or migration.  
56 
 
Fibronectin and Laminin 
Both fibronectin and laminin were slowly thawed, gently shook, and dissolved in PBS 
at a concentration of 10 g/ml and 100 g/ml, respectively. Cell culture plasticware or 
cover slips were incubated with various amounts of solution (indicated below) at 37°C 
for 2 hours, and then washed with PBS 3 times. The coated cell culture plasticware and 
cover slips were used directely or stored for ~ 1 month at 2-8°C. 
 Collagen 
Collagen I was dissolved in 0.01 M HCl at a concentration of 5 mg/ml and stored at 
4°C until needed. Stock collagen was diluted 1:5 with culture-grade water and the diluted 
solution was dispensed in the appropriate amount into desired tissue culture plasticware 
or cover slips. These were left at room temperature overnight in a tissue culture hood. 
The following day, the collagen solution was aspirated and the dishes washed with PBS 3 
times. The dishes were then air dried and stored at 4°C until needed. 
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Table 2-2 Collagen coating parameters 
24-well 500 l per well 
6-well 2.4 ml per well 
10mm petri dish 5 ml 
Electric field chamber 500 l 
2.2.4 Skin explant culture  
C57BL/6 mice were killed by CO2 inhalation and the ears cut at the base with scissors. 
The ears were washed twice with PBS and then with 70% ethanol to sterilise.  The ears 
were then spread out on a petri dish and allowed to dry. 2ml of RPMI 1640 full medium 
was aliquot into the required number of wells of a 24-well plate. Ears were split into 
dorsal and ventral halves with forceps under the dissection microscope, and the dorsal 
halves were floated individually on the medium. The explants were incubated at 37°C in 
a 5% CO2 incubator. In EF-stimulation experiments the explants were transferred to fresh 
medium after 12 hours.   
Experiments were designed to test the effect of either IL-18, EF or both on LC 
migration from the skin explants. The detailed protocol of IL-18 and EF treatment at 
various time points were as described below. 
2.2.5 Cos7 cell culture 
Cos7 cells were maintained with DMEM full medium and incubated at 37°C in a 5% 
CO2 incubator. Cells were split every two days. 
2.2.6 Human skin fibroblast culture 
Cultures of Chronic Wound Fibroblasts (CWF), patient-matched uninvolved dermal 
fibroblasts (CMF) and age-matched healthy person dermal fibroblast (HF) were obtained 
with approval from the Medical Ethical Committee of Cardiff University and Local 
Research Ethical Committee and after written informed consent from patients with 
established venous leg ulcers attending the Wound Healing Clinic at the University 
58 
 
Hospital of Wales, Cardiff.  Fibroblasts were maintained with Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with L-glutamine (2mM), nonessential amino 
acids (1 ×), antibiotics (100 U/ml penicillin, 100 mg/ml streptomycin and 0.25 mg/ml 
amphotericin B) and 10% FBS. The cultures were maintained at 37°C in a 5% CO2 
atmosphere. At confluence, fibroblasts were split at a ratio of 1:3 and cells were utilized 
for all experiments between passage 3 to 10 (Cook et al., 2000). 
2.2.7 Gene expression and Molecular cloning 
RNA isolation by TRIzol method 
Total RNA was isolated from CWF, CMF and HF using the TRIzol method according 
to manufacturer’s protocol. In brief the cell monolayer was first rinsed by pre-cooled PBS 
and then lysed by adding 1 ml TRIzol reagent per 3.5 cm diameter dish. Sequentially, 
cells were gently scraped out of the dishes and the cell lysates aspirated into an EP tube. 
The cell homogenates were kept for 5 minutes at room temperature to allow complete 
dissociation of the nucleoprotein complex. 
Following 1.2×10
4 
rpm, 15 minute centrifugation at 4ºC
 
the supernatants were 
transferred into new PE tubes. 0.2 ml chloroform was then added. After around 15 
seconds of vigorous vortex mixing, the solutions and then were centrifuged at 1.2×10
4 
rpm for 15 minutes at 4ºC. The supernatants were then separated into lower phenol-
chloroform phase, interphase, and a colourless upper aqueous phase. The aqueous phase 
containing nucleic acid was carefully transferred into a new EP tube without disturbing 
the interphase. 
0.5 ml isopropyl alcohol was added to the tube to precipitate the nucleic acid. The 
mixture was incubated for 10 minutes at room temperature followed by a 1.2×10
4 
rpm, 15 
minute centrifugation at 4ºC. The RNA precipitate is often visible at this stage. 
Following supernatant removal the RNA pellet was washed with 0.5 ml 75% ethanol, 
which was added into the tube and then the mixture was incubated for another 10 minutes 
at room temperature. The sample was then spun at 7.5×10
3 
rpm for 5 minutes at 4ºC. The 
above wash process was repeated once more and the remaining ethanol removed. 
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Finally the RNA was air-dried and re-dissolved in DEPC-treated water. The 
concentration and purity of the RNA samples were measured by Nano-drop (GE 
healthcare). 
Reverse Transcription 
Reverse transcription from RNA to cDNA was performed in a 20 μl volume using 
oligo-dT primer, 10 mM dNTP Mix and AMV Reverse Transcriptase (Promega, UK) 
according to manufacturer’s instruction. In brief, the reaction mixture contained 1μl 
oligo-dT primers, 1 μl dNTP mix, 0.5 μg RNA, 1μl transcriptase, 2 μl 2X buffer and 14 
μl ddH2O. The reactions were performed in a thermocycler with the program: 1) 42 ºC 
for 60 minutes; 2) 95 ºC for 5 minutes; 3) 4 ºC for storage. Following reverse 
transcription, the sample concentrations were measured, diluted and stored at -80 ºC for 
future use. 
Classical PCR 
The GoTaq PCR system (Promega) was used to perform classical PCR to amplify 
DNA of interest. The protocol was followed according to the manufacturer’s instruction. 
In brief the reaction consisted of 25 μl master mix, 5 μl cDNA or DNA of interest, 1 μl 
Taq enzyme, 100 mM primers and ddH2O to a final volume of 50 μl. The PCR programs 
used differed in annealing temperatures due to different products and primers. The 
outline of the programs is as follows: 95 ºC for 1 minute for denaturation; 55-65 ºC 1-2 
minutes for annealing; 72 ºC for 2 minutes for elongation; 30-40 cycles the one PCR 
reaction. The PCR products were analysed by agarose gel electrophoresis. 
Taqman qPCR 
For quantification of PDGFs and their receptor expression in fibroblasts, TaqMan 
qPCR was used according to manufacturer’s instructions. The reaction was carried out in 
a 20 μl volume in 96 well plates. Each reaction contained 10 μl of Master Mix, 0.25 μg of 
fluorescence probes (Table 2-3), and 8 μl of diluted cDNA. The reactions were performed 
in a Roche Lightcycler 480 system. The number of PCR cycles needed to reach the 
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fluorescence threshold (Ct) was determined in duplicate for each cDNA, averaged and 
then normalized against the reference gene GAPDH. 
Table 2-3 Primers and Probes used in Taqman qPCR 
Primers and Probes     
    sequence(5'-3') Probe 
PDGF-A forward acacgagcagtgtcaagtgc #77 
 reverse attccaccttggccacct  
PDGF-B forward tgatctccaacgcctgct #55 
 reverse tcatgttcaggtccaactcg  
PDGFR-a forward aggtggttgaccttcaatgg #80 
 reverse tttgatttcttccagcattgtg  
PDGFR-b forward cccttatcatcctcatcatgc #29 
  reverse ccttccatcggatctcgtaa   
 
 
2.2.8 Gene cloning 
PCR and subcloning were performed using standard protocols. Plasmid expressing 
IL18Rα-GFP was constructed by amplifying the coding sequence of [plasmid] and 
cloning into a pcDNA3.1-based vector. GFP was cut from and inserted immediately 
downstream of the IL18Rα coding sequence in the vector. Briefly, human IL18Rα and 
GFP were amplified by PCR from templates respectively. Appropriate restriction enzyme 
sites were also introduced into the PCR products via the amplification primers. 
The PCR products and backbone vectors were purified after running on an agarose gel. 
The purified PCR products and vector backbones were cut by the appropriate restriction 
enzymes in order that the PCR products could be inserted into the vector. The detailed 
protocol of restriction enzyme digestion, gel purification and ligation is shown below. In 
this study, GFP was first inserted into pcDNA3.1 utilizing BamHI and HindIII sites; 
IL18Rα was inserted into pcDNA3.1-GFP afterwards by using EcoR I and Bgl II sites.  
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Restriction enzyme digestion  
A reaction volume of 10 μl was used for the digestion containin 1 μl buffer, 0.5-1.0 μg 
DNA, 1 μl enzyme and ddH2O to 10 μl. The reaction was performed for 1 hour in a 37 ºC 
water bath. The products were analysed and separated on a 0.8% agarose gel.  
DNA gel extraction 
Gel purification was used to ensure only DNA of the correct size was collected and to 
eliminate salts and enzymes from the digestion reaction. In this study Qiagen gel 
extraction kits were used and the protocol was according to the manufacturer’s 
instructions. Briefly, target bands were cut under UV light and weighed. Sequentially, 
three gel volumes of QG buffer were added to the slices and heated at 50 ºC for 10 
minutes to melt the gel. Once gel dissolved, one gel volume of isopropanol was added 
into the tube. This solution was then aspirated and transferred into a QIAquick column 
which was spun 1.3×10
4 
(g) for 1 minute. The column was spun once more after adding 
500 μl QG buffer. Following centrifugation, the tube was then washed using 750 μl PE 
wash buffer and spun at 1.3×10
4 
g for 1 minute. After that the DNA was eluted by ddH2O 
and stored at -20. ºC. 
Ligation 
Ligation was used to insert the restriction-digested gene product into vector. In this 
study the T4 ligation system from Promega was used and the protocol was according to 
the manufacturer’s description. A 1:3 ratio of insert DNA:vector with about 100 ng of 
vector was used in the ligation; a negative control reaction contained only the vector 
fragment. With the vector and insert the ligation system also included 0.5 μg ligase, 1 μl 
buffer and 1 μl ATP. The reaction tubes were incubated at 16 ºC overnight. On the 
following day, the sample mixtures were used for transformation.  
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Transformation into E.coli 
Transformation into E.coli was used in order to maintain stocks of the ligated plasmid. 
In this study, the subcloning competent DH5α E. coli strain form Invitrogen was used; 
protocol was according to manufacturer’s instruction. Firstly, about 1-5 μl ligated 
plasmid solution were added to 50 μl thawed DH5α E.coli and swirled gently. The 
mixture was kept on ice for 15 minutes, followed by a 30 second 42 ºC heat shock 
incubation. The mixture was then kept on ice for 5 minutes. Finally, after centrifugation, 
50 μl pellets were spread onto the surface of LB-Ampicillin plates. Colonies were picked 
next day and used to inoculate 10 ml cultures in order to harvest vector.  
Plasmid mini-prep 
The plasmids were extracted from E. coli for further experiments e.g. transfection. In 
this study, the plasmids were isolated by using a Qiagen mini-prep kit; the protocol 
followed according to the manufacturer’s instructions. Briefly, the overnight cultured 
bacteria were spun and the pellet was re-suspended in 250 μl P1 buffer. 250 μl P2 buffer 
was added and mixed thoroughly. The mixture was then centrifuged for 10 minutes at 
13,000 rpm. The supernatant was aspirated into a Qiaprep spin column and spun for 1 
minute at 7500 rpm. The flow-through was discarded and the column was washed by 
adding 0.75 ml Buffer PE and centrifuged for 1 minute at 7500 rpm. Finally, the plasmid 
was eluted by adding 50 μl EB buffer and stored at -20 ºC for further experiments. 
2.2.9 Gene Transfection 
Transfection with Lipofectamine 2000 
Transfection of various types of cells was carried out with Lipofectamine 200 
(Invitrogen, UK) according to the manufacturer’s instructions. Essentially, cells were 
seeded at 1×10
5 
per well in
 
24 well plates 24 hours before the transfection. Cells were 
then transfected using 1 μg of vector and 2 μL Lipofectamine 2000 reagent per well. 
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Electroporation 
Several cell types in the experiments are difficult to transfect using Lipofectamine 
2000; for these cells, transfection was carried out using an electroporator with appropriate 
settings. For 3T3 cells the setting is 500 V at low Voltage mode, capacitance 1600 μF and 
the chamber gap is 4 mm; for dendritic cells, the conditions are 400 V at low Voltage 
mode, capacitance at 1600 μF and chamber gap of 4mm. Immediately after 
electroporation, cells were incubated on ice for 5 minutes before transferring into full 
medium and culturing at incubator. 
2.2.10 Immunocytostaining protocol 
Immunocytostaining was used to visualize cellular protein expression and distribution. 
Briefly, cells were fixed with 4% paraformaldehyde in PBS at room temperature for 15 
minutes, followed by rinsing in PBS 3 times. The concentration of antibody used was 
according to the description of the manufacturer. Essentially, the cultures were incubated 
with primary antibody at 4°C overnight at appropriate concentration in PBS containing 5% 
BSA. On the following day, cultures were further incubated with fluorescence-conjugated 
second antibody for 2 hours at room temperature. Finally, the slices were mounted with 
Vectashield mounting medium (Vector Laboratories, USA) and observed under a 
fluorescence microscope. 
2.2.11 Western blot assay 
Buffers used in Western blot 
TBST buffer 
Tris-HCl buffered saline/Tween-20 (TBS/T) is the basic buffer used to wash western-
blot membranes. TBS/T containes 50 mM Tris-HCl (pH 8.5), 150 mM NaCl, and 0.1% 
Tween-20.  
Peroxidase-conjugated antibody was diluted in TBS/T containing 5% skimmed milk; 
this is also used to block the western-blot membranes after protein transfer. 
SDS-PAGE buffer 
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SDS-PAGE buffer was composed of 250 mM glycine, 25 mM Tris base and 0.1% 
SDS. It was made as a 10 x stock and diluted by Milli-Q water before use.   
Western-blot transfer buffer  
Towbin buffer was used in this study as a western-blot transfer buffer. It contains 
25mM Tris base, 192 mM glycine and 20% (v/v) methanol. 
Western-blot stripping buffer 
After probing, western-blot membranes can be stripped in a 3 hour incubation at room 
temperature and reprobed with other antibodies up to 2-3 times. The stripping buffer used 
in this study is: 200 mM glycine (pH 2.4), 0.1% Tween-20 and 100 mM β-Me (from 
http://www.koko.gov.my/CocoaBioTech/Membrane%20Transfer9.html).  
Western blot protocol  
Sample preparation 
Freshly trypsinized cells or digested tissue were rinsed twice with cold PBS. The 
pellets were then re-suspended with 100 μL RIPA buffer (Sigma, UK) and kept on ice for 
5 minutes.  The suspension was centrifuged at 14,000× g for 10 minutes at 4 °C to pellet 
cell debris. The supernatant was collected and 5× SDS-PAGE loading buffer added, 
followed bt vortex mixing for 1minute and heating at 95 °C for 5 minutes.  
Running samples on a gel 
For all analysis NuPAGE Novex 4-12% Bis-Tris gels (Invitrogen, UK) were used. 
Gels were cast using a Bio-Rad Mini protean II gel cassette. Gels were run at 200V for 60 
minutes until the dye front came to the leading edge of the gel. Pre-stained protein marker 
(P7708; New England Biolabs) was also loaded to show the molecular weight of proteins. 
Transfer membrane 
Transfer of the gel contents onto a PVDF membrane is required prior to probing with 
antibody. First, the membrane is pre-wetted in transfer buffer. The transfer components 
are then assembled in the following order: case lid (front), sponge, waterman paper, 
membrane (to transfer samples onto), gel (containing samples), waterman paper, sponge, 
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case lid (back). The membrane transfer apparatus were placed into a Bio-Rad mini-gel 
box electrotransferer at 90 V for one hour. 
Staining and detection 
After transfer, the membrane was blocked in 5% skimmed milk in TBS/T for 1 hour at 
room temperature. The membrane was then washed vigorously for 5 minutes in TBS/T 3 
times. Subsequently, the membrane was transferred to a 50 ml tube with 2-10 ml primary 
antibody solution in 2% BSA, TBS/T and put in a rotating mixer overnight at 4 °C. The 
membrane was then taken out of the tube and washed in TBS/T for 5 minutes 3 times. 
Primary antibody solution could be frozen at -18 °C and reused twice more. The 
membrane was then incubated in 10-20 ml peroxidase-conjugated secondary antibody 
solution in 5% skimmed milk, TBS/T for 2-3 hours at room temperature. Secondary 
antibodies were diluted in a ratio between 1:3000 and 1:8000. 
After secondary antibody incubation, the membrane was washed in TBS/T for 5 
minutes 3 times. It was then gently picked up using a pair of forceps and blotted onto a 
piece of tissue to absorb the excessive moisture. 2 ml developing solution (GE healthcare, 
UK) was applied on the membrane for 1 minute. The membrane was again gently blotted 
onto a piece of tissue and placed into a cassette. Horseradish peroxidase catalyses the 
developing reaction, which results in light generation. Light was absorbed on 
photographic film and developed in a Kodak X-OMAT 1000 processor machine. 
Stripping and re-blot 
If the sample needs to be re-probed, the membrane can be stripped and re-blotted. The 
membrane was incubated with stripping buffer for 20 minutes at room temperature on a 
shaking mixer and washed with TBST for 30 minutes.  The membrane could then be 
blocked and re-blotted. 
2.2.12 ELISA protocol 
The levels of INF- in culture supernatants were measured by ELISA, using paired 
antibodies from e-Bioscience (e-Bioscience Biotechnology Ltd). The INF- levels (pg/ml) 
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were determined according to the standard curve. Briefly, anti- INF- monoclonal 
antibody was diluted to 10 μg/ml in the coating buffer (0.1M NaHCO3, pH 8.2) and 50 
μL/well applied to enhanced protein binding ELISA plates (Dynatech Immunlon) 
overnight at 4°C. The plates were washed twice with washing buffer (PBS/Tween 20 
(0.05%)), and blocked with 100 μL/well of 10% FCS in PBS for 1 hour at 37°C, then 
washed twice more with washing buffer. 50 μL of the supernatant from the cell culture 
and diluted cytokine were added to the plate and incubated at 37°C for 3 hours. After 
washing four times with washing buffer, 50 μL of biotinylated anti-INF- detecting 
antibody (1μg/ml) was added and incubated for 1-2 hours at 37°C. The plates were 
washed six times with washing buffer and 100 μL extravidin-peroxidase (2 μg/ml) added, 
followed by incubation for 1 hour at 37°C. The plates were washed six times and the 
colour developed by adding 100 μL/well of TMB substrate for 10-30 minutes. The OD 
was read at 630 nm with a reference filter at 490 nm. 
Calculation of results 
Absorbance values for each set of triplicate standards and samples were averaged. 
(Note: triplicates should be within 20 percent of the mean value.) First, a standard curve 
was created by plotting the mean absorbance value for each standard concentration on the 
ordinate against the human IFN- concentration on the abscissa. A 4-parameter or 5-
parameter curve fit was used to generate a best-fit curve through the points of the graph. 
To determine the concentration of samples, the absorbance value was firstly read on the 
ordinate and the corresponding value on the abscissa taken as the concentration. 
2.2.13 EF stimulation 
Transwell electrical stimulation  
The transwell electric stimulation experiment set up was modified from a previous 
study (Lin et al., 2008). KG-1 cells were pre-treated with 20 ng/ml TNF-α one day before 
the experiment. Sequentially, 200 l cell suspension (about 1×106 cells) was seeded into 
each top inner-well of the transwell plates (3 m pore), (Greiner,Germany) and 500 l 
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RPMI 1640 medium was added into the bottom wells. 10 ng/ml IL-18 was also added 
into each inner well. Various electric field strengths from 10V-30V were applied to the 
transwell plates by two electrically conductive agarose bridges (according to Figure 2-1), 
which were connected to a DC power supply. 
 
 
Electric stimulation lasted 4 hours and the voltage was checked every half hour to 
control current stability. For Western blot experiment, cells were harvested immediately 
after stimulation and washed in pre-cooled PBS twice and frozen down at -80°C for 
further analysis. For ELISA experiments, cells were kept in culture overnight and then 
the supernatant collected. 
 
Figure 2-1 Transwell EF Stimulation Assay 
Schematic illustrates the setup for a Transwell-based EF assay: 1. agar salt bridge 
electrode for carrying electric current; 2. top well; 3. bottom well; 4. membrane.  
The electric fields were applied across the Transwell (10 V-30V) by placing two 
agar salt bridges- which were connected to the DC power supply to the top well 
and bottom wells. Cells were allowed to migrate through the membrane from the 
top well to the bottom well in response to EF stimulation. 
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EF stimulation of 2D culture 
The experimental setup was based on previous work (Song et al., 2007a). The EF is 
applied to cells cultured in a custom-designed chamber via saline ager bridges connected 
to a DC power supply (Figure 2-). Essentially, glass cover slips were cut and glued by 
silicon to surround the electric chamber confining the cells. A 22×22 mm2 no.1 glass 
cover slip was cut into two halves using a diamond pen. These two glass strips were 
glued at the bottom of a petri dish to from a 22×10 mm2 square which was for cell 
seeding. After cell inoculation another 22×22 mm2 glass cover slip was used to cover the 
cell-seeding area. Thus a sandwich-like EF chamber was formed with the petri dish at the 
bottom, cells in the middle and the cover slip on top. The depth and area of the chamber 
can be modified to suit different experimental requirements, i.e. for protein or gene 
analysis the cover glass can be upgraded to No.2 and culture area can be expanded to 
50×40 mm2. The cells inside the chamber can be maintained as a conventional cell 
culture in a 37 ºC, 5% CO2 incubator. 
Application of EF to 3D culture 
 
The processes of a normal cell from division and migration to proliferation are an 
accurately controlled series of events which inherently rely on spatial and temporal 
environmental factors. This makes the application of EFs to 3D cultures technically 
demanding. In this study the widely applied Matrigel method was used to make 3D 
environment for cell culture.  
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The differences compared to EF treatment of a 2D culture include the resuspension of 
cells with Matrigel instead of medium just before inoculating the cells into the chamber. 
The gel should be covered with a glass cover slip before it sets solid, and the chamber 
should be kept moist to avoid gel shrinkage.  
Another 3D culture method used in this study was mouse ear epidermis explant. In 
comparison with the 2D EF treatment setting, the epidermis tissues were put into the 
middle of the chamber instead of cells in culture. However there are two concerns about 
Figure 2-2 Electric field stimulation setup on the microscope stage 
(A) Schematic drawing of the electric field (EF) setup. (B) A photograph of the 
actual setup of the EF application. Electric current from the DC power supply 
goes through the chamber via Ag/AgCl electrodes, Steinberg’s solution and 
saline agar bridges. 
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this setup. The first is the dimension of the tissue as big and thick tissue would generate 
huge amount heat when applying an EF due to the Joule effect, which will inevitably 
damage the tissue and cell viability. Therefore in this study the mouse ear epidermis 
maximum area was 10×10 mm
2
. The second issue is the tissue should be kept relatively 
thin and flat to avoid “short-cut” effect, because current tends to flow through the path 
with the least resistance. 
Electric field application 
The electric field apparatus was set up as in Figure 2-2. Basically, a pair of agar 
bridges (2% agarose in Steinberg’s solution) connecting the media reservoirs in the 
chamber with Steinberg’s solution pools carried the current through the chamber; this 
was done to prevent possible damage to the cells due to the ion exchange between 
electrode and medium should they be directly connected. The pure silver electrodes were 
immersed in the Steinberg’s solution pools, which were connected to the power supply. 
Culture medium was changed every hour to avoid evaporation, as this would break the 
electrical connection. The electric field strength was verified at hourly intervals during 
the experiment to maintain steady stimulation. Data were pooled from at least two 
separate experiments and images were captured using a Delta Vision system. 
2.2.14 In vitro wounding studies 
Wound repopulation ability can be evaluated by using a monolayer scratch wound 
model. Cells were inoculated into an Electric Field chamber and cultured to confluence. 
The artificial wound was made by scratching along the surface of the tissue culture 
plastic with a standard 200 L pipette tip. The cellular monolayer was washed once in 
phosphate-buffered saline, and re-fed with various media according the different 
experiment conditions. Chambers were incubated under a Zeiss Axiovert microscope 
with heating system. Images were collected every 5 or 10 minutes for 6 hours using 
Metamorph software, post-image analysis was carried out by using Image J.  
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Cell behaviour analyses 
Cell tracking and behaviour quantification mainly followed the previous description 
(Zhao et al., 1999). Cell migration efficiency is evaluated and is calculated by the 
formula:  
Efficiency of cell migration = Si×-)(cosi/T 
S is the migration speed,  is the angle between EF vector and cell translocation, i is 
the number of the cells traced and T is the total recording time. 
2.2.15 PDGF and inhibitors treatment 
In PDGF alone and PDGF combined with EF experiments, cells were washed and 
incubated with variable concentrations of PDGF 10 min before recording. In inhibitor 
treatment experiments, cells were treated with 10 ng/ml PDGF together with either 10 
M Tyrphostin AG1296, 10 M Y27632 or 20 M LY294002 for 30 min before EF 
exposure and time-lapse recording.  
2.2.16 Confocal imaging 
The immunocytostaining slices were captured with a Leica SP5 confocal microscope 
with an Argon laser and analysed using Image J software. The fluorescence intensities 
across the cells were measured using a Line profile plugin The colocalization of two 
fluorescence pixels were measured by the Intensity Correlation Analysis plugin.  
2.2.17 Cell migration data analysis 
Image stacks were collected by the DeltaVison system (API, USA) and analysed using 
Image J software. The analysis is described in detail in previous work (Zhao et al., 1999; 
Zhao et al., 1997). The displacement migration rate and direction were calculated by 
comparing the position at time= 0 and the final cell position. The trajectory migration rate 
was calculated by accumulating all the distance between images and divided by total time. 
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Directedness  
A line was drawn between a fixed point and the centre of the cells of the last time 
point. The cosine of the angle between this line and the electric field vector (normally the 
EF vector is horizontal in the time lapse films) was used to calculate directionality. If the 
cosine of this angle equals 1(angle is 0 degree) this indicates that the cells moved directly 
along the electric field vector towards the cathode and conversely if the cosine is -1 this 
indicates that the cells moved in the contrary direction. A value of 0 indicates random 
movement with respect to the cathode and anode. The cosine values were averaged to 
give an average directionality for the cell population.  
Migration rate 
There are two methods to calculate cell migration rate in this study: trajectory speed 
and displacement speed. The trajectory speed indicates the motility of the cells by 
accumulating all tracks of the cell migration. The result was calculated by accumulating 
all the distances travelled at each time point, which were divided by time. The 
displacement speed was measured using the same fixed coordinate method as the 
directionality. The distances and angles between the fixed point and the cells at each time 
point were used to calculate displacement speed. The displacement was calculated from 
the equation  
C=   (a2+b2-2abcos ) 
The displacement was then divided by the time interval between the whole image 
series. 
2.2.18 Isolation and enrichment of lymph node dendritic cells 
Dendritic cells were isolated as previously described by (Price et al., 1997) from 
auricular lymph nodes which drain the ear. In every animal group 5 mice were killed by 
CO2 inhalation about 18 hours following intradermal injection or FITC painting. Lymph 
nodes were excised and pooled in pre-cooled PBS. Lymph node cell suspensions were 
prepared by mechanical disaggregation through a 70 m cell strainer. Cells were washed 
with 10 ml RPMI-1640 full medium, centrifuged for 5 min at 300g and then re-suspended 
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in RPMI full medium. Viable cells were counted by exclusion of 0.5% trypan blue and 
the re-suspended at 5X105/ml full RPMI medium. The DCs were enriched by density 
gradient centrifugation.  2 ml HistoDenz (Sigmaaldrich; 14.5% in full RPMI medium) 
was layered under 8 ml of DC suspension and centrifuged at 600g for 15 min. Interface 
cells (the low buoyant density fraction) were collected, washed once and re-suspended in 
full medium. The number of cells in the resulting cell suspension was counted using a 
haemocytometer and analyzed by flow cytometry.  
2.2.19 FACS analysis 
Cells were identified and analyzed for the presence of various cell markers by flow 
cytometry. Approximately 1 10
5 
cells was re-suspended in FACS buffer and incubated 
on ice with fluorescence-conjugated primary antibody at an optimal concentration (10 
g/ml) for about 30 min. Antibodies used in the experiment are listed in the table below. 
Cells were washed and centrifuged (300g, 5min) three times with 2 ml FACS buffer 
before analysis using the BD FACS calibur flow cytometer. Data were analyzed using 
Flowjo software. The markers used to identify dendritic cells are listed below in Table 
2-4. 
Table 2-4 Markers used to identify dendritic cells 
Name Catalogue 
no. 
Manufacturer 
Anti-mouse CD11C-FITC 11-0114 ebioscience 
Anti-mouse MHC class II PE 12-5322 ebioscience 
Anti-mouse Langerin PE 12-2075 ebioscience 
Armenian Hamster IgG Isotype Control 
FITC 
11-4888 ebioscience 
Rat IgG2b K Isotype Control PE 53-4031 ebioscience 
Rat IgG2a K Isotype Control PE 53-4321 ebioscience 
Anti-mouse IL-18 R alpha Allophycocyanin 
MAb  
FAB1216A R&D 
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Rat IgG1 Allophycocyanin Isotype Control   IC005A R&D 
 
2.2.20 Statistical analysis 
Data were assessed by ANOVA, followed by Tukey-Kramer multiple comparisons 
tests or the Kruskal-Wallis nonparametric test. This in turn was followed either by 
Dunn’s multiple comparisons tests or by unpaired Student’s t-test as appropriate. P value 
< 0.05 was regarded as significant; p < 0.01, very significant. 
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CHAPTER 3  ELECTRIC FIELDS AND IL-18 MODULATE THE 
DENDRITIC CELLS ACTIVITY IN VITRO 
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3.1 Introduction 
This chapter explores the molecular mechanisms involved when an electric field 
applied across various types of dendritic cells, which resulted in an enhanced response to 
IL-18. The cytokine secretion and migration of dendritic cell were analyzed; and the 
intrinsic machinery i.e. the interactions between EF, IL-18 and IL18 receptors were 
investigated. 
3.1.1 Dendritic cells 
Dendritic cells are important antigen presenting cells which are central to the induction 
and regulation of most adaptive immune responses. The capacity for acquiring, 
processing and presenting peptides on MHC molecules are critical for their roles in 
antigen presentation. Unlike other antigen presenting cells such as macrophages and B 
cells, DCs are characterized as homing to the lymphoid organs for interaction with T 
lymphocytes. Thus the migratory capacity is an intrinsic feature distinguishing them from 
other antigen presenting cells (APCs). Many DCs encounter antigens at peripheral organs 
and become activated, thus migrate, with antigen in tow, into downstream lymph nodes. 
The pathways and mechanisms that govern how DCs migrate to lymph node, therefore, 
figure importantly in immune response and pathogen recognition. 
3.1.2  Brief overview of DC research  
Even though the skin dendritic cells were first described in 1868, the systematic and 
comprehensive studies were initiated in 1973 by Steinman and Cohn, when they 
identified mouse spleen DCs (Steinman and Cohn, 1973). Their serial work first 
established the concept that DC is a potent stimulator of primary immune response 
(Steinman et al., 1975; Steinman and Cohn, 1974; Steinman et al., 1979; Steinman et al., 
1974).The consequent observations indicated they are widely distributed not only in 
lymphoid but also in non-lymphoid tissues (Hart and Fabre, 1981a, c; Hart et al., 1981). 
The later discoveries that they played an important role in heart and kidney 
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transplantation rejection generated further and extensive interests in DC research field 
(Hart and Fabre, 1981b, 1982; McKenzie et al., 1984). 
3.1.3 DC isolation and identification 
Due to the paucity of the DC population and the lack of markers, it was difficult to 
identify their residence and distinguish them from monocytes and macrophages. Now it is 
clear that DCs are widely distributed in most of the organs. Except those residing in 
lymphoid organs such as spleen and lymphoid nodes, DCs exert sentinel function mostly 
at peripheral nonlymphoid organs. 
Epidermis Langerhans cells are the best characterized nonlymphoid DCs. Because it is 
feasible to enrich Langerhans cell population by eliminating keratinocytes, the enriched 
Langerhans cell suffice in most functional studies (Steinman, 1991). Several 
transplantation experiments confirmed there were a small group of DCs in heart (Codner 
et al., 1990; Fu et al., 1997; Hikawa et al., 2007). By depletion of macrophages, several 
other studies also revealed DCs’ residence in lung (Benson et al., 2012; Lai et al., 2012) , 
liver (Bamboat et al., 2009; Yu et al., 2012), and gut as well (Howe et al., 2009; Varol et 
al., 2009). 
There are two distinct pathways of DC development which have been identified in 
mice – myeloid and lymphoid. In vitro evidence has shown that myeloid-committed 
precursors give rise to both granulocytes/monocytes and myeloid DCs under the 
influence of GM-CSF (Inaba et al., 1992; Scheicher et al., 1992). On the contrary, the 
development of lymphoid lineage DC is GM-CSF independent (Saunders et al., 1996). 
Myeloid and lymphoid DCs differ in phenotype, localization and function (Banchereau 
et al., 2000). Both subsets have high expression levels of CD11c, MHC class II, and 
costimulatory molecules CD86 and CD40. To date, the most reliable marker to 
distinguish these two subset is CD8α, which is expressed on the surface of lymphoid DC 
but is absent from the myeloid subset (Banchereau et al., 2000). 
Similarly there are two main subsets of DC precursors circulating in the human blood: 
CD14
+
/CD11c
+
 monocytes and CD11c
-IL3Rα+ precursor DCs (Figure 3-1). Those two 
subsets both are differentiated from CD34
+ 
progenitor cells. The CD14
+
, CD11c
+
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monocytes give rise to immature DCs under the influence of GM-CSF and IL-4 or TNF. 
Furthermore, those CD11c
+ 
DCs can differentiate into LCs with TGF-β stimulation (Ito et 
al., 1999; Thomas and Lipsky, 1994). However, the CD11c
-IL3Rα+ precursors display 
many phenotypic differences expressing high level of CD13, CD14, CD33 and their 
differentiation pathway is not clear (Caux et al., 1996). 
3.1.4  KG-1 cells as DC progenitors 
Due to difficulties in the isolation and maintenance of homogenous human DC 
population with sensitivity to manipulation, several cell lines have been established to 
facilitate DC research. KG-1 is a cytokine-responsive, CD34
+
 myelomonocytic cell line 
derived from a patient with erythroleukemia undergoing myeloblastic relapse (Koeffler 
 
Figure 3-1 The subsets of dendritic cells 
The schematic illustrates the hierarchical differentiation of CD34
+
 progenitor 
cells. The myeloid CD34
+
 progenitors differentiate monocytes (CD14
+ 
CD11c
+
) 
that yield the immature DCs in response to GM-CSF and IL-4. Myeloid 
progenitors also can differentiate in to CD11c
+ 
CD14
- 
precursors, which gives 
rise to Langerhans cells when GM-CSF, IL-4 and TGFβ exist. The CD14- 
CD11c
- IL3Rα+DC precursor may originate from lymphoid CD34+ progenitors 
and differentiate into lymphoid DC in response to IL-3 (Banchereau et al., 
2000). 
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and Golde, 1978). Following the discovery of the KG-1 cells, Koeffler discovered that 
with phorbol diesters treatment, kG-1 cells become adherent and develop pseudopodia 
with macrophage characteristics (Koeffler et al., 1981). Further study suggested that PKC 
activation by phorbol diesters is partially involved in KG-1 maturation process (Kiss et 
al., 1987).  
Recently, KG-1 has been shown to have similar multipotent properties to Peripheral 
Blood Mononuclear Cells (PBMCs), possessing the capacity to differentiate into DC-like 
cells (DLCs) upon various treatments (Ackerman and Cresswell, 2003; Bharadwaj et al., 
2005; Teobald et al., 2008). St Louis first reported the signaling pathway of KG-1 cells 
differentiating to DCs (St Louis et al., 1999). They found KG-1 matured into DLCs in 
response to GM-CSF plus TNF-α or PMA, which expressed MHC I+/ MHC 
II
+
/CD83
+
/CD86
+
/CD14
- 
surface markers. Functional analysis also showed KG-1-derived 
DLCs could uptake fluid phase macromolecule and active resting T cells (St Louis et al., 
1999). 
Maturation of primary DC is characterized, except phenotypic extension of dendrites, 
by up-regulation of MHC and costimulatory and altered trafficking of MHC class II 
(Steinman, 1991). Ackerman and Cresswell further confirmed that during KG-1 
maturation into DLCs, MHC I and MHC II molecules were relocated from Golgi 
apparatus to cell surface (Ackerman and Cresswell, 2003). The p38 MAP kinase 
activation was also found to be involved in KG-1 differentiation and antigen uptake and 
presentation (Bharadwaj et al., 2005). 
3.1.5  KG-1 and IL-18 
IL-18 was previously known as IFN-γ inducing factor, because it was originally 
identified by its strong capacity of IFN-γ induction in mice with endotoxin shock 
(Okamura et al., 1995). The immune response function of IL-18 was later determined by 
using KG-1 as a PMBC model in vitro. The results indicated that KG-1 was very 
sensitive to human IL-18 and responded to as low as 0.1 ng/ml which is as 100 times low 
as to mouse IL-18 (Konishi et al., 1997). Moreover, by using DMA/protein binding 
assay, NF-κB was found to be the critical molecule transcriptionally mediating IL-18 
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induced IFN-γ expression in KG-1(Kojima et al., 1999). Another transcription factor T-
box (T-bet) also can be upregulated in KG-1 with 4 hours of IL-18 stimulation. Inhibition 
of p38 MAPK suppresses this upregulation, indicating p38 MAPK is the upstream 
activator of IFN-γ expression (Bachmann et al., 2007b). This was further confirmed by a 
recent study by Koutoulaki, which demonstrated that: 1). IL-18 activated p38 MAPK 
through binding with IL18Rα, and 2). this consequently recruited IL18Rβ therefore 
activated downstream signalling pathway (Koutoulaki et al., 2010a).   
In addition, it was reported that IL-18 selectively upregulated intercellular adhesion 
molecule-1 (ICAM-1) expression in KG-1 cells, through an IFN-γ independent pathway 
(Kohka et al., 1998). This indicates that IL-18 might play potent roles in 
immunoregulation by mediating immune cells infiltration into the tissue. 
3.1.6  In vitro culture of Langerhans cell 
Epidermal Langerhans cells (LCs) are the most important antigen presenting cells of 
the skin immune system (Steinman, 1991). Due to the population scarcity and lack of 
appropriate isolation method, it was difficult to culture LCs until Schuler and Steinman 
reported the characteristics of freshly isolated LCs in 1985 (Schuler and Steinman, 
1985b). The in vitro cultured LCs showed resemblance to spleen DCs in morphology and 
membrane markers, but displayed weak capacity to stimulate T cells which indicated LCs 
were immature (Schuler and Steinman, 1985b). The sequential studies disclosed that 
GM-CSF and IL-1 are essential for the maturation and function of LCs (Heufler et al., 
1988; Witmer-Pack et al., 1987). During the maintenance of in vitro culture, the 
phenotype and function of LCs change significantly after 72 hours. The most striking 
changes have been found are 4 times increase of MHC class II molecules (Witmer-Pack 
et al., 1988). As a result, the LCs upregulate accessory cell functions for primary immune 
response. 
3.1.7  Cytokines mediate LC migration  
The migration capacity of LC is regarded as an indispensable feature for the antigen-
specific sensitization of skin. By using Matrigel invasion assay, Kobayashi reported that 
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haptens treatment resulted in a significant stimulation of LC migration in vitro. 
Moreover, they also found that certain cytokines derived from dermal fibroblasts may 
promote and regulate the directional migration of LCs (Kobayashi et al., 1994). The GM-
CSF that was thought to be important to maintain viability of LC in vitro, has been shown 
as a strong trigger for LC motility in vitro as well (Rupec et al., 1996). Another cytokine 
TNF-α was also considered to play an important role to mediate LC migration via 
membrane-associated MMP-2 and MMP-9 in vitro (Noirey et al., 2002). 
In addition cytokine IL-18 was identified recently as a strong LC migration enhancer. 
In the skin, IL-18 is mainly secreted by keratinocytes and fibroblasts. Because its 
structure closely resembles to IL-1β, which results in a hypothesis that IL-18 may initiate 
immune response of skin sensitization. Cumberbatch first disclosed that intradermal 
administration of IL-18 lead to a significant reduction in epidermal LC densities and a 
marked increase in lymph node DC number (Cumberbatch et al., 2001). Moreover, by 
using IL-18 knockout mice, it has been reported that IL-18 is the key mediator of LC 
migration acting upstream of IL-1β and TNF-α (Antonopoulos et al., 2008). 
3.1.8 EFs mediate immune cell migration 
Physiological EFs have been proved to play important roles in inducing cell migration 
and division during wound healing (McCaig et al., 2009; Zhao, 2009). Recently, Lin 
reported that EFs induced human lymphocytes directional migration to cathode. 
Additionally, activation of Erk1/2 and Akt was required for the stimulation, which was 
shared with chemotaxis signalling pathway (Li et al., 2011). Based on the facts that: 1). 
LCs migrate directionally during wound healing; and 2) endogenous EFs are 
simultaneously generated when wound occurs, I hypothesize that EFs could potentially 
influence LCs’ activities during wound healing. 
This chapter explores the molecular mechanisms involved in EFs regulated cellular 
response of various types of DCs, resulting in an enhanced response to IL-18. The 
cytokine secretion and migration of DCs shall be analyzed, and the intrinsic machinery 
i.e. the interactions between EF, IL-18 and IL-18 receptors shall be investigated. 
82 
 
3.2 Results 
3.2.1 EFs increase IFN-γ expression via activation of p38 MAPK in KG-1 in vitro 
3.2.1.1 EFs increase IFN-γ expression in a dose-dependent pattern  
Although IL-18 could trigger KG-1 to express IFN-γ, the dynamic interaction between 
IL-18 input and IFN-γ output on KG-1 is not clear yet. To establish the reaction curve, 
ELISA was used to measure IFN-γ production and standard curve was generated from 
Four Parameter Logistic Equation (R=0.9983) (Figure 3-2 A).  
IL-18 was titrated to quantitatively illustrate its ability in inducing IFN-γ expression by 
KG-1 (Figure 3-2 B). In order to exclude the perturbation of asynergic expression level of 
the IL18Rα, two groups of KG-1 cells: 50 ng/ml TNF-α overnight pretreated group and 
naïve KG-1 (no TNF-α treated) group were used for a comparative study. IL-18 induced 
IFN-γ expressions were significantly higher in TNF-α treated group than non-treated 
group. KG-1 cells not exposed to TNF-α, but otherwise subject to identical conditions, 
expressed very low amount of IFN-γ. In addition, TNF-α treatment also reduced the IL-
18 requirement to trigger IFN-γ expression 5 times less compared with non-treated group, 
since 2 ng/ml IL-18 treatment induced detectable IFN-γ in treated group, in contrast 10 
ng/ml IL-18 was needed to achieve the same in non-treated group. Furthermore, TNF-α 
treated group showed prominent dose dependent pattern towards IL-18 stimulation. 
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Figure 3-2 EFs increase IFN-gamma expression 
A. Standard cure of IFN-γ concentration ELISA read out   
B. Titration of IL18. IL18 was titrated to illustrate its ability to induce INF-γ 
expression by KG-1 cells. KG-1 cells were primed with or without 20 ng/ml TNF-
a for overnight and washed with fresh medium next day before stimulated with 0-
100 ng/ml IL-18 in 2 x10
6
/ml density in 24 well plate. Data are presented as mean 
± SD 
C. EFs promote INF-γ expression by KG-1 cells. KG-1 cells were pre-treated by 
TNF-a (20ng/ml) overnight and incubated with 10 ng/ml IL-18 for another 24hrs. 
At the beginning 3hrs of addition of IL18, cells were stimulated with EFs from 
10V to 30V  respectively. Data are presented as mean ± SD, *: P<0.05. 
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Based on the results from Figure 3-1 B, 50 ng/ml TNF-α pretreatment plus 20 ng/ml 
IL-18 were used for the EF stimulation experiments. Application of EFs ranged from 
10V-30V 3 hours across cultured KG-1 cells in the trans-well chamber resulted in a 
significant increase of IFN-γ expression in a dose-dependent manner (Figure 3-2 C). 
During the experiments, the temperature of medium were measured and kept at 37 °C in 
order to eliminate the influence by electric current-generated heat. Culture media were 
harvested 24 hours later of EF exposure and the amount of IFN-γ were quantified. Low 
(10V) and high (30V) EFs stimulation increased IFN-γ expression to 423 and 920 ng/ml 
which were 3 and 7 times higher than control, respectively. 
3.2.1.2 Phosphorylation of p38 MAPK were increased in KG-1 when exposed to EFs  
After EFs exposure, KG-1 cell were lysed and cytosolic protein were analyzed by 
Western blot (Figure 3-3). Both IL18Rα and IL18Rβ were found no fluctuating in either 
IL-18 only or EF & IL-18 treatment in comparison with control group (Figure 3-3 A, B). 
Interestingly, phosphorylated p38 MAPK was significantly increased in the group 
exposed to EF & IL-18 treatment (Figure 3-3 C, D). With IL-18 induction, 
phosphorylation of p38 was significantly upregulated as well, which is in consistent with 
previous study (Bachmann et al., 2007b; Koutoulaki et al., 2010b). However, EF & IL-18 
treatment even showed stronger induction on phosphorylation of p38 comparing with IL-
18 stimulation alone, indicating EF & IL-18 have synergistic influence on p38 
phosphorylation. Three independent experiments were carried and representative images 
were shown. 
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Figure 3-3 Phosphorylation of p38 MAPK were increased in KG-1 when 
exposed to EFs 
 
A. KG-1 cells stimulated with IL-18 and EFs plus IL-18 were harvested 
immediately after exposure and the expression of IL18Rα and β were analyzed by 
Western blot, β-actin was taken as internal control. 
B. The relative grey density of Western blot bands of IL18Rα and IL18Rβ were 
analyzed by ImageJ software, where β-actin as internal control. Data are presented 
as mean ± SD,  
C. Both phopho-p38 and total p38 were detected by Western blot using the same 
samples as (A) 
D. The phosphorylation levels of p38 were relatively quantified by using the ratio 
of p-p38 and total p38. Data are presented as mean ± SD, *:P<0.05 
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3.2.2 IL18Rα polarized to anode when exposed to EFs in 2D culture 
Application of 200 mV/mm EFs across cultured KG-1 for 15 minutes in EF stimulation 
chamber resulted in IL18Rα other than IL18Rβ polarizing towards the anode. 
Immediately after EF stimulation, KG-1 cells were directly fixed in situ and stained with 
IL18Rα and IL18Rβ antibodies which were targeted with secondary antibodies 
conjugated to FITC and TRITC, respectively. The distributions of IL18Rs were captured 
under confocal microscope (Figure 3-4).  
On KG-1 cells not exposed to EFs, but otherwise subject to identical conditions, both 
IL18Rα and IL18Rβ distributed evenly across the cell membrane. On the contrary, with 
EF stimulation, IL18Rα was asymmetrically redistributed to the cell membrane facing the 
anode. However, EF did not show such effects on IL18Rβ. 
3.2.3 EFs increase KG-1 sensitivity towards IL-18 in 3D culture 
IL-18 has been previously reported as a chemoattractant to induce T cells and DCs 
morphological polarization and directional migration (Gutzmer et al., 2003; Kaser et al., 
2004; Komai-Koma et al., 2003). In 3D culture, EF stimulation increased the response of 
KG-1 cells to IL-18 (Figure 3-5). KG-1 cells were pretreated with TNF-α overnight to 
induce IL18Rα expression and then the cells were mixed with Matrigel and seeded into 
the electrical chamber. After Matrigel solidified, the cells were treated with either 250 
ng/ml of IL-18 gradient diffused from Matrigel premix (Figure 3-5A, high side of triangle 
indicates high concentration of IL-18) or 200 mV/mm of EFs (Figure 3-5B, anode to the 
right), or a combination of both (Figure 3-5C). The cell migration were tracked, 
migration directedness and speeds were analyzed with Image J software. I found that 
application of a 200 mV/mm EF across KG-1 cells in 3D resulted in a significant increase 
of migration towards IL-18 chemoattractant gradient (Figure 3-5 C, D).  
During the 90 minutes experiment, in the presence of both EF and IL-18, KG-1 cells 
showed constantly directional migration to the source of IL-18. In contrast, the 
orientation of KG-1 cells fluctuated in either IL-18 only group or EF group (Figure 3-5 
A, B). Thus neither EF stimulation nor IL-18 alone is sufficient to induce KG-1 
directional migration in 3D culture. The combination of EF and IL-18 significantly 
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increased KG-1 cell migration speed and directedness. Interestingly, if dividing the 90 
minutes experimental duration into two 45 minutes halves, the cell  migration speed only 
increased in the second half, suggesting a potential build-up of signaling might be 
required before directional migration taking place (Figure 3-5 D). 
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Figure 3-4 IL18Rα polarized to anode when exposed to EFs in 2D culture. 
Immunocytochemistry staining of KG-1 with IL18Rα and IL18Rβ. The cells 
with/without exposure to EFs 15 minutes were fixed and stained with anti-IL18Rα 
and IL18Rβ, which were targeted with the second antibodies conjugated with 
FITC and TRITC, respectively. In control group, both IL18R-α and –β are evenly 
spread around the cell membrane; with EFs treatment IL18Rα shows polarization 
to anode (arrow), IL18Rβ shows no difference to control group. +: anode,- 
cathode.  
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Figure 3-5 EFs increase KG-1 sensitivity towards IL-18 in 3D culture 
A. KG-1 cells were mixed with Matrigel and then seeded into EF chamber. IL-18 
(200 μl, 50 ng/ml) was injected at the right side of the chamber and the IL-18 
gradient across the chamber was established by diffusion. (The high side of 
triangle indicates the high IL-18 concentration). The cells were exposed to IL-18 
gradient for 2 hours and the cells migration were tracked and analyzed. Cells 
display slow migration. B. A 200 mV/mm EFs were applied across the 3D 
Matrigel cultured KG-1 cells. (Arrow indicates the anode) The cells migration 
were tracked and analyzed. Cells exhibited slow migration. C. KG-1 cells were 
exposed to IL-18 and EFs simultaneously in 3D culture, the concentration of IL-
18 is the same as (A) and the strength of EFs was the same as (B). Cells show 
directional migration towards high IL-18 concentration side (the anode). D. 
Migration speed of KG-1 cells in the condition of (A, B, C) were analyzed 
accordingly. In addition, migration speed of cells treated with IL-18 plus EFs 
were split into two halves: the first 45and the following 45 minutes. Data are 
presented as mean ± SD, *: P<0.05. 
3.2.4 Neither IL-18 nor EFs alone is able to polarize IL18Rs of KG-1 in 3D culture 
Immediately after either IL-18, EFs or both stimulations on KG-1 cells in 3D culture, 
cells were fixed and stained with IL-18α and IL-18β antibodies. Fluorescence coupled 
secondary antibodies were used to visualize the distribution of receptor molecules on the 
cell membrane under the confocal microscope (Figure 3-6 and Figure 3-7). Despite the 
application of 250 ng/ml IL-18 at right side (high side of triangle indicates high IL-18 
concentration), both IL18Rα and IL18Rβ are evenly distributed around the cell 
membrane (Figure 3-6A). The similar results are found in the KG-1 cells exposed to 200 
mV/mm EFs alone (Figure 3-6B).  
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Figure 3-6 Neither IL-18 nor EFs alone is able to polarize IL18Rs of KG-1 in 
3D culture 
KG-1 cells exposed with IL-18 gradient (A) and EFs (B) for 2 hours, and 
immediately after exposure cells were fixed and stained with anti-IL18Rα (green) 
and anti-IL18Rβ (red). Triangle indicates the gradient of IL-18 and the high side 
means the high IL-18 concentration. +: anode, -, cathode.  
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3.2.5 EF increases sensitivity of KG-1 in response to IL-18 in 3D culture 
Chemotaxis is postulated to occur through modulation of re-polarization of membrane 
receptors. Based on analysis of two distinct stages of cell migration in response to IL-18 
as a chemoattractant in parallel with the electrotaxis (Figure 3-5D), KG-1 cells were fixed 
and IL18Rs were stained at two counterpart time points: 15 minutes and 60 minutes to 
determine if redistribution of receptors occurred, respectively. The distribution of IL18Rα 
and IL18Rβ were thus observed and analyzed with confocal microscope (Figure 3-7).  
Figure 3-7 A illustrates that in the first 15 minutes only IL18Rα is polarized to IL-18 
gradient (high concentration toward left) in the presence of 200 mV/mm EF treatment 
(anode to the left). In the contrary, the IL18Rβ distributes evenly around the cell 
membrane. The fluorescence intensity across the cells (dashed line) is calculated and the 
intensity pattern is extracted below. Clearly higher fluorescence intensity value of 
IL18Rα shows at the left side of the cell membrane towards the anode of EF and source 
of IL-18 gradient. But, this effect does not show on IL18Rβ. At the 60 minutes time 
point, both IL18Rα and IL18Rβ are asymmetrically redistributed towards the upstream of 
IL-18 gradient in EF. The lineal scanning profiles of fluorescence intensity also confirms 
that both IL18Rα and IL18Rβ signalling are polarized toward the left side of the cell 
membrane where the high IL-18 concentration and anodal of EF reside (Figure 3-7B).  
The interaction of IL18Rα and IL18Rβ has been described as the prerequisite of IL-18 
signalling transduction (Koutoulaki et al., 2010b). The co-localization of both receptor 
subunits is widely used to indicate the probability of their molecular interaction and 
initiation of signalling. Figure 3-7 C and D depict the co-localization of IL18Rα and 
IL18Rβ at 15 minutes and 60 minutes during the experiments.  Although at both time 
points, the co-localization of IL18Rs (indicates as yellow) tend to accumulate at anodal 
side, the stronger yellow signal appears at the 60 minutes implying a stronger co-
localization (Figure 3-7 C). The co-localization can be quantified by using the specific 
software (Bolte and Cordelieres, 2006), and the Pearson’s correlation index is used for 
quantification. After 60 minutes exposure to EF, the Pearson’s correlation index of 
IL18Rs was increased to 0.58 which was significantly higher than the one at 15 minutes 
(Figure 3-7 D). 
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Figure 3-7 EF increases sensitivity of KG-1 to IL-18 in 3D culture 
A-B. IL18Rα and IL18Rβ fluorescence intensity across the KG-1 exposed to EFs plus IL-
18 at 15 minutes and 60 minutes, respectively. Dash lines across the cells on confocal 
image indicate pixels measured in each graph below. At first 15 minutes exposure, 
IL18Rα shows accumulation at anodal side, but IL18Rβ does display this effect (A); after 
60 minutes, both IL18Rα and IL18β exhibit anodal polarization (B). 
C-D. Co-localization of IL18R-α and-β, the images (C) are merged from A (up), and B 
(bottom); (D) and the colocalization were quantified by using ImageJ. Data are presented 
as mean ± SD, *: P<0.05. 
 
3.2.6 IL18Rα-GFP vector construction and expression 
The fluorescence labeling techniques with GFP or other fluorescence proteins 
immensely facilitate the research on molecular dynamic at single cell level. I thus cloned 
the human IL18Rα and conjugated with GFP in order to visualize the IL18Rα movement 
under the EF treatment in real time. 
     The IL18Rα-GFP vector was designed as shown in Figure 3-8 A. The DNA fragment 
IL18Rα-GFP was inserted into pcDNA-3.1 plasmid and the positive clones were 
sequenced. The IL18Rα-GFP vector was then transfected with Cos7 cells using 
lipofectamine 2000 (Invitrogen). The transfection efficiency was approximately 20% 
(Figure 3-8 B, a-b). Sequentially, the transfected cells were split at 1:5 ratio into new 
flasks with the medium containing 50 μg/ml G418. Two weeks later, the G418 resistant 
clones were formed (Figure 3-8 B, c-d), and the clones were picked up, expanded and 
harvested. The human IL18Rα-GFP fusion protein of stable transfected cell line was 
identified by Western Blot (Figure 3-8 C). 
3.2.7 Dynamic movement of IL18Rα when exposed to EFs.  
The dynamic movement of IL18Rα in the presence of EFs can be analyzed with real 
time recording using the stably transfected IL18Ra-GFP cell line. With the EFs 
(200mV/mm) stimulation, GFP signals moved to the anodal side, which indicates 
asymmetrical distribution of IL18Rα activity. The prominent effects started from 450 
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seconds onwards and IL18Rα was constantly accumulated at anodal side of the cell 
membrane in the presence of EF. When EF polarity was reversed, IL18Rα started 
redistribute to the opposite side of the cell membrane to accommodate the new anodal 
orientation. Where IL18Rα-GFP expressing cells were not exposed to EFs, IL18Rα 
randomly fluctuated along the movement of cell lamellipodia. This demonstrates that EFs 
induce IL18Rα moving towards the anode 
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Figure 3-8 Vector pcDNA3.1-IL18Ra-GFP construction and expression 
A. Schematics illustrate the process of vector construction of pcDNA3.1-IL18Rα-
GFP. The human IL18Rα were cloned and tagged with GFP, and then inserted 
into pcDNA3.1 plasmid with indicated restriction enzyme sites. 
B. The Cos-7 cells were transiently transfected with IL18Rα-GFP plasmid (a, b) 
and the transfected cells  formed G418 resistant clones which expressed IL18Rα-
GFP after 2 weeks 50 μg/ml G418 selection (c, d). 
C. Western blot confirms IL18Rα-GFP expression.  
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Figure 3-9 Dynamic movement of IL18Ra when exposed to EFs 
IL18Rα-GFP transfected Cos-7 cells were stimulated with 200 mV/mm EFs (left) 
or no EF control (Right). During the EFs exposure, the direction of EF was 
reversed in the middle of the recording. Arrows indicate the direction of EFs and 
point to anode; arrow heads indicate the distribution of IL18Ra-GFP molecules.  
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3.2.8 Differentiation of KG-1 into dendritic cells 
The cell line KG-1 has been used as an in vitro model for human myeloid dendritic 
study such as differentiation, immune responses, antigen presenting (Bachmann et al., 
2007b; Koutoulaki et al., 2010a; Poleganov et al., 2008). It has been reported that several 
chemicals and cytokines can induce KG-1 differentiation and/or maturation (Teobald et 
al., 2008).KG-1 cells were cultured with 20 ng/ml TNF-α plus 10 ng/ml PMA for 3 or 7 
days to induce their differentiation and/or maturation. Undifferentiated KG-1 cells show 
rounded morphology and grow in suspension with little evidence of adhesion (Teobald et 
al., 2008). TNF-α and PMA induced a proportion of KG-1 cells to differentiate, with 
approximately 20% adhering to the petri dish in 3 days (Figure3-9 A). Whilst continuous 
culturing for 7 days with TNF-α and PMA, cells exhibited obvious morphological 
changes with bigger size and more polarized protrusions (Figure 3-9 B). These 
observations are in agreement with the previous studies (Koeffler et al., 1981; Teobald et 
al., 2008). 
3.2.9 EFs and IL-18 increase the motility of KG-1-derived DCs  
Once KG-1 cell differentiates into DC, it gains the capacity to migrate, along with the 
protrusion of pseudopods and polarization in morphology. After 7 days induction and 
differentiation, KG-1-derived DC stably showed typical characteristic of dendritic cells, 
therefore I used the cells from this time point for the following migration studies. 
The KG-1-derived DCs were consistently treated in the following 3 conditions – 200 
mV/mm EFs only, 100 ng/ml IL-18 only, or EFs plus IL-18, respectively for 2 hours. The 
cell behaviours were tracked (Figure 3-11A), and migration speeds were analysed 
afterwards (Figure 3-11B). The IL-18 and EFs increased cells migration speed up to 
3.71±1.3 and 3.29±0.86 μm/min from the control cells of 2.41±0.54 μm/min, respectively 
Moreover, the combined treatments of EFs (200 mV/mm) and IL-18 (100 ng/ml) 
significantly elevated cell migration speed to 5.76±1.56 μm/min compared with either 
treatment alone or control group ng/ml) significantly elevated cell migration speed to 
5.76±1.56 μm/min compared with either treatment alone or control group 
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Figure 3-10 Differentiation of KG-1 into dendritic cells 
KG-1 cells were induced by TNF-α (20 ng/ml) and PMA (10 ng/ml) for 10 days 
and then showed dendritic cell phenotype. Photomicrographs show the phenotype 
of KG-1-derived DCs at day 3 (up) and day 7(bottom).  
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Figure 3-11 EFs and IL-18 coordinatively increase the motility of KG-
1-derived DCs.  
KG-1-derived DCs were stimulated with EFs (200 mV/ml), IL-18 (100 ng/ml) 
and IL-18 plus EFs, respectively, for 2 hours. The cells movement were tracked 
(A) and the migration speed in each situation were analysed (B). Data are 
presented as mean ± SD, *: P<0.05. 
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3.2.10 High strength EFs trigger the directional migration of KG-1-derived DCs 
towards anode in 2D 
Although DCs showed higher motility under the combined treatments of EFs (200 
mV/mm) and IL-18, the migration directedness appeared to be random without 
persistence in any particular direction. Higher voltage EFs were used to determine if 
these could induce directional migration on DCs like other cells types.  
Briefly, the DCs were treated with 3 conditions: IL-18 (100 ng/ml), 200 mV/mm EF 
plus IL-18 (100 ng/ml) or 400 mV/mm EF plus IL-18 (100 ng/ml), respectively. With the 
treatment of IL-18 and 200 mV/mm plus IL-18, the DCs exhibited migration directedness 
of -0.15 ± 0.05 and -0.26 ± 0.09, respectively. The minus data indicates the migration 
direction is toward the anode of the EF. However, when EF raised to 400 mV/mm, DCs 
showed strong directional migration towards anode with the index as -0.59±0.15, which 
was significantly higher than the IL-18 only or 200 mV/mm Plus IL-18 groups (Figure 
3-12 D, E). This implies that the EF and IL-18 compete on the modulation of elements of 
the cytoskeleton through which cells migrate 
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Figure 3-12 High strength EFs induce KG-1-derived DC directional 
migration 
KG-1-derived DCs were stimulated with IL-18 (100 ng/ml) and IL-18 plus EFs 
(200 mV/mm or 400 mV/mm), respectively for 2 hours. The cells movement were 
tracked and analysed afterwards. 
A-C. composite drawings where each cell is superimposed to origin point and the 
cell migration path traced over 2 hours 
D. cells exposed to 400 mV/mm plus IL18 were traced over 2 hours 
E. The migration directionality in each situation was analysed. Cos(θ) indicates 
the degree of directionality,0 means random migration, 1 means directional 
migration,-means direction towards anode. Data are presented as mean ± SD, *: 
P<0.05. 
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3.2.11 EFs promote DC chemotaxis in response to IL-18 in 3D culture 
IL-18 is an important proinflammatory cytokines and also induces various cells 
migration as a chemoattractant (Bachmann et al., 2007b; Ohtsuki et al., 1997).To further 
confirm whether KG-1-derived DCs have chemotaxis response to IL-18 and whether EFs 
have any influence on the process, I applied similar 3D culture method used in KG-1 
cells to test the KG-1-derived DCs. DCs displayed an evident response to IL-18 and 
migrated towards the IL-18 source on the left (Figure 3-13 A). The EFs enhanced this 
response with increased migration speed of DC from 2.7±0.17 μm/min up to 6.3 μm/min 
(Figure 3-13 B, C).  
3.2.12 IL18Rα is essential for EF-induced directional migration of KG-1-Derived 
DC 
To further confirm if IL18Rs is required for EF induced directional migration of DC, 
the IL18Rα over-expressing cells were used for the following experiments. KG-1 cells 
were firstly induced only by PMA for 3 days to become DC like cells. Because cells had 
not been treated with TNF-α, the KG-1-derived DCs kept low IL18Rα expressing level 
(Koutoulaki et al., 2010b). Before the PMA induction, the KG-1 cells were electroporated 
with IL18Rα-GFP plasmid. The GFP positive cells were then sorted and mixed with non-
transfected cells without TNF- treatment for induction. After PMA induction, the DCs 
were applied with 200 mV/mm EFs and the cells behaviours were recorded by 
fluorescence microscope. 
The further analysis of cell migration exposure to EFs is illustrated as Figure 3-14. The 
GFP positive cells showed directional migration response to EFs toward anode and did 
U-turn with the polarity reversal of EFs (Figure 3-14 A). The GFP negative cells 
displayed very less movement and no response to the EF reversal compared with GFP 
positive cells (Figure 3-14 B). In combination with the previous data that EF triggered 
asymmetric redistribution of IL18Rs (Figure 3-4, 3-7 and 3-9), this observation strongly 
implies that IL18Rs are the key regulator controlling the electrotaxis of DCs. 
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3.2.13 IL-18 increases co-localization of IL18Rα and actin 
The cytoskeleton elements, particularly actin plays an essential role in mediating cell 
motility. To further investigate the potential involvement of actin during DC migration, 
the IL18Rα and actin filament expression were visualized using immunocytochemical 
staining. Rhodamin phalloidin binds and stabilizes microfilaments and an anti-IL18Rα 
antibody indicates the distribution of the IL18Rα. 
The DCs were incubated with 100 ng/ml IL-18 for 15 minutes, and sequentially fixed 
and stained. The none-treated cells were taken as control. The yellow pixel in the merged 
pictures indicates the co-localization of the actin and IL18Rα, and the co-localization 
index was calculated using the software (Bolte and Cordelieres, 2006) .Figure 3-15 
illustrates that the co-localization of IL18Rα and actin increases significantly in IL-18 
treated group to 0.37±0.029 in comparison with the control group which is 0.087±0.014. 
This finding indicates that IL-18 may potentially contribute toward the activation in the 
leading edge of the migrating DCs. 
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Figure 3-13 EFs promote KG-1-derived DC chemotaxis in response to IL-18 
KG-1-derived DCs were mixed with Matrigel and seeded into EF chamber with 
IL18 (200 μl, 50 ng/ml) injected at right side. Cell then were traced without EF 
stimulation (A) or with 200 mV/mm EFs exposure (B) over 2 hours, the migration 
speed corresponds to each situation were analysed using Image J (C). Arrow 
indicates the direction of EFs towards anode, triangle indicate IL-18 gradient and 
the high side means the high IL-18 concentration. Data are presented as mean ± 
SD, *: P<0.05. 
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Figure 3-14 IL18Ra is essential for EF-induced directional migration of DC 
The IL18Rα-GFP over expressed KG-1-dereved DCs were mixed with control 
KG-1-Derived DCs and then exposed to EFs stimulation for 3 hours with EF 
direction reversed at the middle of the process. A. fluorescence images shows 
the movement of IL18Rα-GFP over expressed cells; B both control cells and 
IL18Rα-GFP over expressed cells were tracked during EFs stimulation and the 
image was merged from bright field and fluorescence. Arrow indicates the 
direction of EFs towards anode.   
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Figure 3-15 The co-localization of IL18Ra and actin increased by IL-18 in 
DC.  
A. Immunocytochemistry staining of KG-1-derived DCs. Cells treated with IL-18 
(50 ng/ml) or maintained in normal medium for 15 minutes and then stained with 
Rhodamine phalloidin (red) and anti-IL18Rα (green). The fluorescence images 
were captured using confocal microscope. 
B The colocalization of IL18Rα and actin in (A) were analysed using ImageJ. 
Data are presented as mean ± SD, *: P<0.05. 
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3.3 Discussion 
In this chapter, I tested the hypothesis that EF stimulation triggered the directional 
migration of KG-1 cells and KG-1 derived DCs via IL18Rs signalling. I demonstrated 
that EFs promoted activation and asymmetrical distribution of IL18Rα which potentially 
triggered downstream signalling cascade activation and induced directional migration. 
3.3.1 Immune response of the cells in EFs  
Previous studies have proved that disruption of an epithelial layer instantaneously 
generates endogenous electric fields, which have been shown to be important in wound 
healing. Despite numerous documentations that immuno-modulation is one of the key 
factors regulating wound healing profile, there is little study exploring the involvement of 
EFs in immune response during wound healing. The CD34
+
 myelomonocytic cell line 
KG-1 pocesses similar characteristic of PBMC, and is used as a typical cellular model for 
cytokine response research. Particularly, it dose-dependently responds to cytokine IL-18 
to produce IFN-γ (Koutoulaki et al., 2010a). Based on this model I designed the 
experiments to measure the change of the IFN-γ expression level when applied EFs on 
KG-1, upon which our hypothesis was tested.  
I found that the response of KG-1to IL18 can be enhanced by the application of EFs. 
The IFN-γ expression is lifted up to 3 and 7 times by 10V and 30V in transwell EFs 
stimulation, respectively. Apparently, the signalling cascade of IL-18 induced IFN-γ 
expression starts from the binding of IL-18 to the IL18 receptors. However, I found that 
application of EFs did not alter the expression of IL18 receptors, but increased the 
phosphorylation of p38 MAPK. It is in agreement with the previous report that 
application of EFs to HeLa S3 cells induced phosphorylation of MAPKs, including p38, 
JNK and ERK, and their upstream kinases (Morotomi-Yano et al., 2011). The human 
blood T cells exposure to EFs also showed increased activation of Erk1/2 (a member of 
MAPK family) and Akt. In addition Zhao described that inhibition of MAPK resulted in 
a reduced EF-directed cathodal migration of cornea epithelial cells (Zhao et al., 1999). 
Nevertheless, Rajnicek found that inhibitors of PI3K, MEK1/2 or p38 MAPK did not 
affect EF-induced growth cone turning (Rajnicek et al., 2006b). This may be due to the 
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fact that the response to EF stimulation is cell type specific, and that different cell types 
require different signalling pathway to respond to EFs. 
The shared activation of Erk1/2 and Akt signalling pathway by electrotaxis and 
chemotaxis suggests that cells may have common intracellular machinery to respond to 
extracellular stimuli. However, the kinetics of MAPK and Akt signalling distinguishes 
the electrotactic response from chemotaxis, because even though the phosphorylation of 
p38 MAPK was significant after one hour of EF treatment, this was not appreciable by 
western blot in the first 10 minutes of EF treatment, which forms sharp contrast with the 
rapid action of chemotaxis in seconds (Wang et al., 1998). The mechanism behind this is 
still largely unknown, but one potential explanation is that electrotaxis need to build up 
asymmetric distribution of receptor gradient(s) across the cell membrane, sometimes 
involving several signalling cascades simultaneously, which can be more time consuming 
than a simple ligand – receptor binding reaction in chemotaxis.  
3.3.2  IL-18 regulates immune cells function via activation of p38 
IL-18 is an important regulator of several type of cells during infection or 
inflammatory. The MAPK activation appears to play a prominent role in IL-18 signaling, 
being involved in transcription and translation of IL-18-induced IFN-γ mRNA and IL-18-
induced cytolytic effects. Kalina et al reported that IL-18 strongly enhanced tyrosine 
phosphorylation of STAT3 and of the p38MAPK in NK cells. Additionally, the 
stimulatory effect of IL-18 on IFN-γ protein production was counteracted by inhibition of 
MAPK (Kalina et al., 2000). Furthermore, inhibition of p38 MAPK, blocked enhanced 
regulate stem cell factor expression, indicating that p38 MAPK activity is required for IL-
18-enhanced SCF production in murine melanoma cells.  
On the other hand It has been demonstrated that IL-18 secretion was through p38 and 
ERK1/2 MAPK pathways. Niyonsaba et al reported that the inhibition of p38 and 
ERK1/2, but not JNK, almost completely nullified IL-18 secretion in primary cultured 
human keratinocytes (Niyonsaba et al., 2005). In addition, the synthesis of pro-IL-1beta 
and pro-IL-18 in THP-1 macrophages was also reported by the activation of p38 MAPK 
and NF-κB (He et al., 2012). 
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3.3.3 Receptor polarization in EFs  
It is still very controversial how the cells sense an EF in the first place. In this study, 
IL18Rα was redistributed to one side of the KG-1 cell membrane facing anode in the EFs, 
upon which the chemotaxis to IL-18 was enhanced. This has been further confirmed by in 
situ ICC staining in 3D culture. The real-time fluorescence imaging of the IL18Rα over-
expressed cells revealed the dynamics of IL18Rα in the presence of EFs stimulation. The 
real time movies evidently showed the polarization of IL18R-α can be controlled by the 
direction of EFs in less than 5 minutes, and that over expression of IL18Rα triggered the 
electrotaxis of DCs in comparison with low IL18Rα expressing cells, suggesting that 
IL18Rs may be one of the upstream regulators to initiate EF-induced responses of 
immune cells.  
One potential mechanism of electrotaxis is that cell surface receptors can be re-
distributed by the applied EFs therefore trigger downstream signalling for directional 
sensing, and allowing cells to move along the EF vector directionally. A broad spectrum 
of EF-induced activities involves membrane receptors activation upon EF exposure. Pu 
reported that EF-enhanced directional migration correlates well with the expression level 
of EGF receptor (EGFR/ErbB1) (Pu et al., 2007). In addition, Zhao proposed that EGFR 
asymmetric redistribution triggered electrotactic response of cornea epithelial cells 
(CECs) (Zhao et al., 1997). Moreover, EF-directed reorientation, elongation and 
migration of endothelial cells have been reported to require VEGF receptor activation 
(Zhao et al., 2004). Our finding is consistent with the previous studies that EF-enhanced 
response of KG-1 cells to IL-18 requires the activation of IL18Rα (Koutoulaki et al., 
2010b). However, I showed that the polarization of the receptors rather than the up-
regulation of expression is the key to trigger the downstream pathway. 
I demonstrated that IL18Rs are crucial for sensing EFs. In this study, I discovered that 
DCs overexpressing IL18Rα were responsive to EFs stimulation whilst the cells with less 
IL18Rα expression showed abolished effects. This suggests that potential signalling 
molecules might be intrinsically activated downstream of IL18Rs which interpret electric 
signals to downstream cellular response. In breast cancer cells, inhibition of ErBB1 
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completely abolished the directional response of MTLn3 cell (a breast cancer cell line) to 
EF stimulation. This was confirmed by transfecting low metastatic clone MTC cells with 
human ErbB1, which significantly increased the electrotactic response (Pu et al., 2007). 
Rajnicek proposed that Rho/Cdc42 is a molecular switch to control electrotaxis in CECs. 
They found that attenuation of cdc42 signalling abolished electrotaxis and enhanced 
contact guidance whereas inhibiting Rho signalling enhanced electrotaxis (Rajnicek et al., 
2007a).  
Deciphering the sensing mechanisms and the signalling cascade of electrotaxis is very 
important conceding embryo development, wound healing and cancer invasion. Using 
those “molecular switches” allows us to control cells physiological homeostasis while at 
the same time guiding their directional migration. 
3.3.4 The role of actin in electrotaxis 
It is clear that microfilaments are essential in cell migration. The actin cytoskeleton 
plays a major role in coordinating protrusions such as lamellipodia and filopodia, and 
forming adhesions, and finally retracting the tail (Le Clainche and Carlier, 2008). I 
showed in this study that IL-18 induced the increase of colocalization of IL18Rα and 
actin. One of the explanations of the electrotaxis of KG-1-derived DCs towards IL-18 is 
to be through the polarized colocalization of IL18Rα and actin. Komai-Koma et al first 
identified that IL-18 induced chemotaxis of T cells is via actin filaments assembly 
(Komai-Koma et al., 2003). Asymmetric redistribution of actin was observed in EF-
induced directional migration of CECs (Zhao et al., 1997). Based on previous results, I 
propose in this study that asymmetric actin assembly is involved in the regulation of 
electrotaxis through EF-induced polarization of IL18Rα.  
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3.3.5 Advantage of 3D model 
I adopted 3D culture system in this study to evaluate the interactions between 
electrotaxis and chemotaxis of KG-1 and KG-1-derived DCs. 3D culture system 
 
Figure 3-16 Receptor polarization in EFs 
Schematic illustrates the model of EF-induced cell response. The receptors on the 
cell membrane are polarized to the anodal side by EFs induction. The 
accumulation of the receptors locally enhances the ligand-receptor interaction 
thus triggers the downstream signalling pathways. 
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apparently has several advantages compared to the conventional 2D model. Firstly, even 
though 2D culture technique is routinely and widely used, the cell culture in 2D is 
arguably primitive and does not reproduce the physiological environment in vivo. The 3D 
culture model can overcome these shortcomings and clearly shows more physiological 
relevance. Secondly, the diffusion of IL-18 can be controlled in 3D culture to easily form 
a chemical gradient, thus the cellular response to IL-18 can be measured accordingly. In 
the contrary, it is difficult to generate an IL-18 gradient in 2D culture (doable with coated 
slides through bio-engineering; however it is highly technically demanding). Thirdly, EFs 
application in 3D culture can avoid the disturbance induced by micro movement of 
medium.  
3.4 Summary 
Chemotaxis and Electrotaxis have been compared and argued of their influence in the 
regulation of wound healing. Chemotaxis enables immune cells to reach sites of infection, 
regulate tissue homeostasis and is crucial for forming embryonic patterns (Jin et al., 
2008). Electrotaxis, on the other hand, has been shown to have overriding effects in 
directing cell migration during wound healing and embryo development (Zhao, 2009). 
In this study, I summarized the data with a model of directional sensing and migration 
in electric fields. I propose that the EF-induced re-distribution of the receptors on the cell 
surface results in a shift of membrane receptors between the cathode-facing and the 
anode-facing membrane the cell (Figure 3-16). There would be a higher probability to 
overcome the threshold of signal transduction at the higher density receptor side. The 
downstream signalling cascade therefore can be ignited. Although further evidence is 
required to clarify the electrotactic ability involving various specific membrane receptors 
on difference cell types, the possible differential membrane receptor distribution across 
the cell axis induced by the EFs is expected to initiate the cells to sense the EF.  
More importantly, those data imply that the applied EFs can direct the orientation and 
migration of cells in the presence of a chemoattractant gradient enabled by the receptor 
polarization mechanism. Thus, in the possible physiological situations wherein co-
existing chemoattractant gradients and EFs are presented such as during the wound 
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healing, electrotaxis of relevant cell types may preferentially guide the migration of cells 
over chemotaxis that will either facilitate or delay the normal physiological processes 
depending on the configurations of the co-existing chemical and EFs. Furthermore, such 
preferential migration toward the EFs may permit novel non-invasive clinical 
applications for guiding and manipulating cell trafficking and positioning in tissues 
electrically without the distraction from the chemotactic guiding cues. 
The existence of various chemoattractants in tissues supports the fundamental 
hypothesis that electrotaxis can be initiated by receptor shifting on the cell membrane and 
activated by the chemoattractants. More complications arise by considering polarization 
of multiple cell membrane receptors and multiple cytokines/chemoattractants 
(presumably at different rates and toward different directions relative to the EFs) and the 
downstream signalling processes and interplays triggered by these receptors. Despite 
these limitations and complications, the present studies discussed that EF-induced 
membrane receptor polarization amplifies the downstream signal cascade, provides 
interesting predictions that are consistent with previously reported experimental results, 
and further suggests the possibility of preferential orientation and migration of immune 
cells toward the EFs in coordination with chemoattractant gradients. 
In short, the mechanism of EF-induced KG-1/DC sensitization in responding to 
cytokines and its impact on DC migration were demonstrated for the first time in this 
study. The results indicated that physiological and pathological EFs can be potentially 
involved in the important host immune responses. The finding may have an implication 
of clinical therapy for cancer treatment and help to develop more effective vaccination 
protocols. 
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CHAPTER 4 ELECTRIC FIELDS CONTROL DIRECTIONAL 
MIGRATION OF LANGERHANS CELL IN VITRO AND IN VIVO 
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4.1 Introduction 
In this study I investigated the migratory activity of Langerhans cells exposed to a 
physiological electric field (EF) and IL-18 gradient in vitro and in vivo. Firstly the 
concurrent effects of both guidance cues on 3D cultured Langerhans cells were 
studied; and the migration rate and directionality were analysed. Additionally, this 
was tested on mouse epidermis tissue culture to further explore the Langerhans cell 
migration with these two treatments. Finally, the IL-18 and EFs were applied 
intradermally on mice and the migratory Langerhans cells were isolated, sorted and 
analysed.  
4.1.1 Langerhans cells 
Langerhans cells (LCs) – a specialized subset of dendritic cells (DCs), has been 
consider to be the major sensitizing cells in the skin by initiating productive immunity 
in naïve resting T cells. Epidermal LCs accounts for 3-5% of all nucleated cells in 
epidermis of mice and human. They are arranged in a network close to keratinocytes 
(Figure 4-1). 
LC is derived from bone marrow stem cells, which was found in mice and human 
(Frelinger et al., 1979; Volc-Platzer et al., 1984). LC precursors acquire 
immunologically important molecules/markers such as CD45, MHC class II and 
Langerin. Myeloid monocyte cultures induced with GM-CSF, IL-4 and TGF-β can 
differentiate into dendritic cells / LCs (Geissmann et al., 1998). LCs express typical 
myeloid antigens such as CD11b and CD33. However, LCs also express CD8-α, a 
marker of lymphoid descendants, when they achieve maturation (Anjuere et al., 2000).  
Migration and transport of antigen from the skin to the lymph nodes is an 
important feature of LCs. This may lead to immunity or tolerance, depending on the 
circumstances under which migration takes place (Romani et al., 2003). However, 
there is still no effective and mature method to isolate and primary culture LCs in 
vitro. Moreover, there are two status of LCs residing in the epidermis: resting and 
inflammatory. They are interconvertible in response to stimuli, which also raise the 
bar of difficulty to study the pure group LCs in vivo. 
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4.1.2 How to study LCs 
Histochemistry is the most widely used method for studying distribution of LC in 
the skin. Skin offers a simple and helpful experiment model, because it can be easily 
separated into epidermis and dermis sheets using simple chemicals (EDTA) or 
enzymes. Such sheets allow an en face view onto the epidermis that facilitates 
quantification and investigation. 
The classic method to obtain LC is to enzymatically separate epidermis and dermis 
and to digest epidermis into single cell suspension. Trypsin and dispase are commonly 
used for this purpose. Because the resulting suspension only contains about 1-3% LCs, 
so that the enrichment method becomes crucial for in vitro LC study. However, the 
LC obtained by trypsinization is immature, yet they do not fully represent LCs in situ 
(Schuler and Steinman, 1985a). Secondly cell surface markers may be sensitive to 
trypsin treatment, so freshly isolated LC should be carefully tested. 
Skin explant is a very useful alternative approach to the trypsinization method. 
Enriched LCs would emigrate from the epidermal sheet explant culture over a period 
of 2-4 days. This method has been successfully established in human and mouse skin 
models (Romani et al., 2003). In contrast to the trypsinization method, the LCs 
isolated from skin explants are mature by all established phenotypical, morphological 
and functional criteria (Romani et al., 2003). 
In terms of the application of specific marker for LC, Langerin and other common 
DC markers such as Cd11c, MHC class II largely facilitates the in vivo research. The 
GFP conjugated Langerhans cells and in vivo imaging technology allow visualization 
of LC behaviours in real time. Animal in vivo experiments especially using the 
genetic modified mice have largely expanded our understanding of the functions of 
LCs in both physiological and pathological situations. 
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Figure 4-1 IHC staining of LC 
Left and middle: the typical network of LC on epidermal sheet. The epidermal 
sheet was double -labelled with MHC class II (green fluorescence) and Langerin 
(red fluorescence). Right panel: Section of human skin immunolabeled with 
antibody against Langerin (red/yellow fluorescence) shows exclusive localization 
of Langerhans cells in the epidermis (Romani et al., 2003). 
 
4.1.3 LC migration in vitro 
After the discovery of LC, the characterisation of its physiological function has 
lagged mainly due to the hurdles in isolation and culture techniques. Schuler and 
Steinman first investigated the function of LCs in comparison with spleen DCs in 
vitro (Schuler and Steinman, 1985b). They used trypsinazition method to isolate LCs 
and found LCs were similar to spleen DCs morphologically and functionally. Both 
cell types are non-adherent, appearing buoyant density, and express high level of 
MHC class II. However, during the in vitro culture, the immunostimulatory ability of 
LCs became stronger than spleen DCs with challenged with GM-CSF. Several studies 
confirmed that freshly isolated LCs lack of immunostimulatory and migratory ability, 
but with GM-CSF and IL-4 treatments they became mature (Gerberick et al., 1991; 
Picut et al., 1988). 
Apart from immunostimulatory capacity, migratory ability was also investigated as 
another intrinsic feature of LCs. Kobayashi applied a reconstituted basement 
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membrane invasion assay to evaluate the migratory capacity of LCs in vitro 
(Kobayashi et al., 1995). They showed that hapten could trigger LC migration. 
Additionally, Saitoh showed that anti-IL-6 and anti-TNF-α antibodies inhibited donor 
LC migration into epidermis, which indicates that IL-6 and TNF-α are responsive to 
promote LC migration (Flint et al., 1998). Moreover, Noirey reported that TNF-α 
initiated pro-MMP2 and pro-MMP-9 production followed by cell migration in a dose 
dependent manner in explant culture (Perez et al., 2005). Furthermore they proved 
that antigens (rBet v1) induced synthesis of TNF-α and TNF R II in LCs which 
implied an autocrine loop in antigen-induced LC migration (Noirey et al., 2002). 
However, the mechanism of LC migration in vitro is still an enigma. It is largely 
unknown why the matured LCs gain the capacity to migrate, how these cytokines 
mediate the LC migration, and which signalling cascade(s) are involved. 
4.1.4 LC migration in vivo 
The physiologic roles of LC were characterised by a series of in vivo studies on 
contact hypersensitivity. The typical contact hypersensitivity study is to sensitize 
mouse by painting ears with irritants such as oxazolone and trinitrochlorobenzene. 
The intensity of contact hypersensitivity is indicated by ear swelling. The correlation 
between the density of LC in epidermal and ear swelling index reveals that LCs play 
the main role in the induction of contact hypersensitivity. Additionally, pre-treatment 
with neutralizing IL-1β antibody, but not TNF-α and GM-CSF, significantly 
prevented the allergen-induced contact hypersensitivity of mouse ear (Rambukkana et 
al., 1996). This suggests that IL-1β is crucial for initiation of LC migration in contact 
hypersensitivity. The following studies not only confirmed this result but also 
identified the signalling pathway of allergen-induced LC migration. Antonopoulos 
investigated contact hypersentivity using IL-1β and IL-18 knockout mice and found 
that IL-18 plays a central role in cutaneous immune response by mediating LC 
migration in contact hypersensitivity, acting upstream of IL-1β and TNF-α 
(Antonopoulos et al., 2008). Additionally, IL-4 was found to prevent LC migration 
through downregulating TNF RII (Takayama et al., 1999). Moreover, enhanced LC 
migration was found in IL-10 knockout mice due to its reversed regulation on TNFR 
II expression (Wang et al., 1999b). Except IL-18-IL1β pathway, there are a variety of 
other cytokines which were found also important for DC migration in vivo (Wang et 
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al., 1999a). Sato reported that deficiency of CCR 2 (CC chemokine receptor) led to 
reduced LC migrated to Lymph node. 
Another focused area of LC migration is cell-skeleton molecules. Price found that 
alpha 6 integrin plays an important role to induce LC migration into lymph node by 
regulating access across the epidermal basement membrane (Price et al., 1997). Ross 
reported that beta and gamma actin isoforms were upregualted during LC maturation, 
suggesting actin filaments also are required for LC motility (Ross et al., 1999). In 
addition, the actin-binding protein fascin was reported to be involved in the formation 
of dendritic process of motile LCs (Ross et al., 1998). In short, the in vivo research of 
LC migration is summarized in Figure 4-2. 
 
Based on the fact that the cytokine secretion and electric fields are co-occurring in 
the skin tissue during the wound healing or inflammation, I hypothesise that 
physiological EFs could potentially play a role in IL-18 mediated LC migration in 
vivo and in vitro.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121 
 
 
 
 
Figure 4-2 Schematic of LC migration 
The migratory steps of LCs and major contribution of cytokines are highlighted 
(Wang et al., 1999a): (1) contact allergens penetrate the epidermis. (2) LCs are 
activated by IL-1β and TNF-α. (3) downregulation of E-cadherin leads to LC 
migration from epidermis to dermis. (4) upregulation of CCR7 on LCs and its 
ligand SLC attract LCs into lymphatic. (5). ELC another ligand of CCR7 attracts 
LCs into T cell area. (6). LC present processed antigen to naïve T cells (Ross et 
al., 1998). 
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4.2 Result 
In this chapter EF-modulated migration of LC in response to IL-18 was assessed in 
vitro and in vivo. This allows us to comparatively and systematically study the 
potential roles of electric signals in immune defence of the skin.  
4.2.1 EFs induce LC migration in response to IL-18 in 3D culture 
Primary mouse epidermal LCs were isolated using dispase enzyme and cultured in 
RPMI complete medium containing 50 ng/ml GM-CSF and 20 ng/ml IL-4. Cell were 
maintained in 5% CO2, 37º C incubator for 2 days before EF stimulation. LCs were 
mixed with Matrigel and then seeded into EF chamber for EF stimulation. The EF 
experiments were divided into 4 groups: control, IL-18 only, EFs only and IL18+EFs. 
IL18 was injected locally on one side of the chamber 10 minutes before EFs to 
generate an IL-18 gradient across the gel. The EF strength was 200 mV/mm and the 
whole exposure lasted about 2 hours. 
Upon EFs application to 3D cultured LCs, there was no significant change on 
migration speed and directionality (Figure 4-3, A (a-b) and C (a-b)). The migration 
speed of control and EF stimulation group were 0.77±0.32 μm/min and 0.97±0.34 
μm/min, respectively, and the directionality index were -0.26± 0.067 and -0.17±0.081, 
respectively. In the absence of EFs, the diffused IL-18 slightly upregulated migration 
speed of LC up to 1.74±0.65 μm/min and the directionality is up to -0.43±0.052 
(Figure 4-3, A (c), B (c), C and D). Interestingly, EFs significantly increased the 
migration speed of IL-18 treated LCs to 3.33 μm/min compared with control, EF only 
and IL-18 only groups. EFs also promoted the directedness of LCs to -0.68±0.05, 
indicating that in the presence of EFs LCs sensed IL-18 and moved more persistently 
toward the IL-18 source. 
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4.2.2 EF induce LC migration ex vivo 
Mouse ear skins were split and the epidermis halves were prepared in explant 
culture as described in Chapter 2. After 18 hours of explant culture, the epidermis 
sheets were transferred into EF chamber treated with IL-18 (200 ng/ml), 200 mV/mm 
EFs and IL-18.plus EFs, respectively. The experiments lasted from 60 minutes to 2 
hours, the emigrated LC were counted. It was evident that only in the treatment of 
EFs plus IL-18, a large quantity of LC emigrated out from the epidermis; on the 
contrary, neither EFs nor IL-18 alone induced LC migration out of the epidermis 
(Figure 4-4 and supplemental movies). However, it took about 40 minutes to induce 
LC migrate under EFs plus IL-18 exposure according to the time lapse recording data, 
indicating cells need to be sensitized or activated first to build up the essential 
regulating force(s) before electrotaxis can be initiated. 
  
Figure 4-3 EFs enhance LCs migration towards IL18  
Primary cultured mouse LCs were mixed with Matrigel and then seeded into EF 
chamber. IL-18 (200 μl, 50 ng/ml) was injected at the right side of the chamber and 
the IL-18 gradient across the chamber was established by diffusion (A (c) and (d)). 
(the high side of triangle indicates the high IL-18 concentration ). 
A. The cells were exposed to 200 mV/mm EFs (A (b)), IL-18 gradient (A (c)), and 
EFs plus IL-18 (A (d)), respectively, for 2 hours and the cell migration were 
tracked and analysed. The control group cells were without any treatment. 
B. Composite drawings where each cell is superimposed to origin point and the cell 
migration path traced in each situation corresponding to A. 
C. Migration speed of LCs in each condition of (A) were analyzed accordingly.  
D. Migration directedness of LCs in each condition of (A) was analyzed 
accordingly. Data are presented as mean ± SD, *: P<0.05 
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Figure 4-4 EFs and IL-18 promote LC emigrate from epidermis explants. 
Mouse ear epidermis was cultured in EF chambers and stimulated with EFs (200 
mV/mm), IL-18 (200 ng/ml) and EFs plus IL-18 for 2 hours, respectively. Arrows 
indicate the direction of EFs and the ear tissue are labelled. Compared with the 
limited emigration of cells out of the epidermis when treated with either EF (left) 
or IL-18 alone (middle), a combination of both treatments synergistically 
enhanced the emigration of LCs (right).  
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4.2.3 Quantification of DCs from lymph node 
The inguinal lymph nodes were excised and the total cells were divided into two 
groups. One part cells were enriched by gradient centrifugation and the other group 
 
Figure 4-5 Quantification of DCs from lymph node. 
Total lymph node-resident cells (A right) and gradient centrifugation 
enriched cells (A, middle) were characterized by FACS using MHC class II 
and CD11c as DC markers. The isotype control was shown in A (left). The 
percentage of DCs in total cells and enriched cells population were analysed, 
respectively (B). Data are presented as mean ± SD, *: P<0.05. 
* 
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kept intact. The cells were then incubated with anti-MHC class II-PE and anti-CD11c-
FITC to positively mark dendritic cells.  
The FACS profile shows that about 17.8% cells in gradient centrifugation group 
are MHC calss II
+
 and CD11c
+ 
compared with only 5.38% double positive cells in 
total cell group (Figure 4-5, A). The statistics suggests that the DCs are enriched 
about 3 times by gradient centrifugation (Figure 4-5, B). 
4.2.4 LC isolation and identification 
The DCs in lymph node consist of several group cells come from different sources, 
including residing DCs, skin originated LCs and interstitial tissue derived-DCs (Henri 
et al., 2001). After gradient centrifugation, I stained the enriched DCs with anti-
Langerin-PE and anti-IL18Ra-APC. The FACS results showed that there are about 8% 
Langerin positive DCs, and 3% DCs are Langerin and IL18Rα double positive (Figure 
4-6). 
 
 
Figure 4-6 Identification LC population in DCs.  
The lymph node cells, after gradient centrifugation, were divided into two 
equal parts. Each part was double stained with MHC class II-PE plus CD11c-
FITC (Left) and Langerin-PE plus IL18Rα-APC (right), respectively. Arrow: 
indicates the cells (right) come from which gate area of FACS result (left). 
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Considering that only 12-17% cells in lymph node are MHC class II
+
 and CD11c
+
, 
the Langerin positive cells are less than 1% in the whole cell population. Thus the 
quantification of the proportion of LC in lymph node DCs provides a foundation to 
explore if exogenetic stimuli (EFs and IL-18) could alter the LC migration in epithelia.  
4.2.5 Both IL-18 and EFs induce LC migration into lymph node 
It has been demonstrated that Fluorescein isothiocyanate (FITC) painting is an 
effective way to be used as an immunofluorescence marker for cells and a contact 
sensitizer (Wang et al., 1997). The uptake of FITC by APC can be tracked by 
fluorescence (Bigby et al., 1987; Szczepanik et al., 1998; Wang et al., 1997). In this 
study mice were painted on the shaved tail base with 50 μl ml 0.5% FITC in 1:1 
acetone/dibutylphathalate. The experimental mice were divided into four groups: 
Control (unpainted), FITC painted, FITC painted plus intradermal administration of 
50 ng IL-18, FITC painted plus intradermal administration of 50 μl PGE2 (0.1 mM). 
The drugs were injected 30 minutes after painting to allow FITC to dry down. The 
inguinal lymph nodes were collected from the mice 24 hours after treatments. The 
lymph nodes were gently disrupted and the cells were harvested and enriched as the 
described in Chapter 2. The enriched cells were consequently analysed with FACS. 
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Figure 4-7 Intradermal administration of IL-18 or PGE2 induces LC 
migration into lymph node 
Mouse tail base was painted with FITC (50 μg/ml, 25 ul) and then intradermally 
injected with IL-18 (50 ng; A) or PGE2 (0.1 mM, 50 μl; B), respectively. The 
lymph node resident cells were enriched by gradient centrifugation. The FITC 
fluorescence intensity of the enriched cells were thus analysed by FACS. The 
unpainted naïve mice were taken as control. 
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The histogram in Figure 4- is composed by the number of cells (Y axle) and the 
strength of fluorescence (x axis). With FITC painting, the histogram (blue) shifts to 
right, suggesting there are more cells carrying fluorescence in the lymph node than 
unpainted mice. Intradermal injection of IL-18 enhances the histogram (red) shift to 
right further (Figure 4-A). This implies that IL-18 induces more APC cells migration 
compared to FITC painting alone. 
PGE2 is a strong chloride channel activator and can stimulate an increase in net 
chloride efflux in epithelia layer (Shimizu et al., 1993). It has been demonstrated that 
administration of PGE2 could effectively increase trans-epithelium potential 
difference, which potentially play essential roles in many physiological and 
pathological situations including wound healing (Nuccitelli et al., 2008; Song et al., 
2002). In this study, I intradermally injected PGE2 to increase the TEPD across the 
epidermis. Figure 4- (B) illustrates that PGE2-generated TEPD dramatically shifts the 
histogram to the right, indicating TEPD has induced more FITC positive cells 
migration to lymph nodes compared to FITC painting and control group.  
4.2.6 Quantification of IL-18 induced DC and LC migration 
The FITC bearing cells are supposed to be motile APC cells migrated from skin to 
lymph node. However, except APC the FITC still can be carried into lymph node, 
such as diffusion. Secondly, the APCs in skin are composite of several subsets, 
including LC and dermal DC. Thus, to quantitatively analyse the proportion of LC 
migrated into lymph node, I sorted FITC positive cells out and stained them with 
either DC specific markers MHC Class II and CD11C or LC specific marker Langerin. 
With FITC painting, about 5% FITC bearing DCs showed MHC Class II and 
CD11c double positive; about 1% Langerin positive LCs migrated into lymph node 
(Figure 4-, A, B). With IL-18 stimulation, an increased proportion of DCs (~ 11% of 
total FITC positive cells) appeared in the lymph node, and the proportion of LCs also 
rose to about 5.6% (Figure 4-, A, B). In comparison with FITC painting alone, IL-18 
administration increased the migration of DCs and LCs into lymph node, around 2 
folds and 5 folds, respectively (Figure 4-, C and D). 
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Figure 4-8 IL-18 induces DC/LC migration into lymph node 
Mouse tail base was painted with FITC (50 μg/ml, 25 ul) and injected with IL-18 
(50 ng) and equal amount PBS as control. The next day, dendritic cells from 
inguinal lymph nodes were enriched and double stained with MHC class II-PE 
plus CD11c-APC (A) and Langerin-PE plus CD11c-APC (B), respectively, for 
FACS characterisation.  
The portions of emigrated epidermal DCs (C) and LCs (D) in inguinal lymph 
nodes with FITC painting and IL-18 injection were analyzed, respectively. Data 
are presented as mean ± SD, *: P<0.05. 
 
 
 
* * 
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4.2.7 Quantification of DC/LC migration induced by EFs into lymph node 
Figure 4- A and B illustrate that the proportion of DC and LC induced by PGE2 
generated TEPD are11% and 5.6%, respectively. The statistical analysis suggests that 
there are more DCs and LCs migrate into lymph node when treated with PGE2, with 
about 2 fold and 5 fold more respectively, compared to FITC painting alone (Figure 
4-, C and D). 
Both IL-18 and PGE2 have been shown to induce more proportion of LC to 
migrate into lymph node. However, there is no difference between IL-18 and PGE2 
group. Considering the possibility that PGE2 may also has pharmacological effects on 
LC migration (Preliasco et al., 2008), the actual capacity of PGF2 induced EFs in LC 
migration need to be further investigated with more well-controlled experiments. 
133 
 
 
Figure 4-9 EFs induce DC/LC migration into lymph node 
Mouse tail base was painted with FITC (50 μg/ml, 25 ul) and injected with PGE2 
(0.1 mM, 50 μl) and equal amount PBS as control. The next day, dendritic cells 
from inguinal lymph nodes were enriched and double stained with MHC class II-
PE plus CD11c-APC and Langerin-PE plus CD11c-APC, respectively, for FACS 
analysis. DCs (A) and LCs (B) were characterised in each experimental condition.  
The portions of emigrated epidermal DCs (C) and LCs (D) in inguinal lymph 
nodes with FITC painting and IL-18 injection were analyzed, respectively. Data 
are presented as mean ± SD, *: P<0.05.  
 
* * 
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4.3 Discussion 
In this chapter I discussed the migration of LCs induced by electric signals and IL-
18, and investigated the hypothesis that EFs promote the sensitivity of LC in response 
to IL-18 thus the migration of LC is increased.  
4.3.1 EFs induce LCs migration towards IL-18 gradient in vitro 
In this study I investigated the migration of LC under the exposure of either EFs or 
IL-18 or both in 3D culture. I demonstrated that neither EFs nor IL-18 can alter the 
migration speed of LCs. However, EFs plus IL-18 synergistically increased LC 
migration speed. Additionally, I observed that EFs also increased the sensitivity of 
LCs in response to IL-18, so that LCs directionally migrated towards the source of IL-
18 in the presence of EFs.  
I first established the experimental approach for studying the effects of EFs on LCs 
in response to IL-18 in 3D culture. LC is a type of cell which is fragile to artificial 
environment. Thus I maintained freshly isolated LCs with the full RPMI medium 
containing cytokines GM-CSF and IL-4, which were reported to be essential for 
maintaining the viability of LC in vitro (Rupec et al., 1996; Yokota et al., 1996). 
Moreover, Matrigel was used to build up a 3D environment which is suitable to build 
up cytokines gradient and apply EFs. Using this system, the LC behaviours under 
stimuli in 3D culture were recorded and analysed thereafter. I demonstrated that EFs 
synergistically induced LCs directional migration towards IL-18 gradient; however 
neither IL-18 nor EFs alone could change the directional migration of LCs. Moreover, 
Wang reported that migratory LCs expressed higher IL-18 than static resident LCs 
during contact hypersensitivity (Wang et al., 2002). These data indicate that the 
threshold of LC to sense IL-18 could be potentially reduced by EF and that these 
mechanisms seemed to work via feed-back loop. 
It has been demonstrated that freshly isolated LCs are immature and lack motility 
(Picut et al., 1988; Schuler and Steinman, 1985b). Cytokines such as IL-1β and TNF-
α are supposed to play an important role to promote their maturation in vitro (Noirey 
et al., 2002; Saitoh et al., 1999; Tang and Udey, 1992; Yokota et al., 1996). IL-18 
belongs to IL-1 family and is also suggested to induce LC migration in vivo (Wang et 
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al., 2002). However, in our 3D culture system, IL-18 (50 ng) did not show chemotaxis 
effects on LCs. This could be due to the low IL-18 concentration or the Matrigel 
fibres confine the movement of LCs in a certain level.  
EFs have been found to either play an important role in controlling a variety of 
cells directional migration alone (McCaig et al., 2005; Zhao et al., 2002b) or with 
cytokines together (Li et al., 2011). Moreover, EFs genesis and immune response 
would overlap temporospatially during the wound healing. It has been demonstrated 
that EFs can induce lymphocytes directional migration via activation of MAPK 
signalling cascade (Lin et al., 2008). On the contrary, this study showed that 200 
mV/mm EFs stimulation did not evidently convince LC directional migration in 3D 
culture. That might be because either the EFs was too weak to activate LCs or LCs 
failed to transduce EF signal into motility. 
Interestingly, when both IL-18 gradient and EFs were present, the migration speed 
of LCs increased significantly. Wu and Lin proposed that redistribution of membrane 
receptors induced by EFs mediates electrochemical sensing and migration of the cells 
(Wu and Lin, 2011). Zhao et al proposed that redistribution of EGFRs induced by EFs 
underlie directional migration of CECs (Zhao et al., 1999). This observation has been 
confirmed in a variety of cells types such as breast cancer cells (Pu et al., 2007), 
keratinocytes (Zhao et al., 2006), fibroblasts and Dictyostelium (Zhao et al., 2002a). 
Thus it is tempting to assume that IL-18R would be polarized by EFs and the ligand - 
receptor binding reaction would then be amplified. IL-18 also has been demonstrated 
as a chemoattractant, since it can induce actin assembly of dendritic cells thus activate 
cells motility (Kaser et al., 2004). Thus one of the reasonable explanations is that 
polarization of IL-18Rs induced by EFs leads to the directional actin assembling. 
LCs, like most migratory cells, exist and migrate in a 3D physiological 
environment. However, the majority of understanding of LC migration is limited to 
2D (Haessler et al., 2011). Furthermore, it is suggested that cell migration requires 
different mechanisms in 3D vs. 2D (Lammermann et al., 2008). Matrigel is a 
commercially available reconstituted basement membrane mixture, that has been 
widely used to mimic 3D environment for cell migration (Benhamron et al., 2006; 
Chabot et al., 2006). However, the limitation of this 3D culture model is that it is 
difficult to precisely control cytokine (IL-18) release which might potentially lead to 
the uneven distribution of the gradient. Another shortcoming for EFs study is that 
Matrigel fails to provide ion flux like skin cells which use ion channels to maintain 
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TEP, therefore the conductivity is not the same as real physiological situation. This 
might reduce the sensitivity or the response of cells in Matrigel to the EFs stimulation. 
4.3.2 EFs and IL-18 synergistically promote LC emigrant from epidermis 
explant culture ex vivo 
In this section I used epidermis explant as a model to investigate LCs migration 
under the stimulation of IL-18, EF or both. I found that EFs plus IL-18 exerted a 
synergistic effect on inducing LC emigrant from epidermis. On the contrary, neither 
IL-18 nor EFs alone showed evident effect on LCs migration in explant culture.  
The skin explant culture is a reliable method to study skin cell migration and 
immune reaction, and it has been recognized as a bridge transferring recognitions 
from in vitro to in vivo. Particularly, for the understanding physiological and 
pathological functions of LC, skin explant culture is a very useful model (Caras et al., 
2007; Hofer et al., 2003; Kurz et al., 2002; Lateef et al., 2003; Ratzinger et al., 2002). 
That is because maturation and migration of skin LCs are tightly linked processes. 
Apparent migration of LCs can not occur without concomitant maturation (Hofer et 
al., 2003). LCs in skin explant cultures have presumably received their initial 
maturation and migration stimulus by the cytokines secreted by nearby keratinocytes 
or fibroblasts. Therefore, with the right stimulation or signals they are ready to 
migrate. 
In this study, I found that EFs (200 mV/mm) plus IL-18 (100 ng/ml) treatments 
initiated LC emigrate after 40 minutes exposure. It has been proposed that 
redistribution of chemoattractant receptors induced by EFs enhances the chemotaxis, 
when EFs and chemoattractant both are present (Wu and Lin, 2011). Guo reported 
that it took about 1 hour for dermal fibroblasts to manifest detectable directional 
migration when exposed to EFs (150 mV/mm) (Guo et al., 2010). It is also suggested 
that the sensitivity of response to EFs stimulation varies in different cell types or 
culture systems (Li et al., 2011; Wu and Lin, 2011). Therefore, in our explant culture 
system, the cells might potentially need ~ 40 minutes to build up an enough potential 
difference to drive membrane receptor redistribution, and consequently sense the IL-
18 gradient. 
The advantage of skin explant culture is that the living environment of LCs is 
relatively intact. However, during enzymatic dissociation and separation, the 
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surrounding cells such as keratinocytes, fibroblasts will secrete cytokines, apoptosis, 
or modify gene expression in response to the stress. These changes inevitably would 
affect LCs behaviour in a certain level. Another concern is that IL-18 and EFs may 
have effects on other cells as well, it is thus difficult to prove the directional migration 
of LCs is the direct effects of the stimuli rather than the indirect influence by other 
cell types. 
4.3.3 IL-18 induce LCs migration into draining lymph node in vivo 
In this section, I semi-quantitatively investigated LCs migration with intradermal 
administration of IL-18. The results suggested that IL-18 could induce DCs and LCs 
migration from skin to draining lymph nodes, and the efficiency rose 2 fold and 5 fold 
compared to control group, respectively. 
Within the epidermal environment, keratinocytes and LCs express IL-18, IL-1β 
and Caspase-1; when inflammation occurs, the expression of those molecules is 
upregalated (Antonopoulos et al., 2008; Cumberbatch et al., 2001). It has been 
reported that IL-18 plays a key role in mediating LC migration, acting upstream of IL-
1β and TNF-α. IL-18 belongs to IL-1 family and shares similar structure to IL-1β 
(Dinarello, 2007). Both IL-18 and IL-1β require proteolytic cleavage by caspase-1 
generate mature function form from inactive precursor form. Caspse-1 also has been 
found to induce LC migration that presumably due to its modulation on IL-1β and IL-
18 expression (Antonopoulos et al., 2001).  
However, the recent study by Cumbertatch found that IL-18 and IL-1β were not 
able to initiate LC migration in Langerin-Cre-MyD88 mice, indicating there may 
be an alternative way of IL-18 to induce LC migration. It is also reported that 
preformed IL-1α release is important in initiating LC migration without the 
activation of IL-18 signalling (Cumberbatch et al., 2002). 
4.3.4 Electric signals induce LCs migration into draining lymph node in vivo 
I found that intradermal injection of PGE2 induced LCs migration into draining 
lymph node. PGE2 is a Cl
- 
channel activator and has prominent effects on increasing 
physiological electric signals on epithelium (Song et al., 2002).  
It has been proposed that physiological EFs control directional cell migration in 
vivo (Song et al., 2002). EFs do establish chemical gradients. Injection of fluorescence 
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charged protein into the pre-limb-bud region of amphibian embryos – where an EF 
has been detected, resulted in a comet-tail-like distribution, driven by extracellular 
electrophoresis, rather than symmetric distribution of the fluorescence probe (McCaig 
et al., 2005; Zhao et al., 2006). Application of PGE2 into the wound has been proved 
to increase wound induced EFs and enhance wound healing in vivo (Nuccitelli et al., 
2008). 
The conventional theory for LC migration is based on chemotaxis. It has been 
demonstrated that CCR7 is crucial for LC migration from epidermis to draining 
lymph node, because CCR7-dificient mice (which lack the CCR7 ligand CCL19 and 
CCL-ser) have a severe defect in LC migration to the skin draining lymph node 
(Villablanca and Mora, 2008). Moreover, immune cells such as T cells and 
neutrophils could be activated by EFs (Wu and Lin, 2011; Zhao et al., 2006). Recently, 
Li quantitatively investigated how T cells response to CCL19 with EFs present. They 
demonstrated that optimal electrotactic migration of activated T cells (in a 7 V/cm 
EFs) exhibited comparable motility and even higher orientation responses comparing 
to the optimal T cells chemotaxis to 100nM CCL19 gradient (Li et al., 2011). 
Although endogenous electric signals are generated by ions leakage and PGE2 
indeed has function in increase endogenous electric signals via consistently opening 
Cl
- 
channel, it is still difficult to eliminate its pharmacological effects on LCs or 
surrounding cells. The best way to prove the concept that EFs could induce LCs 
migration might be physically apply electric current across the skin.  
 
4.4 Summary 
The data from this chapter are consistent with my hypothesis: the physiological 
EFs act on LCs and redistribute membrane receptors, thus initiate cell migration in 
response to cytokine (IL-18). This finding may permit novel approaches for 
manipulating the positioning or migration of dendritic cells or other immune cells to 
enhance immune response or antitumor responses. Additionally, it provides a 
potential application to optimise vaccine production as a joint effort to combine EFs 
together. 
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CHAPTER 5 ELECTRIC FIELDS CONTROL CHRONIC WOUND 
FIBROBLAST MIGRATION 
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5.1 Introduction 
5.1.1 Chronic wounds 
Age-associated diseases such as Alzheimer’s disease, diabetes and cancers not only 
have an enormous economic impact but also are of great concern to patients themselves. 
Degenerative potential and decline in repair in the skin of aged population may lead to 
non-healing wounds, such as chronic venous leg ulcers, pressure ulcers, and diabetic 
ulcers. More than 4 million people in the United States are affected by these wounds each 
year (Rayment and Upton, 2009), which are becoming a major cause of pain and anxiety 
and also significantly lessen their mobility and diminish their quality of lives. Large 
variety of causes and many comorbidities associated with chronic wound not only make 
clinical treatment into complexity of different management strategies (Campitiello et al., 
2005; Falanga, 2005; Sporn and Roberts, 1993) but also dive research into specific 
branches without a uniform conclusion (Ching et al., 2005; Stojadinovic et al., 2005).  
Chronic wound pathology 
The tissue damage is primary to some external noxious stimulus, such as edema, 
mechanical injury, persistent eschar, local pathogens, debris, or infection. Eliminating the 
primary noxious factors by conservative wound care effectively heals the majority of the 
wounds (Goldman, 2004). However, there still are some wounds cannot be healed by the 
conservative methods and persistently reoccur. Generally, those chronic wound can be 
divided into three categories: Venous chronic wound, pressure ulcer, and diabetic ulcer. 
Venous ulcer 
The main reason leading to venous ulcer is edema resulting from venous hypertension 
associated with pericapillary cuffing of fibrin, macroglobins, and other macromolecules 
(Falanga and Eaglstein, 1993). It has been postulated that fibrin cuffs sequester growth 
substances, making them unavailable to trigger healing (Braund et al., 2007). Recently it 
has been reported that venous ulcer is associated with a pro-inflammatory environment 
with high expression level of IL-1α, IL-1β, IFN-γ (Beidler et al., 2009). Additionally, 
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upreguated protease was thought to overwhelm the antiproteinase shield, perpetuating 
tissue injury and deactivating growth factors and keeping the healing process delay 
(Goldman, 2004). 
Pressure ulcer 
Although the etiology of pressure ulcer is multifactorial, tissue ischemia has long been 
thought to be the main reason (Saito et al., 2008). Recent studies also indicate that free 
radical oxidative injury can cause inflammation and severe derangement of the cell 
recruitment process to the site of injury (Robson et al., 2000). Furthermore impair of 
endothelial cell function can limit cytokine production and delay wound healing (Saito et 
al., 2008). 
Diabetic ulcer 
Diabetic ulcer is a common complication of diabetic mellitus. The factors contributed 
to the ulcer involve mechanical, vascular, inflammatory, oxidative, endothelial, and 
nutritive causes (Johansen et al., 2009). There is currently no single treatment with 
measurable clinical impact available. The main strategy is modulating inflammatory and 
endothelial function (Torres et al., 2010).  
5.1.2 PDGF and wound healing 
A wide variety of different growth factors orchestrate cell behaviour and interaction 
during all stages of wound healing. Platelet derived growth factor (PDGF) is both potent 
mitogen and chemoattractant in wound healing process (Martin, 1997). PDGF has been 
shown to improve wound healing in both laboratory (Tyrone et al., 2000; Vasquez et al., 
2004) and clinical trials (Koveker, 2000; Margolis et al., 2000; Robson et al., 2000).  
PDGF comprises a family of homo or heterodimeric growth factors and the common 
types are PDGF-AA, PDGF-AB, PDGF-BB, PDGF-CC and PDGF-DD. A few types of 
cell can produce PDGF including platelets, macrophages, vascular endothelium, 
fibroblasts and keratinocytes (Barrientos et al., 2008). The conventional signalling 
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pathway of PDGF is that the ligands bind to PDGF receptor α and PDGF receptor β, 
which causes dimerization of the receptors resulting in the receptors autophosphorylation. 
This creates a docking site for SH2 domain whereby several downstream signal pathways 
are the activated (Werner and Grose, 2003). 
PDGF is involved in each stage of wound healing. At early stage, PDGF is released 
from platelets upon the wound start. The secretion of PDGF in wound bed attracts 
neutrophils, macrophages and fibroblasts migration to the wound side by chemotaxis 
(Schneider et al., 2010). It can also induce macrophages to produce other growth factors 
such as TGF-β. Together with TGF-β, PDGF has been found to enhance granulation 
tissue formation (Konya et al., 2008). In addition PDGF also has been demonstrated to 
play an important role in angiogenesis (Xue et al., 2012). It works synergistically with 
hypoxia to increase the expression of VEGF in ischemia injury (Cao et al., 2003). PDGF 
is particularly important in blood vessel maturation. In vivo experiments suggest that 
PDGF is essential for recruiting pericytes to the capillaris and increases the structure 
integrity of vessels (Hellberg et al., 2010). 
Moreover, PDGF is also important in reepithelialisation by upregulating the 
production of IGF-1 and thrombospondin-1 which increases keratinocyte motility and 
promotes proliferation, respectively (Loot et al., 2002). PDGF has also been proposed to 
enhance ECM production via increasing proliferation of fibroblasts (Xu and Clark, 1996). 
Additionally, it stimulates fibroblasts to contract collagen matrices and induces them into 
myofibroblast phenotype (Leask, 2010).  
The decreased expression of PDGF is thought to be one of the reasons for chronic 
wound (Pierce et al., 1995). It has been shown that PDGF is susceptible to the proteolytic 
environment found in the chronic wound and its degradation can be reversed by addition 
of MMP inhibitors (Mast and Schultz, 1996).  
Clinically, recombinant human variants of PDGF-BB have been the only successful 
cytokine treatment in diabetic chronic wound. The gene delivery of PDGF also has been 
reported that it is effective and safe for chronic wound treatment (Margolis et al., 2000).  
143 
 
5.1.3 Fibroblasts in wound healing 
Fibroblast is one of the main driving forces to accomplish wound healing by providing 
contraction and expressing extracellular matrix and growth factors (Martin, 1997). Upon 
wound, fibroblasts are activated to differentiate into myofibroblasts, which contract and 
reduce the wound size (Li and Wang, 2011). A major function of fibroblast is to 
synthesize ECM proteins, such as collagen type I-VI and XVIII, glycoproteins and 
proteoglycans for normal growth or during wound healing (Powell et al., 1999). 
The contraction is mainly accomplished by the intracellular tension generated by 
fibroblasts and myofibroblates. The cellular actin-myosin filaments transmit the tension 
via focal adhesion and as a result cell traction forces are generated (Han et al., 2012). 
This contraction is regulated by a number of molecules such as myosin light chain kinase 
(Nobes, 2000). In order to heal the wound, the fibroblasts normally are attracted by 
chemoattractant and migrate into wound bed.  
The migration of fibroblasts therefore is indispensable for wound healing. It has been 
demonstrated that the small GTPases are critical for fibroblast migration (Nobes, 2000). 
The major components of the small GTPase involved in cell migration are Rac1, Cdc42 
and RhoA. Rac1 induces the formation of lamellipodia protrusions via activating WAVE 
complex, which provide the driving force for cell migration (Goc et al., 2012). Cdc42 has 
been proved to establish polarity, and inhibition of Cdc42 results in disrupting the 
directional migration (Rajnicek et al., 2007b). On the other hand, RhoA induces the 
contraction of actin filaments to generate contractile force. The RhoA is activated not 
only at the rear of the migrating cells but also at the front, indicating that it may contact 
with Rac1 and Cdc42 to generate membrane ruffles (Tsai et al., 2012). 
Several growth factors have been found to modulate fibroblast migration and 
proliferation during wound healing. Schreier studied the role of bFGF in migration and 
proliferation of fibroblasts in an in vitro model of wound healing (Schreier et al., 1993). 
Chiang reported that PDGF-BB induced human skin fibroblast migration on gelatin and 
collagen through activation of ERK1/2, p38 and JNK signalling pathways, which could 
be inhibited by lycopene (Chiang et al., 2007). 
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Fibroblast dysfunctions, such as loss of response to growth factor (Agren et al., 1999), 
impaired reorganization of extracellular matrix (Cook et al., 2000), decreased expression 
of growth factors (Cha et al., 2008b) and gene expression variation (Wall et al., 2008), all 
play a pivot role in the initiation and development of chronic wounds. Further 
investigation in fibroblast biology, including activity recovery or rectifying impaired 
ability of sensing mechanisms to signals may be a potential solution for chronic wound 
cure. 
5.1.4 Electric field and cell migration 
McCaig and colleagues systematically documented the interactions between Trans-
epithelium potential difference (TEPD), electric signals and cell migration in both 
physiological and pathological conditions. In physiological condition, TEPD is 
established across epithelium barrier, by positively generating the efflux of chloride and 
influx of sodium / potassium, and maintained by the tight junctions between the cells In 
pathological condition where the epithelium barrier is disrupted, TEPD is short circuited 
due to the breach of cell-cell tight junctions, thereby instantly generating endogenous 
electric fields (EFs) (McCaig et al., 2002, 2005; Song et al., 2004). This consequently 
increases the epithelial cell motility and guides them to migrate directionally toward 
wound centre, thus improve wound healing efficiency (Reid et al., 2005; Wang et al., 
2000; Zhao et al., 1999). Wound healing process could potentially be obstructed by either 
blockage of endogenous EFs generation or impaired sensing mechanism of cells to EFs 
(McCaig et al., 2005; Song et al., 2002; Zhao et al., 2006). 
The cytokine receptors have been considered to play a role in EF-induced cell 
migration during the wound healing. It has been demonstrated that EFs can increase 
EGFRs expression, and inhibition of MAPK – one of the downstream messenger engaged 
by EGFR, significantly impairs the response of CECs to EFs (Zhao et al., 1999). In 
addition, Zhao proposed that EF-polarized EGF receptors caused asymmetric signalling 
through MAP kinase, which drove directional cell migration in CECs (Zhao et al., 2002b). 
This however is a cell type dependent event, it has been reported that the sensing and 
transduction of the electric signals are largely independent of G protein-coupled receptor 
signalling in dictyostelium (Zhao et al., 2002a). 
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Except growth factor receptors, MAPK signalling pathway has been proved is 
essential for EF-induced cell migration; PI3K-PTEN is another signalling pathway which 
has been demonstrated to play an important role in electrotaxis. Zhao reported that EFs 
triggered activation of Src and inositol-phospholipid signalling, which were polarized to 
assist the directional cell migration. The genetic disruption of PI3K decreased the EF-
induced signalling and abolished the directed movements of healing epithelium in 
response to electric signals. In addition, deletion of the PTEN enhanced signalling and 
electrotactic responses. This observation has been proved in several different cell types 
such as: neutrophils, fibroblasts, keratinocytes, indicating it is conservative for cells to 
response to EF stimulation. 
However the interactions between PDGF and EFs during wound process are barely 
studied. In this study I comparatively investigate the sensitivity and response of three 
fibroblast cell lines: chronic wound fibroblast (CWF), chronic matched fibroblast (CMF) 
from the intact skin of the same patient, age-matched healthy fibroblast (HF) from 
healthy donor, to applied EFs. I evaluated the PDGF treatment to CWF and CMF in 
response to EFs by directly monitoring the migratory behaviours from both single cell 
and scratched wound. Moreover, by pharmacological inhibition experiments, I analyzed 
the molecular pathway of the high concentration PDGF-induced defect of fibroblast to 
EFs. Our results show that PDGF in optimized concentration could restore CWF’s 
response to EFs, which may be potentially beneficial for clinic application. 
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5.2 Results 
In this chapter three fibroblast cell lines were used: chronic wound fibroblast (CWF) 
from the patient, chronic matched fibroblast (CMF) from the intact skin of the same 
patient, age-matched healthy fibroblast (HF) from healthy donor. Cell migration 
behaviours were assessed in the presence of different guidance cues, including EFs, 
PDGF and PI3K inhibitors, and small GTPases inhibitors. The assessments were mainly 
carried out in the following aspects: 
1. Comparative studies of the responses of three cell lines to EF stimulation. 
2. Comparative studies of the responses of three cell lines exposed to EF and PDGF. 
3. The effects of PDGFR inhibitor, PI3K inhibitor and small GTPase inhibitors on 
EF-induced cell migration. 
This allows us to compare and contrast the signalling cascades activated by each 
guidance cue, and to optimise current PDGF treatment on chronic wound healing 
potentially in conjunction with EF stimulation. 
5.2.1 CWF, CMF and HF behavior in EFs 
EF plays an overriding guidance role in directing epithelial cells migration and 
accelerating wound healing in vitro (Wang et al., 2000; Zhao et al., 1999; Zhao et al., 
2006) or in vivo (Song et al., 2002). Here I utilized a custom-designed chamber (Song et 
al., 2007b) under a time-lapse microscope to investigate the response of different 
fibroblast cells in the EFs gradient (Figure 5-1). 
On application of EFs from 70 mV/mm to 300 mV/mm to the culture of CWF, 
CMF and HF, the motility of all cells was raised prominently in a dose-dependent pattern 
(Figure 5-1A). In the physiological EFs of 150 mV/mm, the motility of CWF, CMF and 
HF cells was lifted up 11.46%, 12.57% and 13.44% respectively. Additionally, in an even 
higher EFs strength as 300 mV/mm, CWF motility reached 0.20 m/min, which was 
13.50 % faster than the migration in no-EF group; HF and CMF were up to 0.23 and 0.25 
μm/min, respectively. Moreover, CWF cells showed a significant defect in responding to 
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EFs from 150 mV/mm (p<0.05) compare with CMF and HF cells. It is noticeable that at 
70 mV/mm EF stimulation, three cell lines did not show any significant difference 
regarding migration speed (Figure 5-1 D). 
The migration directedness also can be analysed using the software. Figure 5-1(B) 
shows that EFs induced cells migration to anode (toward EF vector). Similar to motility 
response, EFs-induced directedness presented a dose-dependent manner. However, CWF 
cells showed a significant electrotactic defect from 150 mV/mm in directedness (P<0.05) 
compare with CMF and HF cells. Nevertheless, there was no obvious difference between 
CMF and HF cells in either EF stimulation or no EF situation. I took the velocity 
component on EF vector orientation as efficient migration intent to focusing on the 
effects by EFs. In this evaluation system (Figure 5-1 C), CWF cells showed significantly 
reduced migration efficiency from 150 mV/mm onwards comparing with both CMF and 
HF cells, which implicated fibroblast’s defect of sensitivity / response to EF might be one 
of the important factors for the sustention of chronic wound. Considering CMF did not 
show any difference in phenotype, migration speed and directedness to EF compared to 
HF, I took CMF cells as the control in the following experiments. 
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5.2.2 PI3K is involved in EF-induced directional migration 
Zhao and colleagues found PI3K and PTEN are essential in controlling EF-induced 
cell migration and wound healing, and that PI3K and Src signals are asymmetrically 
activated at the leading edge of cells (Zhao et al., 2006). The CWF and CMF cells were 
cultured following standard protocol, treated with PI3K inhibitor LY294002 (50 μM) and 
exposed to EFs for 2 hours. I fixed the cells at the end of EF stimulation, and then stained 
with rhodaminephalloidin and an anti-PIP3 antibody to visualize the distribution of actin 
and PIP3, respectively (Figure 5-2). 
Pharmacological inhibition of PI3K with LY204002, triggered a significant reduction 
of both migration speed and directedness of CWF. The CMF also showed similar trend of 
reduction when treated with LY294002 (Figure 5-2A,B). In each condition, there was no 
significant difference between CMF and CWF indicating the reduction was at the same 
magnitude. This also implied that the PI3K is equally important for both type of cells in 
the regulation of their responses to EFs. 
Immunostaining (Figure 5-2 C) depicts that PIP3 was asymmetrically redistributed at 
leading edge of electrotaxis cells. In comparison, in the absence of EFs most cells did not 
show asymmetry of PIP3 distribution. The fluorescence intensity profile showed 
Figure 5-1Human Chronic Wound Fibroblasts (CWF) lost sensitivity to EFs, 
(A) CWF, CMF and HF were plated in the home-made EF chamber in the presence or 
absence of 150 mV/mm, and cell migration were real-timely recorded for 2 hours; see 
Materials and Methods. Representative images of CWF, CMF and HF with or without 
EFs are shown, bar =20 μm. The cells were tracked by Image J software; the arrows 
indicate the direction of cell migration. Trajectories of CWF, CMF and HF cells with 
or without EF stimulation over 2 hours with the starting points positioned at the origin. 
x and y-axes give distance in μm. With the EF-treated cells, the EF vector is horizontal 
with anode to the left and cathode to the right. (B-C) CWF, CMF and HF were treated 
with EFs from 0 mV/mm to 300 mV/mm and the migration were analyzed by Image J 
software. The Directedness (B) and migration speed (D) are shown. (C) Efficient 
migration of CWF, CMF and HF were calculated to indicate how fast the cells migrate 
along the EFs direction according to the formula see Materials and Methods. Results 
are presented as Mean±SD (*: P<0.05.CWF vs. CMF). 
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consistent result that PIP3 distribution accumulated at anode-facing side of the cells and 
the fluorescence intensity was about 3 times higher than opposite site of the cells (Figure 
5-2 E). On the contrary, fluorescence density of PIP3 was evenly distributed across the 
cells with no EF treatment (Figure 5-2 D) 
In summary, the reduced electrotactic response when blocking PI3K, and the 
asymmetric distribution of PIP3 by EFs, coherently suggest that EF-induced fibroblast 
directional migration could be dependent on the PI3K signalling cascade, and this may be 
modulated by the polarization of PIP3, an immediately downstream effectors of PI3K.  
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Figure 5-2PI3K is involved in EF-induced directional migration of human 
dermal fibroblasts 
(A-B) CWF and CMF were EFs (150 mV/mm) stimulated with or without 
the presence of 20 μM LY, and cells migration were recorded. Directedness (A) 
and migration speed (B) were depicted. (C) After EFs stimulation, CWF and CMF 
were fixed and stained with Actin and PIP3 antibodies. The representative 
immunostaining of CWF is shown, Bar = 20 μm, + and – indicate anode and 
cathode respectively. (D-E) Line profile (white dot line) of fluorescence intensity 
of CWF without and with EFs (150 mV/mm) treatment are depicted in (D) and 
(E) respectively. #,*: P<0.05.Results are presented as Mean ±SD.  
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Figure 5-3 PDGFRs expression with/without EFs 
CWF and CMF were EFs (150 mV/mm) treated for 4 hours and mRNA level of 
PDGFRα and β were quantified. Results are presented as Mean ±SD. (*P<0.05 
compared, n=4). 
5.2.3 PDGFR-β is upregulated by EFs 
The deficit of PDGF was found in chronic wound. Thus the expression levels of 
PDGFR-α and PDGFR-β in non-EF treated/ EF-treated CWF and CMF were investigated 
using TaqMan qPCR. The cells were exposed with 150 mV/mm for 4 hours and then total 
mRNA was extracted for PCR reaction (Figure 5-3).  
PDGFR-α was found to mediate 3T3 fibroblast migration stimulated via the Na+/H+ 
exchanger (Schneider et al., 2009). Our results indicated that there was no change of 
PDGFR-α expression between CWF and CMF in the absence of EFs; and EF stimulation 
did not change these neither on both cell types. Gao suggested that deletion of the 
PDGFR-β gene affects key fibroblast functions in wound healing (Gao et al., 2005). I 
found no difference between CMF and CWF regarding PDGFR-β expression in original 
situation. However, it was upregulated significantly by EFs stimulation in both cell types 
(Figure 5-3). 
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5.2.4 EF induced anodal migration is via polarization of p-PDGFR 
To investigate if PDGF receptor is involved in signal transduction during 
electrotaxis, CMF and CWF were pre-treated with PDGF receptor tyrosine kinase blocker 
Tyrphostin AG1296 30 minutes before EF stimulation (Figure 5-4). The cell migration 
speed and directedness were analysed by time-lapse tracking cell movement. The cells 
then were fixed at the end of EF stimulation, sequentially stained with rhodamin-
phalloidin and an anti-p-PDGFR antibody, and finally the distribution of actin and p-
PDGFR were visualized under the fluorescence microscope. 
With the treatment of tyrphostin (10µM), the migration directedness of CMF and 
CWF declined significantly, with the directedness reduced from -0.76 and -0.63 down to 
-0.51 and -0.44, respectively (Figure 5-4, A). However, the migration speed did not 
changed with the treatment in both cell types (Figure 5-4, B). 
Representative microscopic photos of CWF with PIP3 and p-PDGFR-β staining 
are presented, respectively in Figure 5-4C. The p-PDGFR-β was activated and polarized 
to the anterior lamellipodia of the electrotaxis cell toward anode (arrow). Similarly, the 
PIP3 was also accumulated at the anodal facing lamellipodia (arrow in C). On the 
contrary, both p-PDGFR-β and PIP3 were evenly distributed across the cell membrane in 
the absence of EFs. The colocalization of PIP3 and p-PDGFR were then calculated as the 
intensity correlation similarly as described in the previous study. The intensity correlation 
indicates the degree of colocalization of signalling molecules. CWF showed significantly 
increased intensity correlation of p-PDGFR-β and PIP3 when exposed to EF in 
comparison with no EF treated cells (Figure 5-4, D). 
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Figure 5-4PDGFR is required for EF-induced directional migration of 
human dermal fibroblasts. 
(A-B) CWF and CMF were EFs (150 mV/mm) treated with or without the 
presence of 10 μM tyrphostin; Directedness (A) and migration speed (B) were 
depicted. (C) After EFs stimulation, CWF and CMF were fixed and stained with 
p-PDFGRβ and PIP3 antibodies. The representative immunostaining of CWF is 
shown, Bar = 20 μm, + and – indicate anode and cathode; #, *:P<0.05,Results are 
presented as Mean ±SD; n=80-100. (D) The colocalization of p-PDGFR and PIP3 
were analyzed by using Image J. Rectangle area indicates ROI used in software, 
arrow indicates p-PDGFR and PIP3 colocalized at leading edge of the cells treated 
with EFs. *: P<0.05.Results are presented as Mean ±SD; n=35 (no EF), n= 41 
(EF). 
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5.2.5 PDGF raises motility but attenuates directedness of fibroblast in EFs 
Previous studies show that PDGF-BB has prominent ability to promote wound repair 
(Pierce et al., 1994; Robson, 1997; Robson et al., 1992) and recapitulate the activity of 
human serum in human dermal fibroblast migration assay (Li et al., 2004b). In light of 
these studies, I hypothesize that PDGF-BB may restore the sensitivity of CWF to EFs 
thus improve chronic wound healing. Both CWF and CMF were titrated with PDGF from 
0 to 40 ng/ml in the presence of 150 mV/mm EFs. The effects of these two guidance cues 
on CWF and CMF were assessed. The curves of migration speed and directedness vs. 
PDGF concentration were drawn, respectively. 
Since the expression of PDGFR-β was increased by EFs (Figure 5-3), I anticipated 
that PDGF-BB might potentially restore CWF’s sensitivity to EFs. Surprisingly, PDGF-
BB treatment significantly decreased the migration directedness of both CWF and CMF 
when treated with 150 mV/mm EF, in a dose-dependent manner (Figure 5-5, A). 
Coincidently, the directedness of both cell types dropped to about -0.3 indicating random 
movements when the concentration of PDGF-BB was greater than 10 ng/ml. 
 On the contrary, both CWF and CMF were very sensitive to PDGF-BB regarding 
cells migration speed (Figure 5-5, B). Even at the lowest concentration of 0.1 ng/ml 
(~>10 times endogenous concentration (Rollman et al., 2003)), the migration speed of 
CWF and CMF were raised from 0.155 to 0.21 μm/min and 0.19 to 0.27 μm/min, 
respectively. Furthermore, the migration speed of both cell types was increased to the 
maximum value (~ 4 times higher than control) with 10 ng/ml PDGF-BB, and started to 
declined when PDGF was more than 20 ng/ml. The efficient migration (Figure 5-5, B) of 
cells were calculated according to formula in Chapter 2 to indicate the cell migration 
ability in EF vector. Figure 5-5C illustrates that both CWF and CMF display a bell-
shaped curve against PDGF titration. The CMF reached maximum efficient migration to 
0.21 μm/min when treated with 0.5 ng/ml PDGF, whereas CWF reached maximum 
efficient migration of 0.17 μm/min with 5 ng/ml PDGF. This implies that 5 ng/ml PDGF 
treatment could restore the defect of CWF electrotaxis back to the same level as CMF 
without PDGF treatment. If electrotactic deficit of CWF in response to endogenous 
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wound current is one of the factors causing wound healing defect, PDGF treatment can 
potentially help CWF with the restoration of electrotactic response during wound healing.  
Representative migration trajectories of CWF cells are superimposed to illustrate the 
migration pattern of 3 groups: CWF with EFs, CWF+EFs+PDGF (1.0 ng/ml), 
CWF+EFs+PDGF (10 ng/ml), respectively (Figure 5-5, D-F).  With EFs, the migration 
pattern is clearly biased toward left (anode), whereas PDGF treatments gradually change 
the pattern to radial distribution indicating a random migration. 
* 
* 
* * 
* 
* 
* 
* 
* 
* 
* 
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Figure 5-5PDGF negatively regulated sensitivity of human dermal fibroblast 
in response to EFs. 
(A-C) CWF and CMF were treated with both EF (150 mV/mm) and PDGF (X 
axis: 0-40 ng/ml), and cell migration was recorded and analyzed.  Directedness 
(A), migration speed (B) and efficient migration (C) of CWF and CMF were 
drawn against PDGF-BB concentration; details see Materials and Methods. 
*p<0.05, Results are Mean ±SD; n=80-100. (D-F)  Representative migration 
trajectories of 3 experimental groups over the 2 hours recording period: 
CWF+EF, CWF+EF+PDGF (1.0 ng/ml), CWF+EF+PDGF (10 ng/ml), 
respectively; see Materials and Methods. X and Y axes give distance in μm. The 
EF vector is horizontal with anode to the left and cathode to the right. 
 
5.2.6 PDGF reduces EF-induced directedness through ROCK 
To investigate the mechanism why PDGF compromises EF-induced directedness, 
inhibitors were used to screen the potential signalling pathway involved (Figure 5-6). The 
CMF and CWF were exposed with 150 mV/mm EFs plus 1.0 ng/ml PDGF and inhibitors 
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then were added to test if the migration directedness would be restored. The inhibitors 
used were tyrphostin, Y-27632 and LY294002 to block PDGFR, ROCK and PI3K, 
respectively.  
Figure 5-6 (A) illustrates that both tyrphostin and Y-27632 restore the directedness of 
CWF and CMF. The directedness of CMF increased from -0.43 up to -0.77, whilst CWF 
from -0.41 to -0.62 by tyrphostin. Similarly, Y-27632 lifted the directedness of CMF and 
CWF up to 0.63 and 0.56 respectively. However, LY294002 the PI3K inhibitor did not 
alter the directedness of either CWF or CMF. These findings imply that PDGF changes 
persistence of migration of fibroblasts by PDGFR-ROCK rather than PI3K signalling 
pathway. 
Furthermore, all three inhibitors uniformly reduced PDGF+EF induced migration 
speed of both CWF and CMF cells (Figure 5-6, B). This suggests that PDGFR, PI3K and 
ROCK may all be involved in controlling fibroblasts motility induced by EF plus PDGF. 
The cells migration trajectories were tracked after various treatments (Figure 5-6, C 
and supplemental movies).The representative photos of CWF depict the cell behaviours 
under PDGF, EF and three inhibitors, respectively. 
159 
 
 
Figure 5-6PDGF moderates human dermal fibroblasts sensitivity to EFs via 
PDGFR-ROCK pathway 
(A-B) Both CWF and CMF were pretreated with PDGF (1.0 ng/ml) for 30 
minutes before co-stimulated with EF (150 mV/mm) and typhostin (10 μM), or  
LY294002 (20 μM), or Y-27632 (10 μM), respectively. The directedness (A) and 
migration speed (B) of CWF and CMF were summarized. Values plotted are the 
Mean ± SD,*: P<0.05; n=120-150. (C) Representative images of CWF with EF 
and PDGF as the control and plus treatment of Tryphostin, or LY or Y-27632, 
respectively are shown, bar=20 μm, arrows indicate the direction of cell 
migration. 
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5.2.7 Optimized treatment of PDGF and EFs enhanced chronic wound healing 
To investigate whether combination of PDGF and EF could enhance chronic wound 
healing, the scratch wound assay of CWF and CMF under EFs, PDGF or EFs plus PDGF 
were carried out, respectively. The CWF and CMF were seeded into the chamber, until 
the cells became monolayer; the yellow tip was used to scratch across the monolayer to 
create artificial wounds. The wounds then rinsed and kept into fresh medium for 30 
minutes before the treatments. Fibroblasts migrate into scraped space may be affected by 
two factors: migration and proliferation. PDGF was demonstrated as a strong mitogen for 
inducing dermal fibroblast proliferation after longer treatment, usually more than 24 
hours (Agren et al., 1999). Therefore the whole treatments lasted 6 hours and the cell 
migration and wound closure process were recorded (Figure 5-7). 
When treated with either PDGF-BB (5 ng/ml to CWF; 0.5 ng/ml to CMF), EFs (150 
mV/mm) or both, the marked migratory responses of CWF and CMF were observed. 
Additionally, PDGF plus EFs showed a synergistic effect on promoting wound closure 
(Figure 5-7, A and supplemental movies). The column graph (Figure 5-7 B) illustrates the 
wound closure distances in different treatments. All treatments show significant increase 
in the closure distance comparing to control. To quantitatively evaluate the treatments on 
chronic wound healing, the ratio of closure distance between CWF and CMF was 
calculated (Figure 5-7B, line). The PDGF plus EF treatment raised ratio to about 90% 
from less than 70% in control group, which demonstrated the combined treatment could 
effectively recovered chronic wound healing by restoring the migration ability of CWF. 
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Figure 5-7EFs and optimized concentration of PDGF synergistically 
enhanced chronic wound healing 
(A) Monolayer CWF and CMF were gently scratched by yellow tip and treated 
with EFs (150 mV/mm), or PDGF-BB (5 ng/ml to CWF; 0.5ng/ml to CMF), or 
EFs (150 mV/mm) + PDGF-BB (5 ng/ml to CWF; 0.5 ng/ml to CMF), for 6 
hours. (B) The scratch closure distance were measured by image J software and 
summarized referring to left Y axis; the migration ratio, were refer to the right Y 
axis, calculation formula see Material and Methods. Data are presented as the 
Mean ± SD. 
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5.3 Discussion 
In this chapter the chronic wound fibroblasts migration in EFs, PDGF, and PDGF plus 
EFs is investigated. It is shown that: 1). CWF lost sensitivity to EFs in comparison with 
CMF; 2). the migration speed of CWF can be enhanced significantly with EFs greater 
than 150 mV/mm; 3). PDGF treatment attenuates EF-induced directedness of CWF and 
CMF via PDGFR-ROCK signalling pathway; 4). the combination of PDGF with 
optimised concentration and EFs can enhance chronic wound healing.  
5.3.1 The comparative study of CWF, CMF and HF in EFs 
The dermal fibroblasts are the major force to draw the wound bed closure and also 
contribute to the synthesis, bundling, and alignment of the collagen fibres (Shaw and 
Martin, 2009). The impaired ability of repopulation and cytokines secretion of fibroblast 
was the key factors to chronic venous ulcers (Wall et al., 2008). I found that although 
CWF still show directional migration under EFs exposure in a dose-dependent manner; it 
showed impaired responses including migration speed and directedness compared to 
CMF and HF under the same EFs treatment. Endogenous EFs induced by wounds have 
been proved to play an overriding role in promoting directional migration of various cells 
(Zhao, 2009). Zhao and colleagues identified the first genes – PI3K/PTEN which 
modulates directional cell migration in response to electric currents (Zhao et al., 2006). 
Guo found that the human dermal Fibroblasts also showed responses to EFs stimulation 
and migrated to anode. Additionally, the dermal fibroblast of p110γ gene knock-out 
mouse, with inhibited PI3K activity, exhibit significantly reduced electrotaxis (Guo et al., 
2010). 
5.3.2 The PDGFR-PI3K pathway mediates the EF-induced directional migration 
of CWF and CMF 
PI3K signalling pathway was investigated to check if it was the reason of defective 
response of CWF to EFs. In agreement with previous discoveries, our finding revealed 
that PI3K inhibition reduced the response of both fibroblast cell types to EFs. Moreover I 
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also identified that PIP3 – the immediate downstream effector of PI3K was polarized at 
anode-facing side of the fibroblast. In neutrophil, PIP3 induced development of polarity 
and accumulation of F-actin in the leading lamellae thus forge directional migration 
(Niggli, 2000).  
On the other hand these also imply that PI3K may not be the main driving force leads 
to the phenotypic difference between CWF and CMF. Jiang reported that PI3K inhibition 
similarly blocked the chronic wound keratinocytes and healthy keratinocytes migration, 
suggesting this pathway is central for the migration but not specific to the chronic wound 
(Jiang et al., 2010). 
Most growth factors have been characterized by their capacity to play a role in wound 
healing due to their mitosis function (Oliva et al., 2012). Antoniades found that the 
controlled, reversible expression of PDGF and its receptor induced by injury may 
function in an autocrine/paracrine manner on both epithelial cells and fibroblasts to bring 
about their sustained proliferation during the normal healing process (Antoniades et al., 
1991). It also has been suggested the possibility that a defect in PDGFR may be 
associated with chronic wound healing. 
However, I found there was no significant difference of PDGFR-α and PDGFR-β 
expression between CWF and CMF. Cook proposed that impaired matrix 
metalloproteinase-1 and matrix metalloproteinase-2 led to the defective function of CWF 
(Cook et al., 2000). Seah found that the inhibition of Ras activity partially resulted in the 
phenotype of CWF (Seah et al., 2005). Interestingly, I observed that PDGFR-β 
expression were upregulated by EF stimulation. Contrarily, EF stimulation did not 
significant change PDGFR-α expression on both CWF and CMF. Similarly, EGFR was 
demonstrated to be upregulated by EF stimulation by CECs (Zhao et al., 1999). On the 
other hand, Wu and Lin also suggested that the response to EF stimulation is cell type 
specific, EF stimulation would lead to specific gene expression (Wu and Lin, 2011). 
It has been demonstrated that on application of EFs, the MAPK and/or PI3K pathways 
are activated to produce directional cell migration (Wang et al., 2003; Zhao et al., 1999). 
The PDGFR is suggested to be upstream of MAPK and PI3K during the cell migration 
(Choudhury et al., 1997). In our study, inhibition of PDGFR phosphorylation depressed 
EF-induced directional migration on both CWF and CMF, indicating the activation of 
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PDGFR was required for EF-induced cell migration. However, the phosphorylation 
inhibition did not significantly alter the migration speed of both cell types. The inhibitor 
AG1296 is a very specific tyrosine kinase inhibitor and it can selectively and potently 
inhibited autophosphorylation of PDGFR-β (Kovalenko et al., 1997; Tse et al., 2001). 
Moreover, it has been demonstrated that inhibition of PDGFR tyrosine kinase inhibits 
vascular smooth muscle cell migration (Myllarniemi et al., 1997). Therefore, the 
inhibition of PDGFR phosphorylation did not attenuate EF-induced cell migration, may 
be due to the multifunction of EF-induced effects. The blockage of PDGFR pathway may 
be compensated by other EF-activated pathways, such as ERK1/2. Furthermore, it has 
been implicated that the directedness is mainly controlled by persistence of cell polarity 
and the motility is mainly associated with the rate of assembly and disassembly of actin 
(Glasgow and Daniele, 1994). The other possibility is that two hours EF stimulation 
experiment may not able to discriminate the migration speed with/without inhibitor in 
certain concentration. 
The result phosphorylation of PDGFR is redistributed facing anodal side by EF 
stimulation, which is in agreement with previous discoveries. Zhao reported that EGFR 
were polarized and accumulated to cathodal side of the cell by EF stimulation (Zhao et al., 
1999). Moreover I also identified that PIP3 the immediate downstream effector of PI3K 
was polarized at anode-facing side of the fibroblast. In neutrophil, PIP3 induced 
development of polarity and accumulation of F-actin in the leading lamellipodia therefore 
triggers directional migration (Niggli, 2000).   
In addition, for the first time our results reported that the colocalization of p-PDGFR 
and PIP3 was increased at anodal facing protrusion induced by EF stimulation, which 
suggests the regulation of fibroblasts directional migration. This is also consistent with 
the previous report that EGFR accumulation to the cathodal side of bovine corneal 
epithelial cells was induced by EF exposure (Zhao et al., 1999). Therefore the 
accumulation and redistribution of PIP3 may potentially control the persistence of 
migration in a coordinated manner in association with PDGFR. 
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5.3.3 PDGF attenuates EF-induced directedness via ROCK 
The functions of PDGF through PDGFR-PI3K pathway to mediate cytoskeleton 
dynamic and cell migration have been observed in several different cell types (Jimenez et 
al., 2000; Pukac et al., 1998). PDGF also has been widely used for treatment of chronic 
wound (Bennett and Schultz, 1993; Pierce et al., 1995). Unexpectedly I found PDGF 
negatively regulated fibroblasts migration directedness induced by EF stimulation.  
The electric signals controlled migration directedness is suggested to rely on the 
redistribution of membrane growth receptors which leads to polarized actin 
polymerization (Zhao, 2009; Zhao et al., 2006). PDGF has been demonstrated to induce 
actin stress fibre disassembly, and reduce focal adhesion complex, thus influence on 
protrusion and lamellipodium formation (Guan et al., 2009). In addition, it was 
previously reported that PI3Kwas essential for PDGF receptor-induced cytoskeletal 
changes and cell migration (Jimenez et al., 2000). Therefore, EFs and PDGF may 
competitively exert force on fibroblast to induce cell directional migration, because they 
potentially share the same signalling pathway. The competition induced by PDGF thus 
attenuates the influence by EFs. Even more, the EF-induced directional migration is build 
up by formation of leading edge and tail contraction, the addition of PDGF probably 
blocks the consistent head-tail establishment therefore results in random migration. 
To investigate which pathway PDGF uses to antagonise EFs, the inhibitors of PDGFR, 
PI3K and ROCK were screened. I showed that blockage of PDGFR and ROCK rescued 
EF-induced directedness, on the contrary LY294002, the inhibitor of PI3K did not. These 
results indicate that PDGF attenuate EF-induced directional migration through activation 
of PDGFR-ROCK pathway. It was previously reported that PDGF stimulated oral 
fibroblast contraction through Rho kinase and P38 signalling pathway in vitro (Watts and 
Rose, 2010). Additionally, Jackson found that ROCK mediated phosphorylation of 
myosin light chain which led to cell contraction (Jackson et al., 2011). This demonstrates 
that PDGF not only can activate actin dynamic through PI3K but also function on myosin 
contraction via ROCK. However, the EF-induced directedness is based on actin dynamic, 
thus the inhibition of PI3K cannot rescue the antagonist effect of PDGF. 
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5.3.4 Defective response of CWF to EFs 
The reason leading to chronic wound is still not yet very well understood. Phillips et al 
suggested that the microenvironment was the culprit. They reported that chronic wound 
fluid arrested new-born fibroblast growth by preventing the cell cycle (Phillips et al., 
1998). It has been demonstrated that reduced activity of TIMP-1, TIMP-2, and MMP-2 is 
associated with dysfunction of CWF (Cook et al., 2000). 
I explored for the first time the response of CWF to EF stimulation, and found CWF 
showed impaired responses including migration speed and directedness to EFs in 
comparison to CMF and HF. Sequentially, the EF-induced responses were titrated with 
PDGF from 0 to 40 ng/ml. The efficient migration was created by accumulating of the 
cell migration on EF vector to figure the best ratio of two cues: EF and PDGF in 
promoting chronic wound healing. I found that CWF required 5 ng/ml PDGF whereas 
CMF needed 0.5 ng/ml to achieve their best efficient migration in the presence of 150 
mV/mm EF. 
The result that CWF needs as much as 10 times PDGF to migrate similarly as CMF is 
in agreement with previous studies. It has been demonstrated that PDGF is defective in 
CWF and PDGF-BB treatment increases chronic wound healing (Pierce et al., 1995; 
Shukla et al., 1998). Moreover, PDGF-BB becomes the only growth factor approved by 
the FDA for daily application in treating wound healing (Goldman, 2004).  
5.3.5 Combined treatment of PDGF and EFs enhances chronic wound healing 
In scratch wound assay, I revealed that combined treatment of EFs plus PDGF 
significantly increased fibroblast cell migration. Additionally, the combined treatment 
recovered the migration capacity of CWF back to CMF during the wound healing. 
However, due to the effect that PDGF impairs EF-induced directedness in single cell 
level in vitro, there are two feasible solutions: 1). optimising PDGF concentration to 
achieve the best efficient migration; and 2). using oscillating EFs, which has been 
previously tested in spinal cord injury treatment (Borgens et al., 1981).   
In addition to the cytokine treatment, exogenously applied EFs have been shown as a 
promising treatment of chronic wounds (Guo et al., 2010). Considering that several other 
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growth factors (such as IGF, EGF and FGF) have been demonstrated to enhance wound 
healing, and the ligand and receptor reaction can be amplified by EF stimulation, it would 
be very useful to comprehensively test combination treatment with other growth factor 
and EFs. This new treatment would be potentially a practicable approach to enhance 
chronic wound healing in the future. 
5.4 Summary 
The data from this chapter can be summarized as following: 
 EFs induce human dermal fibroblast directional migration in a voltage 
dependent manner 
 CWF shows impaired sensitivity in response to EFs compared to CMF and HF 
 Activation of PDGFR and PI3K are both required for EF-induced directional 
migration 
 PDGF attenuates EF-induced migration directedness through PDGFR-ROCK 
other than PI3K pathway 
 Optimised concentration of PDGF plus physiological EFs enhance chronic 
wound healing 
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CHAPTER 6 CONCLUSIONS AND FUTURE EXPERIMENTS 
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6.1 Conclusions 
6.1.1 EFs promote dendritic cells (DCs) / Langerhans cells (LCs) migration in 
response to IL-18 
1. EFs promoted the responses of KG-1 cells to IL-18, leading to an increase of IFN-
γ expression in a dose-dependent manner. 
2. 3D chemotaxis of KG-1 cell, KG-1-derived DCs and primary cultured Langerhans 
cells in response to IL-18 was also enhanced by EF stimulation. 
3. The EF-induced activation of KG-1 cells was modulated through phosphorylation 
of P38 MAPK rather than up-regulation of IL18Rα expression. 
4. The EF-induced redistribution of IL18Rα colocalized with asymmetric assembly 
of actin, which led to directional migration of DCs. 
5. EFs and IL-18 synergistically induced LCs emigrate from epidermis ex vivo 
6. Both IL-18 and EFs induced LCs migration from epithelia to draining lymph node 
in vivo 
6.1.2 EFs and PDGF modulate cell migration in chronic wound  
1. CWF showed defective migration speed and directedness in EFs stimulation in 
comparison to CMF and HF. 
2. Fibroblasts directional migration was guided through PI3K signalling pathway. 
3. Excessive PDGF treatment impaired directedness of fibroblast migration induced 
by EFs via ROCK pathway. 
4. Optimised PDGF dosage and EFs synergistically promote chronic wound healing. 
6.2 General discussion and clinical applications 
6.2.1 Electric signals and immunomodulation 
DCs are the most potent antigen presenting cells and play a critical role in mediating 
immune response. Activation and maturation of DCs is induced by infectious agents and 
inflammatory products leading to increased expression of co-stimulatory MHC class II 
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molecules and cytokine products (Frick et al., 2010). Toll-like receptors (TLR) ligands 
and cytokines have been demonstrated to affect DCs maturation and migration. 
Particularly, the proinflammatory cytokines such as TNF-α, IL-6, IL-12, IL-1β and IL-18 
are essential for DC induced immune responses. 
IL-18 has been proved to be a multifunctional cytokine. It can induce several different 
cells including spleen cells and T cells to express IFN-γ (Okamura et al., 1998). In 
addition, it has been demonstrated that except for IFN-γ induction, IL-18 upregulates Fas 
ligand expression on NK cells and T cells thus resulting in apoptosis in activated 
lymphocytes during hepatic injury (Tsutsui et al., 1997). Moreover, IL-18 is required for 
initiating LCs migration in contact hypersensitivity (Nakano et al., 2003; Stoll et al., 1998; 
Wang et al., 2002). Those finding suggest that IL-18 play essential roles in various 
immunological events in physiological and pathological situation. 
In recent years, McCaig and colleagues systematically demonstrated and reviewed the 
important roles of EFs exerted on directional cell migration, cell division, gene 
expression, embryogenesis, nerve growth and wound healing both in vitro and in vivo 
(McCaig et al., 2002, 2005). In addition, there are emerging evidences supporting that 
EFs may also play an important role in immunomodulation . 
Firstly, it has been demonstrated that EFs regulate immune cells metabolism. 
Anticevich found that EFs treatment increased responsiveness of sensitized human 
bronchial tissue to neutrophil supernatant (Anticevich et al., 1996). A further study 
showed that low frequency EFs promoted neutrophil extension, metabolic resonance and 
DNA damage when phase-matched with metabolic oscillators in vitro (Kindzelskii and 
Petty, 2000). Furthermore, Yoshikawa, et al. reported low frequency electromagnetic 
field enhanced nitric oxide generation by neutrophils in vivo. Moreover, an EF was 
applied to macrophage cells led to enhance NAD(P)H amplitude, implying that EFs 
might influence macrophage metabolic signals (Adachi et al., 1999). 
Secondly, EFs are found to induce directional migration of immune cells. It has been 
demonstrated that neutrophils can be induced to migrate directionally towards cathode in 
an applied EF (McCaig et al., 2005; Zhao et al., 2006). Lin comparatively investigated 
electrotaxis and chemotaxis on human PBLs and found that, electrical stimulation 
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activates intracellular kinase signalling pathways in association with chemoattractant. 
Additionally, they also found motile cutaneous T cells actively migrate toward the 
cathode of an applied EF in vivo (Lin et al., 2008). Our results also suggest that EFs can 
promote the sensitization of several types of DCs in response to IL-18. These data 
indicate that EFs may play an essential role in regulating immune cell recruitment within 
tissues during inflammation and infection, which could mediate the process of immune 
response. 
Although, the molecular mechanism of how EFs regulate cell behaviours is still not 
clear, several models / theories have been reported. Ion channel clustering has been 
demonstrated to regulate EF-induced neutrophil polarization (Kindzelskii and Petty, 
2005). Moreover, Shanley reported that influx of extracellular Ca2
+
 is necessary for 
electrotaxis in Dictyostelium, which is different from those induced by cAMP and folic 
acid (Shanley et al., 2006). Another theory is that asymmetrical redistribution of cell 
surface receptors induced by EFs controls cell behaviours such as sensing 
chemoattractant gradient, directional migration, division (McCaig et al., 2002, 2005; 
McCaig and Zhao, 1997; Song et al., 2002). In addition, a recent study suggested EF-
induced cell polarization was modulated via intracellular pH and cell polarity inducing 
factors in multiple directions (Minc and Chang, 2010). 
 
6.2.2 Therapeutic applications of EFs  
One major clinical application of EFs is cancer treatment. Nishi reported that using 
pulsed electric field in combination with chemotherapeutic agents or genes achieved an 
efficient result as a clinical treatment of cutaneous tumours and head / neck cancers 
(Nishi et al., 1997)  In addition Plotnikov found that low EFs effectively enhanced 
chemotherapy for mouse metastatic prostate cancer (Plotnikov et al., 2006). Moreover, it 
has been demonstrated that EFs can induce human breast cancer cell directional 
migration, indicating electric signals are involved cancer metastasis (Pu et al., 2007). 
A recent study found application of short pulses of electric current immediately after 
an injection of a genetic vaccine significantly enhanced the transfection efficacy and the 
subsequent vaccine-specific immune responses (Brave et al., 2010). In agreement with 
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this finding, our study for the first time established a molecular basis of how EFs increase 
DCs activity in response to cytokines. These data shall shed light on novel adjuvant 
technology essential in the design / development of high efficiency vaccination. 
Moreover, EF-induced directional migration of DCs also can be used for target-specific 
and precisely controlled cancer therapy. 
6.2.3 EFs and wound healing 
The wound repair is one of the most complex biological process involving not only 
biological guidance cues but also non-biological factors to accomplish the wound closure. 
In general, the wound healing process occurs in almost all types of tissue damage / 
disruption. A huge clinical burden in treating wound healing resulted from inefficient 
handling and treatment due to long and comprehensive process and multiple factors, 
especially when dealing with non-healing chronic wound.  
It has been demonstrated that EFs almost take part in all stages of wound repair. Song 
et al reported that increasing trans corneal potential difference (TCPD) enhanced cornea 
wound healing and decreasing TCPD prolong the wound healing in vivo (Song et al., 
2002). In addition, wound-generated EFs regulated epithelial cell proliferation during 
wound healing (Song et al., 2002). Moreover, it has been demonstrated that EFs can 
induce fibroblast directional migration via PI3K signalling pathway (Guo et al., 2010). 
The membrane growth factor receptors redistribution and Golgi apparatus polarization 
have been thought to be the molecular basis of EF-induced directional migration (Pu et 
al., 2007; Pu and Zhao, 2005; Zhao et al., 2002b). 
6.2.4 Application of EFs in wound healing treatment 
Clinically, application of EFs is a new and challenging avenue to pursue better wound 
healing and regeneration. Adams et al. reported that using pharmacological manipulation 
to activate ion transportation thus speed up wound healing (Adams et al., 2007). Because 
of the intrinsic signalling system of cells to EFs, application of “therapeutic” current for 
wound healing is expected to have positive effects as well (Zhao, 2009). While numerous 
clinical trial have been done and some with very promising results, one device (the 
173 
 
Staodyn Dermapulse) has undergone controlled animal and human test (Gentzkow and 
Miller, 1991), and an application requesting approval for treating dermal ulcers has been 
submitted to FDA. 
Our results, apart from elaborating the molecular mechanism of EF-induced 
fibroblasts directional migration, also raise the possibility that the deficient response to 
physiological EF may contribute at least in part to the slow healing / non-healing of 
chronic wound. Given the fact that cytokine treatment is prevailing in clinical treatment 
of chronic wound, and that endogenous EFs regulate directional cell migration during 
wound healing, our rather surprising finding that over dose of PDGF would attenuate 
electrotactic response of fibroblasts, indicates a clear warning that we must be cautious 
with the strategy of using cytokines in the clinical treatment of chronic wound. Moreover, 
the optimised concentration of PDGF combined with EFs also achieved better wound 
healing efficiency, which may shed light on a comprehensive treatment of chronic wound 
combing cytokines, electrical signals and other factors. 
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6.3 Future experiments 
6.3.1 EF’s function in immunomodulation 
Although, I has  found that EF can modulate DCs sensitization in response to IL-18, 
there still are some gaps to be filled in order to achieve definitive and convincing 
conclusion. 
Firstly, a loss-of-function analysis with either IL18R inhibition or IL18R receptor 
deficiency would be a valuable evidence to verify the conclusion retrorsely. 
Secondly, the study is lack of firm and deliberate proof for the EF-induced signalling 
cascade downstream of IL18Rs. A screening of potential downstream effectors should be 
conducted to measure the alteration of other signalling pathways parallel to P38 MAPK, 
such as Erk1/2, JNK. 
Thirdly, an in vivo experiment to investigate if pharmacologically enhanced TEPD 
plus IL-18 treatment could change LCs migration from skin to draining lymph node will 
be a strong evidence for the regulating effects of EFs on LCs. 
Fourthly, application of electrical stimulation locally on the mouse skin would 
eliminate the pharmacological effects brought by chemicals and provide a definitive 
answer to the EF stimulation effects. 
Fifthly, transgenic mice will always be useful to support and verify the hypothesis; 
therefore further confirmation on IL18R knockout mice would significantly facilitate the 
reliability of the study. 
6.3.2 EFs Application on chronic wound 
To further prove the discovery and conclusions that CWF is lack of response to EFs 
and PDGF impairs fibroblast response to EF stimulation, the following experiments 
would be beneficial.  
Firstly, direct measurement of wound-induced EFs on chronic wound can further 
confirm whether the wound healing defect in chronic wound was due to the defect of the 
CWFs to sense the wound EFs, or the lack of wound EFs.  
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Secondly, because Rho GTPases interact with each other closely, it would be 
necessary to test if Cdc42, Rac are involved in the PDGF-induced random migration 
when EF is present. 
Thirdly, RhoA downstream effector myosin controls cell contraction, thus the study of 
the relation between EF-induced motility and myosin controlled contraction should 
provide a distinctive explanation of PDGF’s function in electrotaxis. 
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